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Abstract 
Assessing the quality of health services remains a major challenge for the less 
industrialized nations of the world. Hospitals consume high proportions of national 
health budgets but approaches to examining their capacities and performance are still 
rudimentary. Better assessment strategies are essential for understanding what 
investments in hospital care and health systems are achieving and whether resources are 
being equitably distributed. Assessing hospital care for children is a particular challenge 
given the multiplicity of steps to be correctly undertaken in examining patients, 
diagnosing disease and giving appropriate treatment. 
This thesis describes the development of a measure of quality of care for children 
admitted to hospital, which can be routinely deployed to form part of future nation-wide 
health system assessments. The measure is based on standards of paediatric care 
described by national clinical practice guidelines for Kenya adapted from WHO 
guidelines. It is constructed using data from a trial of a new intervention to improve 
quality of care in first-level referral hospitals in Kenya. The proposed measure is 
subsequently validated using data from observations of routine hospital care for children 
admitted to a different set of hospitals over a period not covered by the primary data. 
A number of statistical techniques are used in this regard: these include factor analysis 
to explore the dimensions of process of care, logistic regression to study the association 
between the new measure and mortality, and multilevel modelling to explore the 
amount of variability in the data lost through modification of the structure of the 
measure. These analyses show that the items making up the measure are consistent with 
three conceptual domains of clinical process described in guidelines. They also provide 
evidence that the measure is associated with other exposures and outcomes in ways that 
strengthen its validity and suitability of purpose. Specifically, there is strong evidence 
that adherence to each of six generic recommendations of how care should be provided 
is associated with a reduction in odds of death by a fifth. This thesis thus demonstrates 
the usefulness of a generic approach to measuring quality of care, and highlights key 
issues to be addressed when extending this approach to other settings. 
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Chapter 1 – Introduction and a Review of Literature 
1.1. The concept of quality in health care 
Measuring quality of health care is an important aspect of any health system since it 
provides the information necessary to monitor and improve service delivery. However 
quality measurement is not straight-forward because healthcare is complex and quality 
of care is a difficult-to-define concept [Marcinowicz et al. 2009, Chanthong et al. 2009, 
De Maeseneer & De Sutter 2004]. It is known that different aspects of care contribute to 
its overall quality, and for this reason it is important to deconstruct ‘quality’ to allow for 
a clearer understanding. The most commonly discussed framework for measuring 
quality was proposed by Avedis Donabedian when he described three attributes of 
quality of care namely structures, processes and outcomes [Donabedian 1988].  
Structures are the resources that support the delivery of health services, including health 
workers, medical devices and equipment, infrastructure and drugs. Processes refer to 
what is actually done by health workers in providing care, such as taking clinical 
history, performing physical examination, making a diagnosis supported by clinical 
evidence and history, and charting an appropriate course of treatment to restore health. 
Outcomes are the consequences of care, such as death, recovery, satisfaction with care 
received and duration of hospital stay. Good outcomes are ultimately what is always 
sought in healthcare so good quality of care can be conceptualised as the route to 
achieving them. The relevance of outcomes to overall quality of care is generally clear 
and acceptable to providers and users of health care services and is thus rarely 
questioned [Donabedian 2005].   
Assessments of structure make for sensible measures of quality because it is assumed 
that without the appropriate necessary resources favourable outcomes cannot be 
achieved. This is highlighted in low-income countries where insufficiently funded and 
overstrained health systems often suffer serious resource constraints which tend to 
adversely affect the provision of good care [Linden et al. 2012, Leatherman et al. 2010]. 
Not only does poor structure limit the ability and desire of health workers to provide 
care, but it may also reduce demand for services [Collier et al. 2003]. While a link 
between structure and outcomes may appear obvious there is still little clear evidence of 
a cause-effect relationship between them, other than ecological-level associations 
between resource inputs and outcomes. It can therefore be argued that given a basic set 
18 
of resources what is actually done by health workers in providing care – the process of 
care – is possibly what best captures quality [Rutten et al. 2010, Williams et. al. 2006]. 
When process measures are informed by well-established evidence of a link to good 
outcomes, expert opinion or guidelines, they become relevant to what quality is 
perceived to be [Wobrock et al. 2009]. For example, in the management of myocardial 
infarction, timely thrombolysis has been linked to lower morbidity and mortality in 
RCTs, hence the use of ‘door-to-needle’ times as a process-of-care indicator of quality 
[Corfield et al. 2004, FTT Collaborative Group 1994]. 
1.1.1. Current strategies for measuring quality of care in hospitals in developed 
countries 
Quality of care measurement strategies are highly varied because of the varied needs of 
different health systems [Peabody et al. 2006]. In developed countries availability of 
resources is less of a limiting factor to the provision of good hospital care, so quality 
assessments tend to focus on outcome and process measures. For example a multi-
country evaluation of disparities in quality of care for different socioeconomic classes in 
Canada, England, New Zealand and the United States focused on measures of cancer 
survival and screening rates, asthma mortality rates, suicide rates, smoking rates and 
acute myocardial infarction 30-day case fatality rates as indicators of quality of care 
[Hussey et al. 2007]. Similarly the declining trend in childhood cancer mortality in 
economically developed countries as has been considered an indicator of improved 
quality of medical care [La Vecchia et al. 1998].  
Mortality is generally a rare event. Differences in death rates attributable to quality of 
care received are therefore harder to detect, often requiring large datasets collected over 
long periods of time to observe sufficient events to detect these differences. 
Furthermore outcomes tend to be affected by factors such as socio-economic disparities 
and case mix which are unrelated to care given. For example the decline in childhood 
mortality from infectious causes observed in the early 1900’s (even before mainstream 
use of antibiotics) was attributable to factors unrelated to quality of healthcare, such as 
improved nutrition [Cutler & Meara 2001]. These factors fall beyond the realm of 
hospital care and create ‘risk-sets’ of patients which are more powerful pre-
determinants of outcomes than the quality of care given or received [Lilford & 
Pronovost 2010]. If information on these factors is available their effect can be 
estimated or adjusted for [Zaslavsky 2001]. Unfortunately in low-income settings the 
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detailed data required to detect and/or explain trends in outcomes is often unavailable, 
incomplete or too poorly coded to be useful [Kihuba et al. 2014, Williams & Boren 
2008, WHO 2006]. 
Patient satisfaction measures have been developed as an alternative outcome 
specifically to identify, from service consumers’ perspective, shortfalls in service 
delivery for input into quality improvement drives [Doyle et al. 2010]. In developed 
countries this undertaking is aided by the availability of very large databases of data 
routinely collected in inpatient surveys which are virtually non-existent in low income 
countries. But as some studies have reported, patients may not focus on the technical 
aspects of care – whose suitability they often lack the competence to judge [Donabedian 
2005, Harutyunyan et al. 2010] – which directly contribute to restoration of health, but 
rather on social and interpersonal aspects such as perception of kindness, 
communication and respect which are very subjective by nature [Schoenfelder et al. 
2011]. Thus the use of outcome measures especially in the absence of sufficiently 
detailed data may fail to correctly identify ‘problem areas’ in the continuum of care. 
Process-of-care measures make up the core of the clinical audit culture in health 
systems of the developed world where legal and professional pressures and availability 
of resources to support audits has led to their integration into routine clinical practice 
[Maher 1996]. Organizations such as the National Institute of Clinical Excellence 
(NICE) in the UK and the Agency for Healthcare Research and Quality (AHRQ) in the 
United States define national standards of care, promote the use of process-of-care data 
to measure performance against these standards, and direct implementation of changes 
necessary to improve care [NICE 2002]. Additionally process measures have been used 
in evaluating effectiveness of interventions such as the HAPPY AUDIT which aimed to 
reduce inappropriate antibiotic prescriptions for respiratory tract infections in Europe 
and South America [Bjerrum et al. 2010], and in pay-for-performance initiatives to 
identify levels of compliance with process targets to be rewarded [Petersen et al. 2006, 
Rosenthal et al. 2005]. There is little use of structure measures of quality of care 
possibly because of little variation in core staff and equipment across places. However 
there is widespread use of structure to measure equity in healthcare service provision 
[Macinko & Starfield 2002] (for example, in terms of the comparative number of 
specialist clinicians [Cooper et al. 2002]) and its association with outcomes at a 
population level [Vogel & Ackerman 1998, Shi 1994, Shi 1992]. 
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1.1.2. Quality of care measurements in a low income country 
A dearth of resources to support care and translation of existing evidence into practice 
in low income countries has steered quality measurement towards structure and process 
measures because substantial shortfalls in these areas may prevent any meaningful 
progress in improving outcomes [Peabody et al. 2006]. In Kenya assessments of 
structure have taken the form of Service Provision Assessments (SPA) which are rapid 
cross-sectional assessments of resource availability in health facilities using detailed 
check-lists [NCAPD et al. 2011]. SPAs focus on child health, maternity and newborn 
care, family planning, sexually transmitted and other infectious diseases, and 
HIV/AIDS, reporting on hospitals’ infrastructure, resources, systems, drug and vaccines 
supply and availability and counselling services. This wide scope gives a very 
comprehensive picture of the ‘supply side’ of healthcare but yields voluminous reports 
which often do not easily identify where deficiencies are localised within institutions.  
Process-of-care based quality assessments have also been undertaken in Kenya albeit in 
non-routine settings. A study investigating the effect of training of health workers on the 
use of guidelines for case management of severely ill children, supervision and 
feedback on quality of care for these children used 14 indicators of correct care for key 
illnesses as outcome measures to compare the intervention and control hospitals 
[Ayieko et al. 2011]. The multi-country evaluation (MCE) also measured correctness of 
case management practices for different illnesses. In one approach to measurement this 
MCE, instead of reporting performance on each of the several binary indicators 
separately, summarised them into a single mean index of integrated child assessment 
which was then used to compare quality of care provided by health workers with 
different durations of training [Huicho et al. 2008]. 
Even when process of care has been measured for the same illness definitions of correct 
care have varied widely. A review of malaria care quality found that while some studies 
defined correct treatment as use of any anti-malarial drug (sometimes ignoring the 
correctness of dosage), others were stricter, accepting the use of guideline-
recommended drugs only [Zurovac & Rowe 2006].  This lack of uniformity of 
indicators across studies could be attributed to the differences in guideline 
recommendations from illness to illness, coupled with non-systematic selection of 
process of care indicators. Another problem is that indicators tend to be task-specific 
and different tasks are not as easy as each other – checking for fever, for instance, is a 
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relatively straight forward task compared to performing an auscultation for abnormal 
breathing sounds. An intervention effect based on the simpler task might appear larger 
than that measured using the more complex one if task complexity is not taken into 
account. It therefore becomes very difficult to compare effects of different interventions 
whose endpoints are not measured on the same set of indicators [Rowe 2013]. A third 
problem is that multiple indicators may be used to measure quality of care for the same 
illness – a Delphi study to rate the acceptability of quality indicators found that experts 
recommended the use of more than 10 indicators each for 4 different illnesses [Ntoburi 
et al. 2010]. As a result there is a lot of heterogeneity in process-of-care measures 
across studies, a fact which greatly limits their comparability. 
1.1.3. Benchmarking quality of care on established standards and guidelines 
Infectious diseases are responsible for more than 65% of deaths in children aged 1–59 
months globally, majority of these being in low income countries [Liu et al. 2012, Black 
et al. 2010]. Together, pneumonia, malaria and diarrhoea contribute to over 60% of 
these deaths. Effective treatments for these illnesses are available, and strategies for 
delivering them to children who need them have been developed. A notable and widely 
promoted strategy is the Integrated Management of Childhood Illnesses (IMCI) 
strategy. This was published by the WHO as a draft algorithm to guide health workers 
in the management of a range of childhood illnesses responsible for majority of 
morbidity and mortality [WHO 1997]. IMCI algorithms use syndromes – collections of 
signs and symptoms of illness and laboratory test results – to identify and classify 
childhood illnesses by severity and select the most appropriate treatment. Several 
countries have adapted these generic guidelines to fit their own local disease patterns. 
They have also designed and implemented training programmes for health workers on 
the use of guidelines [Lambrechts et al. 1999]. 
Kenya adopted the IMCI approach in 2000 and has had traditional IMCI training for 
over a decade (even though it fell out of favour within the decade due to its high cost). 
This syndromic approach has also been applied to hospital level care [Berkley et al. 
2005, English et al. 2003]. To help implement the hospital care component of IMCI 
new guidelines for care of children hospitalised with acute illnesses – the Basic 
Paediatric Protocols [MoH 2006] – were designed. To promote their uptake the 
Emergency Triage Assessment and Treatment Plus Life Support (ETAT+) course for 
health workers who provide initial care for hospitalised children [Irimu et al. 2008] was 
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designed and a cluster randomised trial conducted to evaluate whether the intervention 
was effective. A summary of the trial is presented in section 1.4. 
There is some evidence that health workers do not always provide optimal care 
[Reyburn et al. 2008, English et al. 2004, Duke & Tamburlini 2003, Nolan et al. 2001]. 
The resulting poor care has been identified as a key limiting factor in the quest for better 
health outcomes [Peabody et al. 2006]. Reasons for poor care may include constraints in 
the resources necessary to support delivery of services [Opondo et al. 2009], negative 
pre-conceptions about some recommended treatments, health workers’ (over)confidence 
in their own capacity to treat severe illness without referral [Walter et al. 2009] and 
medico-legal constraints limiting the range of services that available staff can provide 
[Simoes et al. 2003], among others. This know-do gap results in a degradation of the 
quality of care provided to children admitted to hospital with life-threatening illnesses, 
and although it is widely assumed that poor health in low income countries is mostly 
brought about by limited access to health services (hence the widespread use of 
interventions that focus on providing additional resources for health), inadequate or 
incorrect processes of care may in fact be the main limiting factor to the attainment of 
good health [Das 2011]. Despite this, policy makers in many low-income health systems 
have not yet developed nor implemented quality measurement as part of routine quality 
assurance for hospital care [Ntoburi et al. 2008]. 
Progress is necessary on all fronts: ability to measure structure for the assessment of 
coverage and equity, ability to measure process to identify whether care provided 
complies with the best available evidence, and ability to measure and understand 
outcomes. This thesis is about process, specifically describing the design of a measure 
capable of effectively identifying and reporting problem areas in the process of care. 
The use of a score to measure how closely care provided corresponds to established 
standards of practice is an attractive way to simplify, summarise and report quality and 
compare it between individual patients, clinicians, diseases and hospitals, and to identify 
areas of poor care for improvement. If health systems are to meet health and equity 
goals then policy-makers, planners and researchers seeking to understand health 
systems need quality measures presented in a form that can answer questions such as, 
‘Are all hospitals meeting a minimum standard?’ and ‘Which aspects of hospital care 
are poorest?’. 
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1.1.4. Summary 
Whereas measuring structure is a relatively simple undertaking, structure measurements 
fall short in assessing overall quality of care. Outcomes, while arguably the most 
important, are also the most demanding measures in terms of quantity and quality of 
data required and are prone to interference from factors unrelated to care received. 
Existing process measures are made up of a potentially very large set of disease-specific 
indicators which are hard to use as general measures of quality. Nevertheless process 
measures remain attractive for monitoring the performance of systems of care in a low-
income setting because process of care is frequently the target of improvement efforts in 
the ‘service delivery arena’, an important health systems building block. Thus the 
interest of this work is to develop a measure of quality with a focus on process of care 
for children admitted to hospital, which spans common illnesses that are targets of 
system or service improvement interventions in many low-income countries and which 
can be measured at the individual patient level. The proposed measure is based on 
current clinical management guidelines and would need to be updated alongside future 
updates to these guidelines. 
1.2. Literature review 
Before embarking on the development of a new measure, a review of the literature was 
undertaken to first determine if previous efforts had been made in quality of care 
measurement in low income settings, and to identify the approaches taken by other 
studies that attempted to summarise or report aggregate measures at the patient level. 
1.2.1. Specific objectives of the review 
i. To identify literature describing the development of summary measures of 
quality of care for children in low income settings. 
ii. To identify literature providing descriptions of methodological approaches to 
developing summary scores for measuring quality of care. 
1.2.2. Methods 
The literature search was done on MEDLINE/PubMed and Embase. Details of the 
search terms are presented in Appendix A.1. A broad literature search of articles 
published in English was undertaken and 2 different criteria applied to the results to 
meet objectives (i) and (ii). The reason for this approach to the search was that any 
literature potentially addressing the first objective was likely to be a subset of 
body of literature that describes the 
these could be sought using slightly less restrictive search terms and inclusion/exclus
criteria. For the first objective the review was limited to studies measuring quality of 
care for children aged 0
surgical treatment (specifically acute illnesses included in the inpatient IM
guidelines), in a low
Studies in an older population, developed country setting, or focusing on other attribute 
of quality of care were excluded. For the second objective any study reporting
development of a summary measure, score or composite indicator for measuring quality 
of process or outcomes, and those from non
settings were included. 
population, and a summary of statistical methods and findings. Key references were 
flagged and reviewed for more information pertaining to methods used. Quality 
assessment tools for methodological studies are still poorly developed and during this 
review two reports were found which broadly discussed methods of constructing 
measures of complex constructs [Harris 
steps for constructing composite indicators
these reports and used to characterise the studies.
1.2.3. Results 
The searches yielded 277 
title and a further 41 after screening by abstract. 
text of 4 pre-1995 reports could not be located. 21 articles 
by content and 6 of 
found to report on the development of composite quality measures 
none met the criteria set out in 
results of each step of the search.
summarised in Table 
Figure 1.2-1: Summary of 
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277 hits
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Table 1.2-1: Summary of the reviewed studies 
Check-list adapted from the OECD handbook for constructing composite indicators and Harris et al. 2009. See Appendix A.2 for explanations of 
suggested steps 
Suggested steps Chen 2011 
Wierenga 
2011 
Bamm 
2010 
Mael 
2010 
Suhonen 
2010 
Chevat 
2009 
Klassen 
2009 
Saloojee 
2009 
Siebes 
2008 
Najjar-
Pellet 
2008 
Llewellyn 
2007 
Siebes 
2006 
Sixma 
2000 
Ashton 
1999 
Symmons 
1995 
Perspective of quality 
measurement 
+ + + + + + + + + + + + + + + 
Data selection, sample size + - - - - - - - - + + + + + 0 
Handling of missing data* 0 0 0 0 0 0 - 0 0 0 0 0 0 0 0 
Multivariate analysis + 0 + 0 + + + + + 0 0 0 + + 0 
Weighting, aggregation, 
generation of a summary 
measure 
0 0 0 0 + + - 0 - + + 0 0 + + 
Assessment of robustness and 
sensitivity analysis 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Reliability and validity + + + + + + + + + 0 + + + + + 
Links to other indicators and 
measures 
0 + + 0 0 + + + + 0 0 + 0 0 + 
Key: (+) reported and appropriate; (-) reported but not appropriate; (0) not reported; *some multivariate methods adjust for missingness-at-random but do not justify this assumption 
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1.2.4. Overview of the studies reviewed to explore methodologies 
A majority of the studies were conducted in developed countries, mostly North America 
and Europe, except two: one in South Africa [Saloojee et al. 2009] and another in China 
[Chen et al. 2011]. Most study populations were patients receiving care, their caregivers 
or health workers providing care and 3 studies reported work in a paediatric care setting. 
All studies provided good descriptions of the clinical area in which the measure was to 
be applied and perspectives from which quality was considered. For example 5 studies 
described score development using the Measure of Process of Care (MPOC) as a 
starting point [Bamm et al. 2010, Saloojee et al. 2009, Klassen et al. 2009, Siebes et al. 
2008, Siebes et al. 2006]. Developed by a multidisciplinary team of clinical neuro-
development and rehabilitation researchers in Canada the MPOC was designed to 
measure the process of family-focused intervention services for children’s rehabilitation 
services by using the behaviour and interaction of providers and caretakers. This focus 
was taken based on the assumption that parents of children receiving care would 
appreciate the identification and modification of processes they perceived as poor. A 
similar study measuring quality of pharmaceutical care for Dutch elderly patients 
discussed the links between prevention, diagnosis, treatment and follow-up of diseases 
in this group and the risks of adverse drug events, poly-pharmacy, under-treatment, 
functional decline and other important outcomes [Wierenga et al. 2011]. To generate 
items and domains the MPOC studies focused on care-giving as a construct to generate 
a pool of potential representative items while Wierenga et al. used an established quality 
indicator set from the Assessing Care of Vulnerable Elders (ACOVE) study [Wenger et 
al. 2001]. The items had been designed to capture quantifiable perceptual elements of 
the construct of interest using semi-quantitative (Likert-type) and binary responses. 
All 15 studies used either a multivariate analysis or expert opinion or a mix of both to 
refine, clarify and group the list of selected items into ‘scales’ or ‘domains’ which 
represent a specific dimension of quality. Multivariate methods used were based on 
factor analysis (FA) which assumes that there exist latent variables which are not 
directly observed but are measured through other observed variables (alternatively 
referred to here as ‘items’). FA aims to measure these latent variables or factors and 
estimate their effects on some outcome. This technique may also be used for data 
reduction by decomposing the set of items measuring an underlying construct into a 
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series of uncorrelated linear combinations or groupings of related items. If there is no a 
priori belief on the nature of groupings of items, then this multivariate method is useful 
for identifying these groupings. In situations where there is reasonable knowledge of the 
phenomenon or construct that the set of observed variables represent, a confirmatory 
factor analysis (CFA) can be set up to refine item groupings. However the results of FA 
tend to be inconsistent, yielding different item groupings whenever small changes occur 
in the underlying datasets and this could explain why validation studies replicating 
quality measures in new settings sometimes fail to confirm the usefulness of measures 
[Saloogee et al. 2009]. Moreover groupings solely determined by statistical processes 
may not be relevant to real-life settings. For these reasons other studies favoured expert 
opinion for item grouping refined through a consensus approach such as the Delphi 
method [Wierenga et al. 2011, Najjar-Pellet et al. 2008], or a combination of statistical 
methods reinforced by expert opinion or consensus [Chen et al. 2011, Suhonen et al. 
2010]. The Delphi technique refines expert opinion in several rounds during which 
information is collected from panelists, collated and presented back to them to form the 
basis of the next round, allowing them to revise their opinion based on this feedback 
until consensus is reached. Through repeated feedback cycles this technique helps refine 
the selection and aggregation of items to be measured. 
The review highlighted some inadequacies in statistical approaches. For example 
considerations for sample size estimation and handling of missing data were poorly 
reported in all studies. Less than half of the reviewed studies even mentioned their 
sample sizes, and those which did used Nunally’s suggested criterion for scale 
validation of 5-10 observations per item [Streiner & Norman 1989]. The rest were 
nested within broader studies for which sample sizes had been determined based on the 
main objectives but were not reported, and none reported the statistical considerations 
used to estimate them. Similarly no study discussed whether missing data was 
encountered, the mechanisms of missingness or its implications on the final measure. 
One study examined the effect of differential weighting of items as suggested by a panel 
of experts, concluding that it made no difference to the eventual score’s predictive 
validity [Ashton et al. 1999]. However none explored any potential changes due to 
sampling variation or different methods of score generation. Nevertheless reliability and 
validity testing was extensively done in all studies. Internal consistencies were tested 
using methods that compare performance over time or across different raters. Validity 
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checks included comparison with other tools for measuring the same construct and 
checks on between-scale correlations. 
Outputs of the studies were broadly categorized into two: those with a composite 
indicator set proposed for measuring the complex construct being studied, and those 
which reported an overall score which was the result of summarising scores assigned to 
each item in the composite indicator list using some suitable method (such as 
summation of individual scores where there was no justification for weighting). 
1.2.5. Discussion 
Some useful techniques for measuring quality of health care and other complex 
constructs have been described in the literature. In general the process of constructing a 
measure involves first describing the perspective to be applied in the measurement, 
followed by identifying or generating a list of items potentially relevant to 
characterising quality in that perspective, refining the list and grouping items into scales 
which represent clinically-relevant domains of quality; finally using the items as criteria 
for measurement and where appropriate, summarising them into aggregate measures 
and reporting findings. However none of the studies discussed the implications of 
missing data. Additionally techniques for addressing uncertainty due to sampling 
variation and methodological differences are also poorly developed, and the need for 
easy-to-use tools to collect, process, and report assessment findings quickly and 
efficiently is still unmet. 
As discussed earlier shortfalls in data management in health systems of many low-
income countries are likely to pose special difficulties in obtaining complete data; 
indeed missingness of data in case record forms is commonplace [Gathara et al. 2011, 
Mwakyusa et al. 2006, English et al. 2004]. As such, a well-designed quality measure 
must include checks of data completeness and considerations for imputing or ignoring 
missing data, and analyses to check the robustness of the measure in the face of missing 
data. The reporting needs of different levels of the healthcare system must also be 
considered. Most of the studies above do not do this; where a summary measure is 
provided the unit of aggregation is at a higher level, usually the hospital. This limits the 
ability of the measure to distinguish between quality of care for individuals with 
different characteristics – e.g. diagnosis, co-morbidities, carer, all of which are potential 
modifiers of quality of care and outcomes – which would have been achievable using a 
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measure that encompasses quality of care across multiple diseases as an individual 
(patient)-level measure.  
1.2.6. Summary 
This literature review demonstrates the potential usefulness of process measures of 
quality of care. It highlights methods of developing aggregate measures that could be 
useful in a low-income country like Kenya where standards of care backed by good 
clinical evidence and supported by health policy makers are already in place but quality 
measurement is still rudimentary. The review also shows that methods to deal with 
challenges such as poor documentation of process of care and the multiplicity of 
guideline recommendations across illnesses and severity classifications are still poorly 
developed. This work was therefore set up to address some of these shortfalls while 
demonstrating the use of routine process-of-care data in identifying weaknesses in 
management of common childhood illnesses during a critical time of care when most 
deaths occur. 
1.3. Objectives of the research work 
1.3.1. Overall objective 
The overall objective of the work presented in this thesis is to design and test a patient-
level score to measure quality of the initial admission care for children under 60 months 
admitted with common childhood illnesses to hospitals in Kenya by focusing on 
multiple tasks that comprise the process of care. 
1.3.2. Specific objectives 
1. To design a quality measure that summarises hospital care for children admitted to 
hospital in a low-income setting: 
i. to identify process-of-care tasks and domains of care for children admitted to 
hospital with malaria, pneumonia or diarrhoea/dehydration; 
ii. to explore simple and intuitive scoring approaches for summarising process-
of-care tasks into a measure of quality of care at different levels (domain, 
disease, patient, clinician, hospital) and to combine them to an overall score; 
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iii. to identify a coherent set of methods and tools for reporting the measure to 
its various audiences. 
2. To demonstrate the validity, reliability and potential advantages of the quality of 
care measure: 
i. to show that the items within domains of the quality of care measure are 
internally consistent; 
ii. to explore links between this measure and outcomes of care; 
iii. to test the generalisability of the measure to different situations. 
1.4. Background of the research work 
This thesis relies on and extends previous studies undertaken by the Health Services 
Unit (previously known as the Child and Newborn Health Group and later Health 
Services Research Group) which is in the Public Health Research Department of the 
KEMRI-Wellcome Trust Research Programme in Nairobi, Kenya, to which the author 
belongs. Key elements of the Unit’s work which this thesis builds upon are the 
development of the Basic Paediatric Protocols (‘guidelines’) for management of 
childhood illnesses, a training programme for health workers on the use of the 
guidelines, and a trial to investigate the effect of training and the use of the guidelines, 
supervision and feedback on the quality of hospital care for children admitted in Kenyan 
hospitals with the illnesses responsible for majority of deaths in this setting. 
1.4.1. Development of the basic paediatric protocols 
Previous studies had noted that hospital care for children in low income countries was 
poor and that improvement was possible by promoting the application of existing 
evidence into practice [English et al. 2004, Nolan et al. 2001]. Guidelines on how to 
provide care were rare and even where available they had neither been updated nor put 
to actual use. Therefore evidence-based clinical practice guidelines (CPGs) for 
paediatric care in Kenya were developed to improve diagnosis and treatment of 
childhood illnesses [Irimu et al. 2008]. The guidelines were developed through 
adaptation of the World Health Organization (WHO) guidelines to focus on illnesses 
responsible for a majority of childhood deaths in this setting, namely anaemia, birth 
asphyxia, diarrhoea/dehydration, malaria, meningitis, neonatal sepsis, pneumonia and 
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prematurity/low birth weight, and also on basic life support including resuscitation 
management of shock and convulsion. 
The CPGs were designed to aid clinicians in providing the best care possible within the 
available resources because most children were initially attended to by nurses, clinical 
officers (health workers with a diploma in clinical medicine), medical interns and junior 
medical officers who did not have extensive training or experience in paediatric care. 
Health policy makers within the Ministries of Health, medical schools and research 
organisations were co-opted to advise, adapt and further develop the CPGs culminating 
in the production and publication of the ‘Basic Paediatric Protocols’ booklet [MoH 
2006]. Involving a large range of stakeholders, it was hoped, would help facilitate 
widespread acceptance of the guidelines. 
A training programme on the use of the guidelines, named Emergency Triage 
Assessment and Treatment plus admission care (ETAT+), was developed, tested at a 
national referral hospital, a smaller rural hospital and a medical training centre [Irimu et 
al. 2008] and refined using feedback from these pilot runs. The ETAT+ course includes 
lectures and practical training to impart knowledge and build skills on life support using 
the airway-breathing-circulation-disability (ABCD) model. Eventually, increasing need 
and demand for ETAT+ training spurred the continued scaling up of training coverage 
in local and regional hospitals and medical schools [English et al. 2011]. 
1.4.2. The Kenyan district hospitals trial 
A cluster-randomised controlled trial of an intervention to improve referral care for 
children admitted to Kenyan district hospitals with acute illnesses began in September 
2006 and was delivered over 18 months until April 2008 with a 12-month continuation 
phase in the intervention sites up to April 2009 to assess whether any changes observed 
were sustained [Ayieko et al. 2011]. The intervention was to promote and support 
hospital implementation of the CPGs described above. Elements of the intervention 
included a five-and-a-half day training programme for health care workers on the 
ETAT+ approach to case management in line with guidelines, external supervision by 
paediatricians from the study team, an on-site facilitator at each hospital to provide a 
link to the external supervisor and support for general delivery of the intervention.  
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Practice guideline booklets, job aids such as drug and fluid dose charts and structured 
paediatric admission record forms were provided to both groups at the start of the trial. 
In place of the training programme the control group received a one-and-a-half day 
lecture introducing the guidelines. Surveys were conducted every six months. At each 
survey data on case management practices were collected from a sample of 
approximately 400 admission records at each hospital selected using their admission 
dates from a randomisation list generated using Stata™. Both groups of hospitals 
received written feedback of survey findings three to six weeks after each survey. The 
intervention hospitals additionally received face-to-face feedback. 
1.4.3. Use of an assessment score to measure health workers’ adherence to 
guidelines 
In investigating the effect of the intervention in the Kenyan district hospitals study, 
health worker performance was assessed using process-of-care indicators of adherence 
to key guideline recommendations for treatment of malaria, pneumonia and 
diarrhoea/dehydration. Binary variables were defined for process-of-care tasks, errors of 
treatment and supportive care, such as correct drug, fluid or oxygen prescription, and 
use of recommended severity classification of illness. Proportions of admission records 
in which the admitting clinicians correctly performed 13 indicator tasks were reported 
for each hospital, and the differences in proportions in the intervention vs. control group 
for each indicator used as a hospital-level measure of the intervention effects. 
Separately to summarise health workers’ assessment of clinical signs and symptoms – a 
patient-level measure – an assessment score for each child was reported by dividing the 
number of documented signs and symptoms by the total number expected depending on 
the child’s diagnosis. For example if a child was diagnosed with severe pneumonia and 
severe malaria it was expected that 8 signs and symptoms for pneumonia and 6 for 
malaria be documented. If only 10 signs were documented then the child’s assessment 
score was 10/14 i.e. 0.625. Assessment scores were averaged at hospital level then used to 
compare the intervention and control groups. 
Both methods of assessing the effectiveness of the intervention provided evidence of a 
greater improvement in the intervention than control hospitals by the main study end-
point. However this approach to reporting the trial endpoints had potentially limited 
interpretability for several reasons. First, the assessment score represented only one 
33 
 
aspect (‘domain’) of process of care as laid out in the guidelines. The 13 indicators 
spanning diagnosis and treatment were reported separately as independent tasks and this 
was unable to shed light on each individual’s experience of the continuum of care from 
assessment to diagnosis to treatment. Additionally measures could only be reported for 
each specific illness independently. For these reasons it was not possible to summarise 
overall hospital or clinician-level performance across tasks and across diseases. 
Secondly, some guideline-recommended aspects of correctness of diagnosis and 
treatment such as correct route, frequency and duration of drug therapy were not 
included as trial outcome indicators, as shown in Table 1.4-1.  
Table 1.4-1: A comparison of items in the assessment score for malaria in the Kenyan district 
hospitals study with the full guideline recommendations for malaria case management 
Signs and symptoms 
Part of malaria 
assessment score/ 
process indicators 
Fever indicated as present or absent or temperature indicated Yes 
Convulsions indicated as present or absent Yes 
Acidotic breathing indicated as present or absent Yes 
Degree of pallor indicated as ‘0’, ‘+’ or ‘+++’ Yes 
Ability to drink or breastfeed reported in the affirmative or negative Yes 
Level of consciousness classified as ‘alert’, ‘responsive to voice’, ‘responsive to 
pain’ or ‘unconscious’ 
Yes 
Diagnosis  
Malaria is classified explicitly as ‘severe’ or ‘non-severe’ Yes 
Classification is consistent with observed signs and symptoms No 
Treatment  
Coartem or quinine only is prescribed for severe or non-severe malaria respectively No 
Route of administration of Coartem is oral, quinine is intramuscular or intravenous No 
Number of Coartem tablets prescribed is 1, 2, 3 or 4 for child weighing 5.0–14.9kg, 
15.0–24.9kg, 25.0–34.9kg or 35.0kg+, respectively; loading dose of quinine is 
20mg/kg and maintenance dose is 10mg/kg 
Yes 
Frequency of daily dosing of each drug is twice daily No 
Duration of treatment with antimalarial is specified No 
Thus a clinician could have been rated highly on the assessment with scores of 6/6 but 
still be failing to provide optimal care, with diagnosis and treatment scores of 0 or 1, as 
is the case in patient IDs 3, 6, 10, 12 and 16 in Appendix A.4. Thirdly, many children 
were diagnosed as having more than one illness yet the method employed in combining 
assessments for different illnesses into an assessment score left no scope for 
distinguishing between care for the different illnesses; this would have been useful for 
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identifying illnesses for which care was poor. Missing documentation of clinical enquiry 
was common in these data, as shown in Table 1.4-2; not only did this characterise care 
as poor but also made it difficult to determine the correctness of classification and 
treatment according to guidelines. For example less than half of the 8,090 children with 
malaria had all assessments documented. 
Table 1.4-2: Completeness and appropriateness of assessment, classification and treatment of 
malaria in the Kenyan district hospitals study according to guideline recommendations 
Assessment (fraction performed) Number of cases (percentage of total malaria cases) 
Complete (6/6) 3,887 (48.1%) 
High (4/6 to 5/6) 1,172 (14.5%) 
Low (1/6 to 3/6) 2,935 (36.3%) 
Incomplete (0/6) 96 (1.2%) 
Classification  
Severe 2,954 (36.5%) classified, 1,728 (58.5%) of these correctly 
Non-severe 1,851 (22.9%) classified, 886 (47.9%) of these correctly 
Not classified 3,285 (40.6%) 
Treatment Severe, n=2,954 Non-severe, n=1,851 Not classified, n=3,285 
Drug correctly selected 2,533 (85.7%) 401 (21.7%) (cannot be determined) 
Route correctly specified 1,935 (65.5%) 382 (20.6%) 261 (7.9%) 
Dose correct for body weight 20 (0.7%) 346 (18.7%) 76 (2.3%) 
Frequency correctly specified 1,738 (58.8%) 386 (20.9%) 202 (6.1%) 
Duration (any) specified 3 (0.1%) 401 (21.7%) 966 (29.4%) 
Classification of severity was a key guideline recommendation yet only 4,805 (59.6%) 
cases had this done; the rest were either incorrectly classified or unclassifiable due to 
insufficient assessment. Consequently only 2,934 children received the correct drug for 
their severity classification, the remaining 5,156 being a mix of incorrectly treated 
children and those for whom correctness of treatment could not be determined. 
Classification and treatment errors are not equal in relation to their perceived 
consequences on quality of care [Rowe et al. 2003]: a child incorrectly classified and 
treated for a more severe illness than they actually have would still likely have a 
favourable outcome but resources would have been wasted; on the other hand a child 
being inappropriately treated for an illness of lower severity than they had could be at 
risk of adverse outcomes. 
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1.4.4. Rationale for scope of proposed work 
The work undertaken in this thesis will attempt to demonstrate how to measure the 
process of care for under-5 year olds admitted to hospital with the three commonest 
childhood illnesses in a low-income setting – namely pneumonia, diarrhoea and malaria. 
This is because these illnesses are responsible for more than half of deaths from 
infectious diseases in childhood. Recent estimates show that pneumonia was the single 
biggest driver of under-5 mortality, the cause of between 1.1 and 1.6 million deaths 
annually from 2008 to 2010 while diarrhoea was responsible for 15% of under-5 
mortality worldwide in 2008 and 9.9% in 2010 [Liu et al. 2012, Black et al. 2010]. 
Malaria was the cause of 564,000 deaths (7.4% of total mortality). Additionally, as 
illustrated in sections 2.2 and 2.3, they are also responsible for a majority of hospital 
admissions in Kenya. 
Although the global burden of malaria morbidity and mortality are on the decline in 
many places [WHO 2011] – mostly due to the development of effective treatment and 
control strategies – there is still some evidence that use of inappropriate treatments or 
incorrect use of recommended treatments is widespread [Ajayi et al. 2008, Oshikoya & 
Ojo 2007, Nshakira et al. 2002]. These missed opportunities to provide optimum care 
likely lead to preventable deaths that unnecessarily increase mortality. This thesis forms 
a potential starting point to the improvement of care by describing the systematic 
development of a tool for identifying weaknesses in care delivery through measurement 
of process of care.  
1.4.5. The author’s contribution to previous work 
The author was involved with the development stages of the ETAT+ training 
programme as a trainee. Feedback from the early trainees was used to refine the training 
programme. During the main trial he supported and supervised data collection, collated 
survey findings, wrote and disseminated post-survey reports to participating hospitals 
and conducted data management. He also helped refine data collection and entry 
procedures for the trial and developed operating procedures for electronic data 
collection in the last three surveys. Many of the techniques he developed at this stage 
have been adapted for use in data collection and management for other studies at the 
Programme since then. At the end of the study he analysed data and co-authored key 
reports of main and secondary findings [Opondo et al. 2011, Ayieko et al. 2011, 
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Opondo et al. 2009]. While developing the proposal for this work he undertook the 
review of trial endpoints which highlighted the weaknesses of the assessment score and 
the other outcome measures, and the need to expand their scope. 
1.5. Summary 
The primary and secondary analyses of the Kenyan district hospitals trial data 
demonstrated the need to expand the scope of quality measures through: identification 
and inclusion of all guideline-recommended aspects of process of care to improve the 
ability of the measure to characterise a patient’s admission episode; development of 
summary measures separately for each illness, to enable identification of illnesses for 
which care is poor and to better characterise care for children with co-morbidities; 
domain-level summaries of quality within and across illnesses to better identify problem 
areas of care; and identification of different forms of missing data and strategies to 
handle them and their consequences on quality of care evaluation. 
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Chapter 2 – Data for Designing and Testing the Proposed 
Measure 
2.1. Introduction 
2.1.1. Rationale for choice of data 
The poor state of clinical data capture, storage and retrieval in Kenya and many low 
income countries makes the quality measurements targeted at improving care difficult to 
undertake. It has long been recognised that data quality could be greatly improved by 
the use of dedicated electronic medical records and information systems such as those 
which support the process of care in many developed countries. However these are rare 
in the Kenyan health system. The use of these technologies has to date been limited to 
externally-funded programmes focused on single diseases or one group of diseases 
[Tierney et al. 2010, Forster et al. 2008] and collaborations between select health 
facilities and academic institutions [Rotich et al. 2003, Hannan et al. 2001, Hannan et 
al. 2000] with varied success at actually improving patient records and patient care. 
Despite the poor state of clinical data management systems, procedures for manual data 
retrieval from existing paper-based patient records have effectively been used for data 
collection in trials and observational studies examining processes of care. For example 
detailed case record data have previously been successfully obtained by retrospective 
random sampling and abstraction of patients’ admission records [MoH 2013, Ayieko et 
al. 2011]. This is a rapid, low-cost and non-invasive approach which provides clinical 
data that reasonably replicate the information stored in most Kenyan hospital records. It 
is often data summarised from admission records which are eventually used to generate 
morbidity and mortality statistics at hospital level; these are then collated all the way up 
to the national level to produce a country’s health indicators. Patient records are thus an 
important source of information for inference on the state of the health system. The data 
obtained from them are, in the absence of better approaches to quality assessment, very 
important component of a quality of care measure intended for routine use.  
2.1.2. Intended uses for the data 
Procedures for setting up a new method of measurement recommend that the measure 
undergoes validation after the design phase. Internal validity of the measure is tested 
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during the design phase using statistical methods described in detail in Chapter 4. 
Subsequently, external validity is demonstrated by the degree to which the procedures 
for creating the measure are applicable to a different situation. This can be achieved 
through systematic replication [Barlow & Hersen 1984], which is an extension of 
procedures undertaken in setting up the measure to a validation dataset arising from a 
routine care setting. Such data are preferred because the measure is intended for 
characterisation of routine care. 
2.2. Data for designing the process of care measure 
The Kenyan district hospitals data come from 12,036 admission episodes of children 
aged less than 60 months admitted to hospital with acute illnesses included in the 
inpatient IMCI guidelines, namely: malaria, pneumonia, meningitis, malnutrition, 
diarrhoea with or without dehydration, neonatal sepsis, prematurity and/or low birth 
weight. The data were collected retrospectively from paediatric admission records in 8 
first-level referral hospitals in Kenya whose characteristics are summarised in Table 
2.2-1. The hospitals each had between 1,100 and 4,500 paediatric admissions and 1,200 
deliveries annually and were deliberately selected to be representative of the variety of 
rural Kenyan hospitals. 
Table 2.2-1: Characteristics of hospitals in the Kenyan district hospitals study 
Hospital 
Malaria 
transmission 
setting 
Antenatal HIV 
prevalence 
(High=>10%, 
Mod=5-10%) 
Infant 
mortality 
rate per 
1,000 
Catchment 
population with 
income < $2 a 
day 
Paediatric 
admissions 
per year 
Paediatrician 
and Medical 
Officer interns 
H1 Intense High >100 50-70% 3,500 No 
H2 Highland High ~70 50-70% 5,000 Yes 
H3 Low Moderate ~40 ~35% 3,300 No 
H4 Arid Moderate ~70 50-70% 1,700 No 
H5 Intense High >100 50-70% 2,500 No 
H6 Arid Moderate ~70 50-70% 1,100 No 
H7 Highland High >100 50-70% 4,500 Yes 
H8 Low Moderate ~40 ~35% 1,800 No 
H1 - H4 are intervention hospitals, H5 - H8 are controls 
Adapted from Opondo et. al 2009 
The admissions occurred over a 40-month period between December 2005 and March 
2009 inclusive, during the study described briefly in section 1.4.2 [Ayieko et al. 2011]. 
Four 6-monthly surveys were undertaken at each hospital, the first one focusing on 
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admissions in the 9-month period preceding it. Two additional surveys were conducted 
at the intervention group of hospitals after the active intervention had ended to explore 
any potential residual effects. The target sample size per hospital at each survey was 
400. In many of the smaller hospitals this was often not achieved even when all 
paediatric records meeting the inclusion criteria were included in the sample. Table 
2.2-2 shows the distribution of admission episodes across hospital and time and the 
number of admitting clinicians per hospital. Variables collected from the admission 
records were: children’s age, sex, weight, vaccination status; history of current episode 
of illness including presenting symptoms and length of illness; clinical signs including 
the state of airway, breathing, circulation, neurological and gastrointestinal function, 
nutritional status; admission diagnosis; laboratory tests and their results if available; 
treatments prescribed (drugs, fluids, blood, oxygen, nutritional support) including their 
doses, routes, frequencies and durations of administration; date of end of admission and 
whether they were alive, dead or referred for further treatment, and whether a check-up 
date was scheduled. The data collection tool is shown in Appendix A.5. 
The data were abstracted over 1 to 2 week periods during the 6-monthly hospital visits. 
Of the 12,036 admission episodes, 2,450 were abstracted at the baseline survey 
followed by 2,119 and 2,176 in the next 2 follow-up surveys. Data for the study’s main 
end-point were collected during the fourth survey in which 2,714 records were 
abstracted. A total of 2,577 records were abstracted in the post-intervention period. 
Linked to each admission episode were unique ID numbers which identified admitting 
clinicians; these were further linked to their individual characteristics such as age, 
gender, qualification, years of practice and trainings attended. There were 557 clinicians 
uniquely identified across the 8 hospitals. There was a separate group of clinicians who 
were not identified; these were mostly trainees who spent a minimum amount of time in 
the paediatric wards and only attended to a small proportion – 1.6% (194) – of 
admissions. That each child’s admission episode is linked to the admitting clinician, 
several observations are linked to each clinician and several clinicians are linked to a 
hospital indicate that these data are hierarchical; therefore hierarchical analytical 
techniques are required for statistical inference.  
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Table 2.2-2: Number of episodes at each hospital across surveys, and admitting clinicians per hospital 
 Survey  
Hospital Baseline 1st follow-up 2nd follow-up End-point 1st post-
intervention 
2nd post-
intervention 
Total 
(percentage) 
No. of 
clinicians* 
H1 327 315 309 349 333 366 1,999 (16.6%) 101 
H2 334 342 356 351 347 323 2,053 (17.1%) 55 
H3 288 277 305 362 310 345 1,887 (15.7%) 164 
H4 342 219 299 351 216 336 1,763 (14.6%) 29 
H5 142 153 175 366   836 (6.9%) 32 
H6 331 224 231 211   997 (8.3%) 29 
H7 348 334 250 373   1,305 (10.8%) 83 
H8 338 255 251 351   1,195 (9.9%) 64 
Total 2,450 2,119 2,176 2,714 1,206 1,370 12,035† 557 
H1 - H4 are intervention hospitals; H5 - H8 are controls and were not part of the last two surveys; * Number identified – unidentified clinicians were lumped together into a single separate group in 
each hospital. †One observation is missing a survey indicator 
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Processes of care undertaken during the initial 24 hours of admission – the target of the 
intervention – were extracted from these admission records using the data collection 
tool. Processes examined included documentation of clinical signs and symptoms, 
diagnostic tests, illness diagnosis and severity classification, drug prescription, and post-
admission care. Outcomes data collected included status at the end of hospital stay 
(discharged alive, dead, referred to another hospital or absconded) and date of discharge 
from which duration of admission was calculated. Most of the data were categorical, 
indicating the presence, absence or missingness of key features of illness from the case 
records; there were however a few continuous variables, including age, weight, height, 
temperature, duration of symptoms, respiratory rate and heart rate. 
The process of care for malaria, pneumonia and diarrhoea are the focus of this work for 
reasons discussed in section 1.4.4. Figure 2.2-1 shows that these three diseases were 
responsible for 8,090, 5,231 and 2,543 admission diagnoses respectively, of varying 
severity across the six surveys conducted over the course of the study.  
Figure 2.2-1: Summary of diagnoses and illness severity classifications observed in the data 
for designing the process of care measure 
The diagnoses are not mutually exclusive within patient 
There were 6,150 (51.1%) episodes with only one of the three diseases diagnosed. 
Another 4,188 (34.8%) episodes had two diseases diagnosed; of these 2,832 were of 
malaria and pneumonia, 1,142 of malaria and diarrhoea, and 223 of pneumonia and 
diarrhoea. Only 466 (3.7%) episodes had all three diseases diagnosed. There were 1,252 
(10.4%) episodes which did not feature any of the three diseases – this means only 
10,784 of the 12,036 admission episodes were relevant to this work. The largest 
42 
 
proportion of the admission episodes were observed at the baseline survey (2,450 – 
20.4%) and fourth survey which was also the main study end-point (2,714 – 22.6%). In 
the first follow-up (second) and second follow-up (third) survey 2,119 (17.6%) and 
2,176 (18.1%) episodes respectively were observed. The fifth and sixth surveys were 
undertaken to examine whether any intervention effects in the main study could be 
sustained upon withdrawal of the intervention; they were conducted in the intervention 
hospitals only. For this reason the number of admissions in this phase of the study was 
much lower – 1,206 (10.0%) and 1,370 (11.4%) respectively – than each of the four 
previous surveys. Table 2.2-3 details the distribution of disease episodes over time. 
Table 2.2-3: Number of episodes of each disease/comorbidity across surveys 
 Survey 
Disease Baseline 1st 
follow
-up 
2nd 
follow-
up 
End-
point 
1st post-
intervention 
2nd post-
intervention 
Total 
None* 262 233 254 234 122 147 1,252 
Malaria 953 646 581 750 312 437 3,679 
Pneumonia 304 336 350 419 157 173 1,739 
Diarrhoea** 108 102 111 208 99 104 732 
Malaria+Pneumonia 548 494 600 579 333 269 2,823 
Malaria+Diarrhoea 225 172 155 328 102 159 1,141 
Pneumonia+Diarrhoea 13 55 35 64 25 31 223 
Malaria+Pneumonia+ 
Diarrhoea 
37 81 90 132 56 50 446 
Total 2,450 2,119 2,176 2,714 1,206 1,370 12,035† 
*May include other diseases than the three considered here; **Diarrhoea with or without dehydration at each mention; †One 
observation is missing a survey indicator 
Mortality was similar across groups over time, albeit nominally higher in the 
intervention hospitals in three of the four time points when data was available from both 
groups as shown in Table 2.2-4. The outcomes for 295 (2.5%) children were missing. 
Table 2.2-4: Percentage (95% confidence intervals)[n] of deaths in the intervention and 
control hospitals across surveys 
Survey Control Intervention Overall 
Baseline 5.7 (4.3 – 7.0) [1,111] 7.0 (5.6 – 8.4) [1,274]  6.4 (5.4 – 7.4) [2,385] 
1st follow-up 7.1 (5.4 – 8.7) [   935] 8.2 (6.6 – 9.9) [1,094] 7.7 (6.5 – 8.8) [2,029] 
2nd follow-up 8.9 (7.0 – 10.8) [   858] 8.8 (7.2 – 10.4) [1,228] 8.8 (7.6 – 10.0) [2,086] 
End-point 6.8 (5.4 – 8.2) [1,276] 10.5 (8.9 – 12.1) [1,388] 8.7 (7.7 – 9.8) [2,664] 
1st post-intervention __ 10.9 (9.1 – 12.6) [1,206] 10.9 (9.1 – 12.6) [1,206] 
2nd post-intervention __ 8.8 (7.3 – 10.3) [1,370] 8.8 (7.3 – 10.3) [1,370] 
Overall 7.0 (6.2 – 7.8) [4,180] 9.1 (8.4 – 9.7) [7,560] 8.3 (7.8 – 8.8) [11,740] 
Only data collected over the active intervention phase of the study – 9,459 cases records 
in the first four surveys and specifically the 8,476 with at least one of the three diseases 
– are of interest to this work. Over this period there was a significant difference between 
the two groups of hospitals in the proportions of admissions attributed to the three 
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diseases. There were not only more admissions in the intervention than control hospitals 
at each time-point but also more episodes featuring at least one of the three diseases. At 
the baseline and first follow-up survey 89.5% (95% CI 87.8% to 91.1%) and 89.6% 
(95% CI 87.8% to 91.4%) respectively of episodes in the intervention group, and 89.1% 
(95%CI 87.3% to 90.9%) and 88.3% (95% CI 86.3% to 90.3%) respectively of episodes 
in the control group were attributed to at least one of the three diseases. By the second 
follow-up and main end-point surveys these proportions were significantly higher in the 
intervention group – 91.4% (95% CI 89.9% to 93.0%) and 93.8% (95% CI 92.6% to 
95.1%) respectively – than the control group – 84.0% (95% CI 81.6% to 86.4%) and 
88.7% (95% CI 87.0% to 90.4%) respectively. 
Most children had a diagnosis of malaria or pneumonia or both; diarrhoea alone or in 
combination with another disease was less commonly diagnosed. Children in the 
intervention group were more likely to have at least one of the three diseases diagnosed, 
as shown in Table 2.2-5. This was most likely because the intervention encouraged 
clinicians to record a diagnosis for any child whose signs and symptoms were consistent 
with the criteria for that diagnosis laid out in the guidelines. Overall, there were 8.4% 
more children the intervention arm than the control arm in this group of children. 
Table 2.2-5: Number (percentage) of episodes of each disease and disease combination in the 
intervention and control hospitals in the first four surveys 
Disease(s) Control Intervention Total 
None 531 (54.0) 452 (46.0) 983 (10.4) 
Malaria 1,414 (48.3) 1,516 (51.7) 2,930 (31.0) 
Pneumonia 738 (52.4) 671 (47.6) 1,409 (14.9) 
Diarrhoea 252 (47.6) 277 (52.4) 529 (5.6) 
Malaria + Pneumonia 822 (37.0) 1,399 (63.0) 2,221 (23.5) 
Malaria + Diarrhoea 404 (45.9) 476 (54.1) 880 (9.3) 
Pneumonia + Diarrhoea 83 (49.7) 84 (50.3) 167 (1.8) 
Malaria + Pneumonia + Diarrhoea 89 (26.2) 251 (73.8) 340 (3.6) 
Total 4,333 (45.8) 5,126 (54.2) 9,459 (100) 
Demographic characteristics and other features of the admission episodes, shown in 
Table 2.2-6, indicate that the groups were balanced with respect to most exposure and 
outcome variables except mortality which was slightly higher in the intervention group. 
Table 2.2-6: Demographic characteristics and characteristics of the admission episodes in the 
intervention and control hospitals in the first four surveys 
Characteristic Control Intervention Overall 
Age in months, median (IQR) 12 (7 – 24) 13 (7 – 24) 12 (7 – 24) 
Gender, percent male (95% CI) 45.6 (44.1 – 47.2) 44.8 (43.6 – 46.0) 45.1 (44.1 – 46.1) 
No. of diseases, median (IQR) 1 (1 – 2) 1 (1 – 2) 1 (1 – 2) 
Duration of admission, median (IQR) 3 (2 – 5) 3 (2 – 6) 3 (2 – 5) 
Mortality, percent (95% CI) 7.0 (6.3 – 7.8) 9.1 (8.4 – 9.7) 8.3 (7.8 – 8.8) 
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2.3. Source of data for external validation 
Two datasets are available for external validation. One is a cross-sectional survey of 22 
training hospitals in Kenya undertaken in 2012 by the Ministry of Health [MoH 2013], 
and the other is a retrospective cross-section of paediatric admissions in 7 hospitals. The 
aim of the 22-hospital survey was to evaluate routine service delivery in maternal, 
neonatal, paediatric, internal medical and surgical units of the surveyed hospitals. Data 
on process of care were collected from case record forms which were identified from 
inpatient registers starting from 31st May 2012 backwards until the desired sample of 
approximately 60 records per unit per hospital was achieved. The 7-hospital cross-
sectional data were collected in parallel with a trial seeking to demonstrate non-
inferiority of oral amoxicillin when compared to injected penicillin for the treatment of 
severe pneumonia. They span the period between September 2011 and August 2013 and 
include all children with non-surgical diagnoses admitted to the paediatric wards during 
the trial other than those randomised to either arm of the study. The purpose of 
collecting observational data in this trial was to determine whether children recruited 
into the trial differed systematically from other children receiving routine care. 
Together these two validation datasets count for 12,772 admission episodes over a 2½ 
year period not covered by the Kenyan district hospitals data. They are suitable for 
validating the proposed measure for a number of reasons. Firstly, they are broadly 
representative of the variety of practice settings which exist in the Kenyan health system 
compared to the relatively smaller sample of four hospitals per arm in the Kenyan 
district hospitals study which were systematically selected for inclusion into the study 
based on considerations of feasibility. There is however some overlap in the 
contribution of the various hospitals to the three datasets: 6 of the 8 hospitals in the 
district hospitals study were also included in the MoH survey of hospitals, and 4 of the 
22 hospitals in the MoH survey were among the 7 sites that were part of the study 
evaluating all hospital admissions linked to the pneumonia study. This is illustrated in 
Appendix A.6. Table 2.3-1 details the numbers of admission episodes and admitting 
clinicians in each of the two datasets. 
Secondly, the care provided to children in the validation datasets can be considered to 
be ‘routine’ because it was not subject to the influences of an external intervention 
specifically aimed at changing the quality of care. This is in contrast with the district 
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hospitals study which involved provision of different intensities of an intervention to 
both groups of hospitals, which potentially altered the environment of care making it 
less representative of the process of care in a routine setting. For example one 
component of the intervention was the provision of structured admission record forms to 
clinicians to facilitate documentation of the process of care. Although similar job aids 
are provided in many hospitals in Kenya their actual use is varied. One study 
established that when structured admission record forms were provided to clinicians in 
the absence of any other supervision or incentive, adoption ranged from 50% to 84% 
[Mwakyusa et al. 2006]. In the district hospitals study only 34 out of 2,450 admission 
episodes (1.4%), all from the same hospital, were made on a structured admission form 
at baseline before the intervention had a chance to catch on. 
To summarise, the validation data represent a different case mix of the three diseases, as 
shown in Figure 2.3-1 and Table 2.3-2, different mortality risks – 6.0%, 95% CI 5.5 to 
6.4 in the pneumonia study, and 4.7%, 95% CI 3.7 to 6.0 in the MoH survey data – and 
different demographic characteristics, presented in Table 2.3-3, as compared to the 
district hospitals data. Nevertheless there is sufficient overlap between the variables 
collected in them and those in the district hospitals data to allow for determination of 
whether the methods developed for measuring the quality of process of care in the latter 
situation are applicable to a more general setting. 
Figure 2.3-1: Summary of diagnoses and illness severity classifications observed in the data 
for external validation of the process of care measure 
The diagnoses are not mutually exclusive within patient and exclude diseases not of interest to 
this work. 
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Table 2.3-1: Number of admission episodes and clinicians across hospitals in the validation datasets 
Hospital ID  
(ID in DH 
dataset) 
No. of  Dataset  Hospital ID  
(ID in DH 
dataset) 
No. of  Dataset 
episodes clinicians  episodes clinicians 
1 1,952 70 Pneumonia trial  14 2,520 60 Pneumonia trial 
1 63 10 MoH survey  15 60 30 MoH survey 
2 (H5) 59 11 MoH survey  16 59 15 MoH survey 
3 541 31 Pneumonia trial  17 60 10 MoH survey 
4 60 20 MoH survey  18 2,181 122 Pneumonia trial 
5 1,756 73 Pneumonia trial  18 75 11 MoH survey 
5 60 19 MoH survey  19 60 9 MoH survey 
6 60 13 MoH survey  20 59 20 MoH survey 
7 (H1) 60 21 MoH survey  21 61 17 MoH survey 
8 (H6) 60 5 MoH survey  22 60 10 MoH survey 
9 (H7) 60 21 MoH survey  23 447 50 Pneumonia trial 
10 61 18 MoH survey  23 60 16 MoH survey 
11 (H2) 2,037 28 Pneumonia trial  24 60 8 MoH survey 
12 60 14 MoH survey  25 60 16 MoH survey 
13 (H3) 60 30 MoH survey  *1 observation in the pneumonia trial dataset is missing its hospital ID 
 
Table 2.3-2: Number (percentage) of episodes of each disease and disease combination in the two validation datasets 
Dataset None Malaria Pneumonia Diarrhoea Malaria and Pneumonia 
Malaria and 
Diarrhoea 
Pneumonia 
and Diarrhoea 
Malaria, 
Pneumonia 
and Diarrhoea 
Total 
POD* 3,956 (34.6) 1,165 (10.2) 3,846 (33.6) 1.381 (12.1) 263 (2.3) 71 (0.6) 729 (6.4) 24 (0.2) 11,435 (100) 
PSS** 535 (40.0) 151 (11.3) 559 (41.8) 34 (2.5) 36 (2.7) 7 (0.5) 13 (1.0) 2 (0.2) 1,337 (100) 
*POD = pneumonia trial observational data; **PSS = Ministry of Health survey data 
 
Table 2.3-3: Demographic characteristics and characteristics of the admission episodes in the two validation datasets 
Characteristic Pneumonia trial MoH survey Overall 
Age in months, median (IQR) 14 (7 – 34) 16 (8 – 30) 14 (7 – 33) 
Gender, percent male (95% CI) 55.5 (54.6 – 56.4) 58.4 (55.7 – 61.0) 55.8 (54.9 – 56.7) 
No. of diseases, median (IQR) 1 (0 – 1) 1 (0 – 1) 1 (0 – 1) 
Duration of admission, median (IQR) 3 (2 – 6) 3 (2 – 6) 3 (2 – 6) 
Mortality, percent (95% CI) 6.0 (5.5 – 6.4) 4.7 (3.7 – 6.0) 5.8 (5.4 – 6.3) 
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Chapter 3 – Scale Construction and Item Selection 
3.1. Introduction 
Measuring a construct such as quality of care involves assigning numbers or symbols to 
items related to it in a way that corresponds to their relationship with the construct 
[Rosenthal & Westen 2003]. For this reason constructing a scale for measurement 
begins with the identification of a set of such items. According to the domain sampling 
theory [Ghiselli et al. 1981, Kline 1960] there are many possible items which could be 
sufficiently related to any construct to justify their use in measurement, but it is not 
always possible to identify them all; selection therefore seeks to identify items which 
are most relevant for the intended application. Selected items are then summarised into 
a measure, often by adding up item scores. This summation may be weighted if there is 
good evidence of greater importance of some items over others; an unweighted sum of 
scores may however be preferred for its simplicity and intuitiveness. Subsequently the 
functional and numeric properties of the measure are tested and refined until a 
satisfactory measure is identified (Figure 3.1-1). These steps outline the approach to 
development of a novel measure that is adopted in this thesis. 
 
Figure 3.1-1: Generic steps in constructing a measure 
Dashed arrows are optional loops through which candidate measures are modified 
Functionally a measure and all its component parts should be seen to measure what it is 
intended to, and this constitutes its internal validity [Brewer 2000, Cozby 1993]. The 
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measure should also be externally valid, that is, applicable to a broad range of new 
settings which are sufficiently similar to those under which it was developed and to 
which it is intended to be used [Steckler & McLeroy 2008]. The measure should also be 
reliable; this refers to the consistency of measurement by its component parts or upon 
repeated use across time or by different raters [McDowell & Newell 2006]. A brief 
discussion of these concepts is presented in Appendix A.7. 
Numerically a measure should ideally exhibit normality, approximate normality or 
normality upon suitable transformation. This ensures that the intuitive measures of 
central tendency and dispersion such as means and variances, and the simpler and more 
powerful parametric statistical methods are valid for inference. The components of an 
observed measure, X, are theoretically related to the quantity of a construct’s attribute 
being measured, T, by: 
Xi ~ Ti + ei 
where e is normally distributed with a mean of zero and standard deviation of 1 and 
uncorrelated with T and itself across i. Under these circumstances X should be normally 
distributed or at least tend towards normal following the central limit theorem. The 
numerical properties of a measure are thus largely determined by its level of 
measurement, a brief discussion of which is presented in Appendix A.8. 
3.2. Approaches to measuring health-related constructs 
There is precedence to the application of the generic approach illustrated in Figure 3.1-1 
to the development of measures of health-related constructs. Many of these are well 
established measures with demonstrable relevance, reliability and validity which are 
still in use to date in their original or improved forms. Three specific applications of two 
broad examples are described here in brief. 
3.2.1. Example 1: prognostic scores 
The Glasgow Coma Scale (GCS) for evaluating and monitoring level of consciousness 
in individuals with brain trauma has been used successfully for almost thirty years, and 
attempts to replace it with other measures have mostly been unsuccessful due to its 
simplicity and practicality [Nye et al. 2012, Zuercher et al. 2009, Wijdicks 2006]. The 
GCS has three components, namely motor response, verbal response and eye opening. 
49 
 
Six grades of motor response are defined representing six distinct but ordered levels of 
motor activity. Similarly five levels of verbal response and four of eye opening are 
defined. Each component is scored separately as the patient’s level of response on that 
component and an overall score is created by summing the component scores. Higher 
scores represent better neurological function therefore less severe injury (Table 3.2-1). 
Table 3.2-1: Items scored in the Glasgow Coma Scale (GCS) and the Acute Physiology and 
Chronic Health Evaluation (APACHE) score  
Glasgow Coma Scale (GCS) 
 
Grades of Best Motor Response 
6 Carrying out requests 
5 Localising response to pain 
4 Withdrawal to pain 
3 Flexor response to pain 
2 Extensor posturing to pain 
1 No response to pain 
 
Grades of Best Verbal Response 
5 Oriented 
4 Confused conversation 
3 Inappropriate speech 
2 Incomprehensible speech 
1 No verbal response 
 
Eye Opening 
4 Spontaneous eye opening 
3 Eye opening in response to speech 
2 Eye opening in response to pain 
1 No eye opening 
 
Interpretation of total score: <9: severe 
injury, 9-12: moderate injury, 13-15: 
minor injury 
Acute Physiology and Chronic Health Evaluation 
(APACHE II) items and their scores for 
derangement from normal 
 
Age 0-6 
Haematocrit 0-4 
White blood cell count 0-4 
Rectal temperature 0-4 
Mean arterial blood pressure 0-4 
Heart rate 0-4 
Respiratory rate 0-4 
Serum sodium 0-4 
Serum potassium 0-4 
Serum creatinine 0-4 
Serum bicarbonate 0-4 
Oxygen saturation 0-4 
Alveolar-arterial oxygen concentration gradient 0-4 
Arterial pH 0-4 
History of immunocompromisation or organ failure 0-5 
Glasgow Coma Scale score 0-15 
 
Estimated mortality risk for total scores: 0-4: 4%, 5-
9: 8%, 10-14: 15%, 15-19: 25%, 20-24: 40%, 25-29: 
55%, 30-34: 75%, >34: 85%. 
A similar approach is taken in the Acute Physiology and Chronic Health Evaluation 
(APACHE) score for classifying severity of illness for patients admitted for intensive 
care [Knaus et al. 1985]. Items indicative of acute and chronic health status are assigned 
scores mostly between 0 and 4 to represent their derangement from normal levels or 
levels associated with the best prognosis. For example, very high and very low heart-
rates are scored 4, intermediately high and low ones 2 and normal rates scored 0. The 
item scores are summed up to a total APACHE score; higher scores represent increased 
risk of mortality. 
There have been several studies of these associations which have shown high agreement 
between score-predicted and observed mortality [Minne et al. 2008, Zimmerman et al. 
2006, Markgraf et al. 2000, Vassar et al. 1999, Zimmerman et al. 1998, Beck et al. 
1997, Murphy-Filkins et al. 1996, Zhu et al. 1996]. Where agreement has been poor 
 attempts have been undertaken to refine and improve the scores. Refinements to t
original APACHE score for example have produced the APACHE II and APACHE III 
scores which have even better accuracy in predicting mortality than the original score 
[Mann et al. 2012, Zali 
mortality risk using their total score 
3.2.2. Example 2: quality of life measures
Quality of life measures
more traditional clinical and economic outcomes commonly reported in 
research, quality of care and healthcare evaluation liter
1999]. They are not only inherently subjectiv
observable and non-observable factors 
quality of life measures are multidimension
relating to physical and psychological well
of activities, but may also include
health perception [Smith 
Figure 3.2-1: Determinants of  quality of life in a health
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et al. 2012]. It is currently possible to 
– these estimates are shown in
 
 can be thought of as humanistic outcomes in contrast to the 
ature [Maloney & Chaiken 
e, but also highly confounded by many 
such as those summarised in 
al constructs, encompassing several 
-being often described in terms of limitation 
 items to quantify pain, vitality, cognition and general 
et al. 2005].  
-related quality of life conceptual model 
he 
predict a patient’s 
 Table 3.2-1. 
clinical 
Figure 3.2-1. Many 
items 
 
 
[Wilson & Cleary 1995] 
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Items contributing to quality of life measured vary widely across measures: the original 
WHO Quality of Life Group Scale (WHO-QOL) has 15 items [Burckhardt & Anderson 
2003], the Nottingham Health Profile (NHP) has 38 items [Hunt et al. 1985], and the 
Sickness Impact Profile (SIP) has 136 items measuring 2 dimensions of well-being 
[Gilson et al. 1975]. There is some overlap of items across the measures. These 
differences and their subjective nature could be part of the reason quality of life 
measures do not always yield consistent results even when used together in the same 
study [Klevsgård et al. 2002, Chetter et al. 1997]. Additionally, unlike with prognostic 
scores, it is not always possible to validate a quality of life measure using an objective 
outcome even when links to such an outcome may be obvious at face value. Such 
outcomes may simply be non-existent for that measure, or perhaps links with the 
construct it is thought to measure may be difficult to demonstrate due to complex, 
poorly-defined or highly confounded relationships. 
Nevertheless none of these shortfalls invalidate their use as outcome measures in their 
own right. In fact quality of life measures have become the main tools for assessing 
health status according to patients’ own experiences, allowing impacts of illnesses or 
interventions to be examined from patients’ points of view [Smith et al. 2005]. Utility 
measures such as Quality Adjusted Life Years (QALYs) and Disability Adjusted Life 
Years (DALYs) have been derived from health related quality of life measures by 
combining them with measures of quantity of life. QALYs and DALYs are interpreted 
as population-averaged preferences of alternative health statuses [Smith et al. 2005] and 
are used in evaluating cost-effectiveness of many health interventions [Sassi 2006, 
Prieto & Sacristan 2003]. 
3.3. Item selection for quality of care measurement 
3.3.1. General considerations in item selection 
There are parallels between the properties of quality of life measures and prognostic 
scores, and the features of a quality of care measure which could inform the selection of 
suitable items for the measure. One is that if an objective or desired outcome – such as 
death or survival, physiological states and duration of hospital stay – is known or 
thought to be associated with the items to be used for constructing the measure, then 
item selection can be based on how well the items relate to the objective or desired 
outcome. This explains why items such as indicators of verbal and motor response, 
52 
 
which are physiologically related to level of incapacity and risk of death, are included in 
a prognostic score. Ideal as this approach may be in informing item selection for the 
quality of care measure, it is not always possible to clearly demonstrate associations 
between indicator items and an objective outcome, and it may simply be sufficient that 
there is a reasonable expectation that the candidate items relate to what could plausibly 
lead to desirable outcomes. Alternatively, suitable items for the proposed measure may 
be ones that relate to a targeted or preferred standard of care, just as QALYs and 
DALYs relate to preferred health statuses. 
In this thesis it is the standards of care described by clinical practice guidelines for 
management of acute childhood illnesses which will inform item selection. This is a 
hybrid of the approaches to item selection for prognostic scores and quality of life 
measures: it is similar to the prognostic scores in that it implicitly links the items 
contributing to the measure – derived from guideline recommendations – to the best 
possible outcomes. It is also similar to the quality of life measures by focusing on items 
that measure how well what is done at the point of care is aligned with what ought to be 
done, in so doing linking the measure to an established desired level of care, just as 
items in quality of life measures relate to desired levels of physical and mental well-
being. It thus provides a good starting point to flagging weaknesses in the process of 
care which if reduced or eliminated could improve outcomes and overall care. 
Importantly, this approach solely focuses on appropriateness of processes at the point of 
care. It does not attempt to describe or quantify other contextual factors and health 
system complexities known to influence quality of care such as (lack of) resources, 
institutional and government policies, and organizational culture. In so doing it 
potentially represents a major leap forward in a low-income setting where routine 
quality of care measurement and reporting is virtually non-existent making it impossible 
to examine causes of variation in outcomes across places.  
3.3.2. Guideline-defined standards of care 
In Kenya, standards of in-patient care for children are defined in the Basic Paediatric 
Protocols [MoH 2010, MoH 2007, MoH 2006]. These are a set of practice guidelines 
for health care workers who provide care to hospitalized children. The guidelines aim to 
steer care towards practices which are linked to good outcomes. They provide guidance 
on key diagnostic signs of illness to be documented during initial clinical assessment, 
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criteria for distinguishing illness severity based on history, signs and symptoms and 
diagnostic test results, and recommendations on treatments appropriate for various 
illnesses and severity classifications (Figure 3.3-1, Figure 3.3-2 and Figure 3.3-3).  
 
Figure 3.3-1: Guidelines on clinical management of malaria from the Basic Paediatric 
Protocols 
AVPU = alert, responsive to voice, responsive to pain, unconscious; a scale for 
characterising a patient’s level of (un)consciousness 
AL = artemether-lumefantrin, a fixed dose combination antimalarial drug that is the 
first-line of treatment for non-severe malaria at the time of publication of these 
guidelines 
[MoH 2010] 
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Figure 3.3-2: Guidelines on management of acute respiratory infections and pneumonia from 
the Basic Paediatric Protocols  
AVPU = alert, responsive to voice, responsive to pain, unconscious, a scale for 
characterising a patient’s level of (un)consciousness 
URTI = upper respiratory tract infection 
[MoH 2010] 
 
  
55 
 
 
Figure 3.3-3: Guidelines on management of diarrhoea/dehydration from the Basic Paediatric 
Protocols  
AVPU = alert, responsive to voice, responsive to pain, unconscious, a scale for 
characterising a patient’s level of (un)consciousness  
GE = gastroenteritis 
ORS = oral rehydration salt solution 
[MoH 2010] 
Directions on the use of recommended drug treatments including dosages, routes, 
frequencies and durations of treatment are also given in the protocols (Appendix A.9). 
From these protocols three distinct steps in the process of care can be defined which not 
only represent different dimensions of process but also distinct competencies. An initial 
assessment step encompasses the documentation of signs and symptoms key to 
identifying illnesses and determining their severity. It may be guided by tools (such as a 
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paper or computer-based structured assessment tool) and may simply involve following 
rules in checking off signs and symptoms. 
This step is followed by the diagnosis phase which sets out algorithms on how the 
recorded clinical signs and symptoms can be used to identify the presenting illness. 
There is also guidance on classifying illness severity based on the presence or absence 
of danger signs. From a process of care perspective it represents a cognitively more 
complex set of tasks than assessment and is highly dependent on a complete assessment. 
The third step is the treatment step. Guidance on treatment steers the choice of correct 
drug(s) for treating the diagnosed illness and severity classification and their correct 
use. Accurate treatment is also a cognitively complex task as it requires integrating the 
drug use and dosing information presented in guidelines and calculation of very specific 
dosages. It is less dependent on completeness of information from other domains since 
once a choice is made to follow any course of treatment then that treatment ought to be 
provided as recommended. The guidelines thus provide a starting point for identifying 
suitable quality ‘items’ to be used for constructing the quality of care measure. 
3.3.3. Domains in the proposed quality of care measure 
Many measures found in the literature group items into domains: these are abstract 
higher-level units representing distinct dimensions of the construct of interest which are 
themselves of interest in their own right. Indeed domain-level measures are simply 
distinct elements of an overall summary measure which quantify how its different 
conceptual parts contribute to the measure. For example, the original 15-item WHO-
QOL considered quality of life to span five domains named material and physical well-
being, relationships with other people, social, community and civic activities, personal 
development and fulfilment, and recreation [Burckhardt & Anderson 2003]. The 
Nottingham Health Profile quantifies stress related to potentially disabling conditions 
through six domains namely pain, physical mobility, emotional reactions, energy, social 
isolation and sleep [Klevsgård et al. 2002]. 
In a similar fashion indicator items identified from guideline-recommended phases of 
process of care can be grouped into distinct domains of generic relevance to the clinical 
process. In this thesis three domains are proposed, and nomenclature linked to 
conceptual labels of sets of guideline-recommended clinical processes undertaken at 
each domain are assigned to them. These are: assessment of signs and symptoms of 
 disease (‘assessment’), diagnosis of disease and classification of severity 
(‘classification’), and treatment
allow for the use of different items 
measures) but linkable to common domains for scoring 
measures). Conceptually domains also allow 
disease episodes within patients (admission or episode
patients (patient-, clinician
effectively provides an 
the key capabilities required of 
specific measures allow for the identification of ‘problem areas’ in the process of care; 
2) disease-specific measures provide the capability to identify
poor; 3) patient-specific measures enable the exami
admission experience and, potentially, linking of care to outcomes with adjustment for 
important individual-
clinician, departmental
care. Figure 3.3-4 provides an outline of the design of the measure proposed in this 
thesis which has not been reported in literatur
Figure 3.3-4: Outline
individual level. 
Items contributing to the measure and which may be unique for each illness are 
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same clinician or at a department or 
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3.4. Summary 
A measure of quality of care is proposed to quantify how well the process of care for 
admitted children follows the recommended standards of care set out in clinical practice 
guidelines. The measure is constructed by first identifying relevant indicator items for 
process of care from the Basic Paediatric Protocols – these are the established standards 
of paediatric inpatient care for children admitted to Kenyan hospitals suffering from the 
commonest causes of illness in this age group. The binary scores from these items are 
then summed into a measure intended to characterise care at the patient level, allowing 
for adjustment for other important predictors of care at this level as may be required in 
statistical analysis, and also being aggregated at higher levels for reporting to target 
audiences for the purposes of quality assurance and improvement. The construction of 
the proposed measure follows a widely accepted approach to creating a novel metric for 
a multidimensional construct as illustrated with some examples of measures of other 
health related constructs. Nevertheless there is a need to demonstrate that the same 
approach, when applied to a measure of quality of care, possesses the desired functional 
properties – good reliability and validity – which positively impact on its suitability for 
the intended applications. Chapter 4 describes the statistical methods for exploring and 
testing these properties. 
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Chapter 4 – Statistical Methods 
4.1. Introduction 
This Chapter presents an overview of the two main statistical methods underlying the 
analyses to be applied in testing some characteristics of the proposed measure. The first 
is factor analysis, a multivariate approach to exploring patterns of variation in the items 
contributing to a measure. It is needed for exploring the proposed abstraction of items 
into domains. Related to this are polychoric correlation coefficients for measuring 
correlations between binary items. The second group of methods is generalised linear 
models. These are required for examining the association between the proposed measure 
and objective outcomes of care to establish external validity, and also for assessing 
agreement between different measures.  
4.2. Proposed exploration of item groupings and domains 
Item selection and aggregation has to this point relied on logical arguments about how 
items relate to quality of care and aggregate together in domains, because this approach 
is arguably important when attempting to design a measure that is meaningful to health 
workers, managers and policy makers. However there are statistical methods to help the 
score development process further by not only examining the structure of relationships 
among items, but also between them and a construct. This can be undertaken even in the 
absence of a hypothesis about these relationships, and allow for testing the assumptions 
underlying these relationships. The most commonly reported of these techniques is 
factor analysis: this is a set of procedures which helps identify relationships between 
items and group them into factors – analogous to the domains previously discussed – 
representing sub-groups of items which define discrete characteristics within a construct 
[Nunnally & Bernstein 1994]. 
4.2.1. Overview of factor analysis 
The main assumption in factor analysis is that there exist factors, F1, F2, F3… Fm, which 
are not directly observed but which manifest themselves through observable items T1, 
T2, T3… Tn measured with some errors e1, e2, e3… en that are independent of both the 
factor and each other and identically distributed with a mean of zero and some variance. 
Given a factor, Fm, the items measuring it are independent of each other and any 
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relationship between items is only through the factor (Figure 4.2-1). Models that make 
this assumption are known as orthogonal factor models while those that relax this 
assumption are called dependent factor models. 
 
Figure 4.2-1: Path diagram showing the relationship between latent factors, Fm, observed 
items, Tn and measurement errors, en 
Factor analysis is about examining correlations between items and factors. The 
correlation between the factor, Fm and any item, Tn, is measured through the item’s 
loading on the factor, λnm. If the items are normally distributed with zero mean and unit 
variance then the loadings are equivalent to the regression slope of the corresponding 
item on the factor or a correlation between the item and the factor, or the proportion of 
variability in the item explained by the factor. Factor loadings, which range in value 
from -1 to 1, could be interpreted in a similar fashion as regression coefficients or path 
coefficients in path analysis, that is, the magnitude and direction of the link between 
items and factors.  
The path diagram in Figure 4.2-1 can be expressed mathematically as: 
T1 = λ11F1 + λ12F2 + λ13F3 + … λ1mFm + e1 
T2 = λ21F1 + λ22F2 + λ23F3 + … λ2mFm + e2 
Tn = λn1F1 + λn2F2 + λn3F3 + … λnmFm + en 
It can also be expressed in matrix notation as: 
Tnx1 = λnxm Fmx1 + enx1 
which is equivalent to:
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Figure 4.2-2: Matrix notation for factor analysis 
The error terms e1 – en are independent of each other so that E(en) = 0 and Var(en) = 
σ2n.The factors Fm are independent of each other and of the en such that E(Fm) = 0 and 
Var(Fm) = 1. Each factor is therefore a combination of items, loadings and errors. Every 
item may load on more than one factor but the maximum number of factors that can be 
extracted from a set of items is equal to the number of items. In the context of this work 
this implies that more domains could in theory be identified from the list of quality 
items and each item can ‘belong’ to more than one domain. For this reason the final 
design of the score must not only be consistent with an identifiable factor structure but 
also be clinically relevant. 
The variance of each item can be calculated as a function of all the factors it loads on as: 
Var(Tn) = λ2n1Var(F1) + λ2n2 Var(F2) + λ2n3 Var(F3) + … λ2nm Var(Fm) + Var(en) 
= λ2n1 + λ2n2 + λ2n3 + … λ2nm + σ2n  
The proportion of total variance in an item explained by the factors, termed 
communality of the item, is the sum of loadings of all the factors it loads on (λ2n1 + λ2n2 
+ λ2n3 + … λ2nm). This intuitively suggests that items with high communality load on 
more factors and are therefore less unique. A related characteristic, the uniqueness of an 
item, is given by 1 minus its communality. This implies that higher communalities 
correspond to higher factor variances, while higher uniquenesses correspond to higher 
error variances. The simplest approach to estimating item communalities is the principal 
components analysis (PCA) method described in section 4.2.3. It accounts for all 
variance in the correlation matrix, including variances due to measurement error 
[Nunnally & Bernstein 1994]. Due to this method’s dependence on total variance it is 
important that the items being considered be measured on the same scale. If this is not 
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the case they may be standardised to have zero means and variances of 1 (giving total 
variances equal to the number of items), or using correlation coefficients obtained from 
the correlation matrix of the items. The latter method is usually applied in PCA. An 
approach which removes measurement error from an item’s unique variance in the 
correlation matrix is the common factor analysis which results in total extracted 
variances of less than 100%. 
4.2.2. Characteristics of item correlations, variances and covariances in factor 
analysis 
Factor analysis makes repeated use of correlations or covariances to examine 
relationships between items. The covariance between two sequential items Tn and T(n-1) 
is: 
Cov(Tn,T(n-1)) = λn1λ(n-1)1Var(F1) + λn2λ(n-1)2 Var(F2) + λn3λ(n-1)3 Var(F3)  +…+ λnmλ(n-1)m 
 Var(Fm) = λn1λ(n-1)1 + λn2λ(n-1)2 + λn3λ(n-1)3  +… + λnmλ(n-1)m 
The variances and covariances are arranged into a symmetric matrix implied by the 
model assumptions: the theoretical variance-covariance matrix. An observed variance-
covariance matrix is then obtained from the observed items. Since the factors are 
unobservable and unitless, it is often assumed for the sake of mathematical convenience 
that they are standardised; this allows the interchangeable use of correlations and 
covariances in the estimation procedure. An iterative algorithm is then applied to 
produce factor estimates and loadings corresponding to a theoretical matrix which is as 
close to the observed one as possible. 
If there are sufficient relationships to enable identification of common underlying 
factors then this covariance or correlation matrix should be significantly different from 
an identity matrix, I. For this not to be the case would imply no relationship at all 
between any two items. The Bartlett’s test of sphericity is an initial chi-squared test to 
examine whether a set of items is factorable by checking that the correlation matrix is 
sufficiently different from an identity matrix [Bartlett 1950]. If N observations on t 
items have a correlation matrix whose determinant is |D| then the test statistic, which 
has ½ t(t – 1) degrees of freedom, is: 
χ = −  − 1 −  
2 + 56   || 
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The correlation matrix must also be invertible. If C is a correlation matrix then its 
inverse, C-1, is the matrix such that [C][C-1] = I. To be invertible the determinant of a 
matrix must not be zero [Hays 1994]. The determinant is calculated by Laplacian 
expansion [Doherty et al. 1949]. For example, for a 2x2 matrix it is the difference 
between the products of all elements of the matrix’s leading and lagging diagonals. A 
non-invertible square matrix – a singular or non-positive definite matrix – has a zero 
determinant and is not factorable [Fraleigh et al. 1994]. Such a situation may arise if 
items are too highly correlated with each other as may be the case if some items are a 
combination of others. The dependent items must then be removed from the analysis.  
Every factorable n x n correlation matrix is also associated with n values of a scalar, λ, 
such that: 
|C – λI| = 0 
Each λ is an eigenvalue of the correlation matrix C and is associated with an n x 1 
column vector, v, such that: 
Cv = λv 
Similarly each v is an eigenvector of C. In factor analysis eigenvectors and eigenvalues 
correspond to factors and the amount of variance they explain, respectively. Factor 
loadings are the product of the elements of each eigenvector and the square-root of its 
eigenvalue. 
4.2.3. Factor extraction 
Factor analysis begins with an examination of the pattern of correlations between items 
to identify those that are highly correlated with each other; these are assumed to be the 
observed manifestations of the same unobserved factors, and the less uncorrelated items 
are assumed to be influenced by different factors [DeCoster 1998]. The aim of the 
process is to recreate the correlation matrix of the observed items using a set of factors 
which is a function of the observed items [Pett et al. 2003]. 
Computationally, factor extraction begins with the creation of an arbitrary row vector – 
the first trial eigenvector – by adding up the elements of each of the columns of the 
correlation coefficient. The sum of the squared elements of the trial eigenvector gives 
the length of the vector. Each of this vector’s elements is then divided by the square-
root of its length to obtain the first normalized trial vector. The sum of squares of the 
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elements of a normalized vector is always 1. This vector is also an approximation of the 
eigenvector of the first factor; a better estimate – the second trial eigenvector – is 
obtained by multiplying it by the original correlation matrix. A second normalized trial 
vector is obtained from the second trial eigenvector by dividing each of its elements by 
the square-root of its length. This iterative process is repeated until the sum of squared 
differences between the final and penultimate normalized trial vectors is less than 
0.00001 – at this point convergence has been achieved [Kline 1994]. The final 
normalized vector is the first eigenvector of the correlation matrix, and the square-root 
of final trial eigenvector’s length is its first eigenvalue. Item loadings on the first factor 
are the product of the first eigenvector and the square-root of its eigenvalue. 
Item loadings on the second factor are obtained following the same iterative process, 
starting with a residual matrix of the original correlation matrix from which the effect of 
the first factor has been subtracted. The squared elements of the leading diagonal of a 
matrix made up of all possible cross-products of factor loadings of the first factor 
provides an estimate of its effect. The leading diagonal of the residual correlation matrix 
is no longer made up of 1’s but the proportion of remaining variance unexplained by the 
first extracted factor, and many of the remaining correlations are small or even negative; 
this presents a problem because to identify any remaining factors there must be 
sufficient residual correlation between items even after extraction of initial ones. The 
solution is to identify columns of the matrix for which if the negative correlation 
coefficients of their elements are inverted then column sums, hence correlation 
coefficients, are maximised. Later when factor loadings have been estimated the 
negative signs will be restored to them. The maximised column sums are now the 
second trial eigenvector, and the process proceeds to convergence as previously 
described. 
The extraction procedure described in the last two paragraphs is called the principle 
components analysis (PCA). There are other extraction methods which vary slightly 
from this. For example the principal factor analysis (PFA) method begins by inserting 
communalities estimated from the squared multiple correlations or highest absolute 
correlations in a row into the leading diagonal of the correlation matrix to replace the 
1’s then proceeding like in a PCA; iterative principal factor (IPF) or least squares 
method is akin to a PFA with re-estimation of communalities after each factor 
extraction; and maximum likelihood method is an iterative procedure that assumes 
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normal distribution of factors and uses a likelihood function that maximizes parameters 
to estimate them. 
The maximum number of extractable factors is equal to the number of items. However 
each successive factor explains only part of the variability remaining after extraction of 
– and always less overall variability than – the previous ones. Thus if the aim of the 
analysis is to identify a set of factors responsible for most of the variability in the items 
(a form of ‘data reduction’) then factor extraction is stopped when factors explaining a 
pre-determined amount of variability have been extracted, a pre-planned number of 
factors have been obtained, or factors with eignevalues greater than 1 have been 
identified. Ultimately it is the interpretation and intended application of the extracted 
factors that should be used as a guide on the number to be extracted [Nunnally & 
Bernstein 1994]. 
Finally to improve interpretability of the extracted factors, item loadings are jointly 
‘rotated’ so that loadings are highly positive or negative on some factors while very low 
on others. If the factors are thought to be completely independent then orthogonal 
rotation techniques are applied. These achieve rotation through maximizing squared 
loading variances across items by adding over factors (varimax rotation) or across 
factors by adding over items (quartimax rotation). Alternatively if there is thought to be 
some relationship between factors then oblique rotations which minimize squared 
loading covariance between factors (oblimin) or use simplified orthogonal rotation 
(promax) are applied. 
4.2.4. Exploratory and confirmatory factor analysis, and structural equation 
modelling 
Factor analysis could be undertaken to identify and quantify factors relating to observed 
items, or to test theorized factor models against observed data. These distinct 
applications, summarised in Table 4.2-1, are referred to as exploratory factor analysis 
(EFA) and confirmatory factor analysis (CFA) respectively. Generally EFA is applied in 
situations where the underlying construct or domain structure of data is unknown while 
CFA is used when there is a theory about domain structure to be tested. EFA may be 
used to generate a theory on domain structure followed by CFA to test the theory. For 
the latter application it is advisable fit the confirmatory model on different dataset (e.g. 
a validation dataset) or different halves of the same dataset if there is still a sufficient 
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number of observations in the split dataset, remembering that factor analysis requires 
relatively large number of observations compared to many other multivariate methods. 
EFA and CFA may also be applied in repeated cycles to generate, modify and refine 
theories about the underlying factor structure in observed data. 
Table 4.2-1: Contrasting exploratory and confirmatory factor analysis 
Exploratory factor analysis (EFA) Confirmatory factor analysis (CFA) 
Steps 
1. Measure construct of interest using 
suitable items 
2. Create the correlation matrix of the items 
3. Select a number of factors to retain 
4. Extract the factors 
5. Rotate the factors 
6. Interpret the factors 
7. Create factor scores for further analysis if 
required 
1. Define factor model 
2. Measure construct of interest using 
suitable items 
3. Create the correlation matrix of the items 
4. Fit defined factor model to the data 
5. Test goodness of fit of model 
6. Compare with alternatively formulated 
factor models 
Uses 
• Identify nature of factors influencing 
measures 
• Determine how items group together into 
domains 
• Show the dimensions of a construct that a 
scale is capable of measuring 
• Identify the most important domains of 
constructs. 
• Create factor scores to be used for further 
analyses 
• Test the validity of any given factor 
model 
• Compare the fits of alternate factor 
models to the same data 
• Compare factor loadings and test their 
significance 
• Examine correlation between factors 
• Examine convergent and discriminant 
validity of different measures 
[DeCoster, 1998] 
Structural equation modelling (SEM) is a technique that combines CFA with multiple 
regression [Ullman 2001]. An SEM has two parts: a measurement model – the CFA– 
and a structural model (also referred to as a path model) which is essentially a series of 
linear relationships estimated simultaneously using multiple regression. The regression 
component in SEM is used to explore associations between observed non-measurement 
exogenous (independent) variables and latent variables estimated through CFA, and also 
with endogenous (dependent) variables in causal hypotheses. Thus SEM extends the 
hypothesis testing approach in CFA to a multivariate analysis of a theory that poses 
causal relationships among several variables [Lei & Wu 2007]. 
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4.2.5. Goodness-of-fit assessment for factor analysis models 
Model fit assessment begins by working back from the error variances and predicted 
correlations to obtain the item correlation matrix implied by the extracted factors; this is 
then compared to the original correlation matrix [Prudon 2013, Hooper et al. 2008]. The 
difference between these two matrices is the residual matrix, which is a function of 
prediction error of the model and random error arising from the estimation sample 
[Cudeck & Henly 1991]. If the correlation matrix implied by the factor analysis model 
is: 
I = L' L + Ψ 
where L is a matrix of the factor loadings, the diagonals of the matrix Ψ bear the 
variances, and: 
 
where S as the sample correlation matrix, then a test statistic for goodness of fit – the 
Bartlett-Corrected Likelihood Ratio Test Statistic – is given by: 
 
where t is the number of items, m the number of factors and n the number of 
observations. The degrees-of-freedom for the χ2 statistic is: 
 =   +  −  − 2  
Under the null hypothesis there is no difference between the matrices and χ2 should be 
small; a large value (corresponding to a small p-value) therefore indicates poor fit. 
However, because χ2 is a function of n, large samples (approximately n > 200) will 
almost certainly correspond to small χ2 values, regardless of model fit. For this reason 
other fit indices are often preferred for larger studies. They either assess how far the 
model is from a perfect fit (absolute fit indices), how far the model fit is from the best 
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possible fit for the data (incremental or relative fit indices), or how well the model fits 
with adjustment for its complexity and sample size (parsimony fit indices).  
They include: 
• root mean square error of approximation (RMSEA), an absolute fit index which 
is a modification of the χ2 which favours large samples: 
 =   χ − 1! − 1  
Smaller RMSEAs indicate better fitting models. Conventionally models with 
RMSEA equal to or less than 0.06 are considered to be well fitting [Hu & 
Bentler 1999]. 
• standardised root mean square residual (SRMSR) which is also an absolute fit 
index obtained from the sum of the squared residuals comparing the sample 
correlation matrix to the implied correlation matrix as follows: 
 =  "1# $%& − '%& 
where r is the number of residuals given by t(t+1)/2 [Jöreskog & Sörbom 1988]. 
Similar to the RMSEA smaller values of SRMSR indicate better fits, but unlike 
the former this index is not based on the χ2. The conventional cut-off for a 
model to be considered well-fitting is SRMSR equal to or less than 0.08 [Hu & 
Bentler 1999]. 
• Tucker-Lewis index (TLI) [Tucker & Lewis 1973] which is a comparative fit 
index. It is the ratio of the χ2 of the implied correlation matrix to that of a null 
model that assumes that all items are uncorrelated: 
()' =  χ !* − χ +,+-
χ − 1 !*  
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The closer the TLI is to 1 the better the model fit. The conventional cut-off for a 
well-fitting model is a TLI equal to or greater than 0.90. Some studies have 
suggested a higher threshold of 0.95 to further reduce the risk of accepting mis-
specified models [Bentler 1990, Hu & Bentler 1999]. The TLI is also sensitive 
to sample size: it sometimes indicates poor fit even when other indices point to 
good fit when sample sizes are small [Bentler 1990, Kline 2005, Tabachnick & 
Fidell 2007] 
• Comparative fit index (CFI) [Bentler 1990] which is similar to the TLI in its 
derivation and interpretation: 
./' = 1 − χ − +,+-χ − !*  
• Akaike information criterion (AIC) [Akaike 1974], a parsimony fit index 
obtained by 2k – 2loge(L) where k and L are the number of parameters and the 
maximum likelihood estimate of the model, and a variety of eponymous 
goodness-of-fit indices which adjust for sample size and model complexity. 
The various fit indices give information on different aspects of the fit of the factor 
analysis model; it is therefore good practice to report at least one of each type [Hooper 
et al. 2008]. It is also worth noting that although it is common practice to use 
conventional cut-offs of fit indices to decide whether to reject or adopt a model, fit 
indices have different sensitivities to peculiarities across models, such as sample sizes 
and degrees of freedom [Fan & Sivo 2007]. For this reason the suggested cut-offs 
should not be interpreted too strictly. Table 4.2-2 provides some guidance on the 
interpretation of three commonly reported fit indices. 
Table 4.2-2: Suggested criteria for assessing the fit of confirmatory factor analysis models 
Fit index Good fit Acceptable fit Marginal fit Poor fit 
CFI > 0.95 0.90 – 0.95 0.85 – 0.89 < 0.85 
TLI > 0.95 0.90 – 0.95 0.85 – 0.89 < 0.85 
RMSEA < 0.05 0.05 – 0.08 0.09 – 0.10 > 0.10 
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4.3. Application of factor analysis to the development of a measure of 
process of care 
Factor analysis can enrich the score development process in several ways. First, as 
noted at the beginning of this section, the initial phases of the process have relied on a 
plausibility approach to determine the properties of a measure that make it sensible and 
meaningful to its target audience and users. A confirmation of the proposed domains 
and item relationships may demonstrate the internal consistency of the design of this 
measure. This can be achieved by performing factor analysis on a test dataset to identify 
latent factors most responsible for observed variability. 
Secondly, the factor extraction process allows for identification of items which do not 
add value to the score, either because they are redundant due to very high correlation 
with other items, or because they do not exhibit sufficient variability across individuals 
or places to be useful in measuring variability in the process of care. This arguably 
increases the sensitivity of the measure to real and clinically significant changes in the 
process of care which the measure seeks to identify in the first place. 
Lastly, a combined application of exploratory and confirmatory factor analysis can test 
and refine the proposed score design to yield a more robust measure better supported by 
data or one which better fits the proposed application. Factor analysis also allows for the 
testing of various assumptions about how the domains relate to each other, for example, 
whether data supports the idea that they could be completely independent of each other 
(as proposed in an orthogonal factor model) or whether there are indeed some 
relationships between them. 
4.4. Comparison of alternate candidate measures 
Refining the design of the proposed measure is likely to yield alternative formulations 
of the measure. Comparisons between the different forms of the measure allows for 
alternate-form reliability testing, and investigation of potential loss of information that 
can be taken into account to inform any necessary design adjustments. The choice of 
method for comparison depends on characteristics of the measures being compared, 
such as the type of scale of measurement (whether categorical or continuous), 
multiplicity of comparison (i.e. simultaneous comparison of two or more measures) and 
whether additional sources of variation are to be accounted for in the comparison. 
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The Pearson correlation coefficient, r, this is the most commonly reported measure of 
the relationship between measures or variables in data. It quantifies the strength of a 
linear relationship between a pair of continuous measures Xi and Yi [Pearson 1901]. It is 
given by: 
# = ∑ y2 − y3x2 − x35%678∑ y2 − y39267 8∑ x2 − x39267  
It is constrained to -1 ≤ r ≤ 1. Values close to these extremes imply strong linear 
relationship. Positive and negative values imply positive and negative linear 
relationships (correlations) respectively. Zero values mean there is no correlation 
between the two measures; however, this is not the same as there being no relationship 
between them – two measures with a quadratic relationship may have a correlation of 
zero because the relationship between them can be perfectly non-linear. A suggested 
interpretation of the absolute values of r is, in increasing quintiles, ‘very weak’, ‘weak’, 
‘moderate’, ‘strong’ and ‘very strong’ correlations respectively [Evans 1996, Cohen 
1992, Taylor 1990]. A Pearson correlation is only valid for measurements on an interval 
or ratio scale and which are both normally distributed; it is sensitive to deviations from 
normality including skewness and outliers. A non-parametric equivalent for non-
normally distributed interval or ratio scale measures is the Spearman rank correlation 
coefficient, ρ, which is essentially a Pearson correlation coefficient calculated not on the 
raw continuous measures Xi and Yi but on their ranks. 
For measures on an ordinal scale, such as binary and ordered categorical measures, 
polychoric correlation coefficients are the appropriate way of examining linear 
relationships [Pearson 1901]. These can be used even if the measures being examined 
have different numbers of categories. Polychoric correlations have one characteristic in 
common with factor analysis: they are a special case of latent trait modelling. They are 
based on the assumption that underneath the ordinal scale of a measure is a continuous 
normally distributed latent trait, and that the levels of the scale represent ordered 
categories of the trait which depend on some underlying thresholds [Uebersax 2006]. In 
calculating polychoric correlations this trait need not necessarily be normally 
distributed; any unimodal and approximately symmetrically distributed trait is sufficient 
to estimate valid polychoric correlation coefficients. 
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If X1 and X2 are measures of the same outcome on scales 1 and 2, and Y1 and Y2 are the 
underlying latent trait levels distinguished into the observed ordered levels of X1 and X2 
by some thresholds on Y1 and Y2; assuming the true unknown level of the trait is L, then: 
Y1 = βL + u1 + e1 and Y2 = βL + u2 + e2 
where u is the observer-specific impression of the trait measured with error e1, e2 ~ N(0, 
σe) independent and identically distributed, and var(e1) = var(e2). 
This can be simplified to:  
Y1 = β1L + e1 and Y2 = β2L + e2 
If L is standardised to be N(0, 1) then var(Y1) = var(Y2) = 1, and also β1 = β2 = β,  and 
the polychoric (tetrachoric if X1 and X2 are binary) correlation coefficient r is given by 
β2. 
Factor analysis of categorical measures uses polychoric correlation matrices of items to 
identify patterns of relationships between them when performing the factor extraction 
procedure described in section 4.2.3. 
When exploring sources of variation beyond the individual level, then regression 
modelling is the preferred approach of comparing alternate measures. A generalized 
linear model of a measure Y on a reference measure X can be defined as: 
E(Y) = µ = f(Xβ) 
where E(Y) is the expectation of Y and β is a maximum likelihood estimate of an 
unknown parameter which when multiplied by an X and transformed through f – the link 
function – gives Y. The link function is monotonic (order-preserving) and its choice is 
influenced by the distribution of Y (Table 4.4-1). More formally for multilevel data: 
E(Y) = f(Xβ + Zu + e) 
where Z is a sub-matrix of X, u ~ N(0, σu), e ~ N(0, σe) and u are completely 
independent of e. Once β has been estimated using a calibration sample or a random 
half of the data, it is used to predict Y given the observed X’s. The proportion of 
agreement between predicted and observed Y’s provides an estimate of agreement of the 
two measures. Through repeated sampling of the data by bootstrapping or Markov 
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Chain Monte Carlo (MCMC) technique, estimates of uncertainty about the calculated 
rates of agreement can be produced. 
Table 4.4-1: Link functions for some distributions of Y 
Type of 
distribution 
Name of link 
function 
Expression of link function 
Normal Identity Xβ = µ 
Binomial, 
Categorical 
Logit 
Xβ = ln µ1 − µ 
Poisson Log Xβ = ln µ 
Exponential Inverse Xβ = -µ−1 
The amount variability in predicted Y explained by X at each level of clustering is the 
intraclass correlation (ICC). It is interpreted at the proportional agreement between 
measurements. It is particularly useful when none of the measures is a gold-standard 
and the interest is simply in exploring consistency between them. It is calculated as: 
ρ =  σu
σu+σe 
The assumption of independence between σu and σe is important because it implies that 
X and Y do not introduce additional variability in the underlying construct during 
measurement. If this assumption does not hold then this extra source of variability must 
be added to the denominator. 
4.5. Association with mortality 
4.5.1. Specification of the model 
Averting mortality and other adverse outcomes is often the objective of providing care. 
For this reason mortality rates are often a key measure of the quality of care. However 
as established in section 1.1.1 a variety of factors often confound the relationship 
between the quality of care given to an individual and their risk or odds of death. The 
proposed measure is designed to allow for adjusting for some of these factors and, in so 
doing, fostering better estimation of the relationship between care given and outcomes 
of care. The measure focuses on the admission care that may be critical to clinical 
progress in the first 48 hours of hospital stay for children, a period during which when 
many deaths occur [Couto et al. 2013, Adeboye et al. 2010, Campbell et al. 2004, 
Berkley et al. 2003, Sodemann et al. 1997, Commey et al. 1994]. This large number of 
74 
 
events increases the power of analyses which explore the association of the score with 
mortality adjusted for: individual level factors such as illness severity and number of 
concurrent diagnoses which potentially modify the risk of mortality; hospital level 
effects such as resource availability and nursing care, and other cluster-level predictors 
of mortality that may not be directly observed or quantified; and other known factors 
which could potentially affect mortality risk such as temporal and group effects. 
For the purposes of this work the mortality risk of a child i in hospital j is defined as the 
probability of death being the outcome of this episode of hospitalisation: Pr(Yij = 1). 
This probability is predicted in a random effects logistic regression model: 
logit[Pr(Yij = 1)] = β0 + Σ1k [βkxkij] + µj 
where β0 is the baseline risk of death and Σ1k [βkxkij] is the sum of effects of k predictors 
of mortality related to this episode. µj represents the hospital-specific random variations 
which are normally distributed with a zero mean and variance of σ2u for children with 
the same values of the mortality-predicting covariates. It is minimized by covariate sets 
which are highly predictive of mortality. For any variable, the proportion by which µj 
declines upon adjustment for quality of care provides an estimate of that variable’s 
contribution to predicting mortality. This approach can be used to test the validity of the 
measure by estimating the magnitude and strength of evidence for better care in averting 
mortality. 
4.5.2. Assessment of model goodness-of-fit 
The model has a fixed part and a random part, and for this reason its overall fit is 
assessed by considering these two parts separately. The fit of the fixed part is assessed 
in a similar fashion as a linear model fitted using the ordinary least squares (OLS) 
method: by checking that residuals – the difference between model-predicted and 
observed values of the outcome – are normally distributed with a mean of zero 
[Weisberg 2005, Haessel 1978]. Under this assumption outcome is neither 
underestimated nor overestimated all through its range of possible values. 
The logistic regression model yields predicted probabilities of the outcome taking on 
one of two possible values. For example the predicted probability that Yij = 1 is given 
by: 
 Predicted probabilities 
be normally distributed unlike those
should be no association between the predicted probabilities and the levels of the 
outcome, since such association would imply that the model overestimates or 
underestimates the outcome 
obtained from the observed
product of the sample size, 
If there are continuous predictors in the model
values will be too small for the predictions to follow a 
this problem is to group the predicted values
numbers of observations in the resulting contingency 
2000]. An H statistic which follows a 
where Og is the number of predicted values in the 
expected number of predicted values in the 
of observations and pi
risk. The main criticisms 
especially in models based on 
selection is often arbitrary 
The fit of the random part of the 
assumption of normality of random effects is
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histogram of cluster level random effects, or a plot of cluster level random effects 
versus their ranks [Rabe-Hesketh & Skrondal 2008].  
4.5.3. Pooling evidence of association from different studies 
If yi is the estimate of the odds of death per unit increase in the score with vari as its 
variance and θ is the overall pooled estimate across k studies, then the chi-squared 
statistic, Q, is calculated as: 
J   $  KDLDMNO%  
where: 
P%  1QR#% 
with k-1 degrees of freedom. The inverse of the variance of each estimate also 
represents its weight wi, in the pooled estimate which is obtained by: 
S   ∑P%I%∑P%  
Larger values of the test statistic correspond to more evidence for the presence 
heterogeneity across studies. The proportion of variability across studies attributable to 
heterogeneity, I2, is calculated as: 
'  J  T + 1J  
The estimate of between-study variance τ2, obtained by: 
τ  J  T + 1∑P%  ∑P%∑P%  
Using this estimate new inverse variance weights are calculated for each study as: 
P%∗  1QR#% + τ 
and an updated overall pooled estimate of the effect of the score on mortality estimated 
as: 
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S∗  ∑P%∗I%∑P%∗  
with standard error given by: 
S∗  18∑P%∗ 
The updated overall pooled estimate and its standard error is then used for hypothesis 
testing. 
4.6. Summary 
The univariate and multivariate techniques described in this chapter are integral 
components of the statistical toolkit to be used for exploring the characteristics of the 
proposed measure of process of care. Factor analysis can be applied in the assessment of 
whether items selected for the measure aggregate in groupings which are consistent with 
what is hypothesised. This is useful for establishing construct validity of the measure, 
and also in identifying redundant items either for modification or removal from the 
score. Regression methods are useful for examining associations between the proposed 
measure and other variables, most notably mortality, as another layer of validation. 
Measures of agreement help in determining the extent to which different measures of 
the same construct lead to similar conclusions. 
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Chapter 5 – Construction of the Proposed Measure and 
Preliminary Validation 
5.1. Introduction 
In this first results Chapter the proposed measure of quality of care is constructed from 
process indicator items derived from clinical practice guidelines. Data from the Kenyan 
district hospitals study, described in detail in section 2.2, are used to illustrate the steps 
of score construction. The data contain detailed information on patient-level process of 
care across place (hospital), care provider (clinician) and time (survey), and between 
two groups distinguished by a quality improvement intervention. Using these data a 
score is derived from items identified for measurement. Characteristics of the score, 
including its distribution and differences across diseases, groups and time, are examined 
to identify and implement necessary improvements to the proposed design. 
5.2. Score construction 
5.2.1. Domains of the measure 
The proposed domains are derived from clinical practice guidelines for management of 
childhood illnesses in Kenya which recommend that the process of care for a sick child 
should be a logical and step-wise process informed by a large body of evidence of links 
to good outcomes. In the initial phase of the process a clinician interviews the child’s 
caretaker to obtain a history of illness, performs a physical examination of the child and 
may also order any necessary diagnostic tests to confirm the diagnosis of suspected 
illnesses. Although it is recommended that a uniform set of initial assessment tasks is 
conducted for all sick children, the core tasks necessary to identify common and 
important causes of severe illness are fewer and vary from illness to illness. 
In the next phase the clinician uses their knowledge and experience to identify the most 
likely cause of illness and make a classification of its severity based on the history of 
symptoms, observed clinical signs and results of diagnostic tests. Severity 
classifications vary across illnesses, with the more severe classifications being 
associated with higher risks of worse outcomes. In the third phase the clinician charts 
the most appropriate course of treatment which also varies across illness and severity 
classification. Variations in clinicians’ performance at each of these phases contribute to 
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overall variation in the process of care. When considered singly these core assessment 
tasks, diagnostic classifications and recommended treatments make for useful illness-
specific indicator items for the process of care [Rowe 2013, Irimu et al. 2012, Opondo 
et al. 2011, Osterholt et al. 2009]. 
5.2.2. The basic score 
Guidelines on how to provide care are outlined in the Basic Paediatric Protocols and the 
ETAT+ training course for health workers providing initial care to children admitted to 
hospital. The development of both components of the intervention has been described in 
section 1.4.1, the guidelines on assessment of disease signs and symptoms presented in 
Figure 3.3-1, Figure 3.3-2, Figure 3.3-3, and treatment guidelines shown in Appendix 
A.9. A list of items corresponding to specific recommendations on how to deliver care 
was identified from these guidelines. They are listed in Table 5.2-1 and Table 5.2-2. The 
items were binary, to be scored 1 if they were undertaken as recommended and 0 
otherwise. Item scores were aggregated within domains, which were conceptual higher-
level units proposed to represent distinct dimensions of the process of care, namely 
‘assessment’, ‘diagnosis’ and ‘treatment’ introduced in section 3.3.3. 
Table 5.2-1: Items in the assessment and diagnosis domains of the basic process-of-care score 
Domain Disease 
Malaria Pneumonia Diarrhoea/dehydration 
Assessment 
 
Each item 
scored 1 if 
documented 
(present, absent, 
quality or 
quantity) and 0 
otherwise 
 
 
 
1. Fever 
2. Convulsions  
3. Acidotic breathing 
4. Pallor 
5. (In)ability to drink or 
breastfeed 
6. Level of 
consciousness 
(AVPU) 
7. Indrawing 
8. Blood test for malaria 
 
1. Cough 
2. Difficult breathing 
3. Central cyanosis 
4. (In)ability to drink or 
breastfeed 
5. Level of 
consciousness 
(AVPU) 
6. Grunting 
7. Indrawing 
8. Respiratory rate 
1. Diarrhoea 
2. Vomiting 
3. Capillary refill 
4. (In)ability to drink or 
breastfeed 
5. Level of 
consciousness 
(AVPU) 
6. Sunken eyes 
7. Return of skin pinch 
8. Character of pulse 
Diagnosis 
 
Item score is 1 if 
a relevant 
severity 
classification is 
indicated, 0 
otherwise 
1. Classification: severe 
or non-severe 
1. Classification: very 
severe, severe or 
non-severe 
1. Classification: shock, 
severe, some or none 
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Table 5.2-2: Items in the treatment domain of the basic process-of-care score 
Domain Disease 
Malaria Pneumonia Diarrhoea/dehydration 
Treatment 
 
Score items 
depend on 
severity 
classification 
 
‘Drug’ score is 1 
if correct (singly 
or in 
recommended 
combinations 
where 
applicable) 
according to 
guidelines for 
indicated severity 
classification 
 
‘Route’, ‘dose’, 
‘duration’ and 
‘frequency’ each 
score 1 if correct 
(singly and in 
combination 
where 
applicable) for 
choice of drug(s) 
according to 
guideline 
recommendations 
for their use, 0 
otherwise 
Severe malaria: 
1. Drug: quinine 
(loading and 
maintenance) 
2. Route: IV or IM 
3. Dose:20mg/kg 
loading, 10mg/kg 
maintenance +/- 
20% 
4. Frequency: twice 
daily 
5. Duration: Stat for 
loading dose and 
any duration for 
maintenance dose 
 
Non-severe malaria: 
1. Drug: artemether-
lumefantrine or 
quinine 
2. Route: oral 
3. Dose: 5-14.9kg – 
1 tab; 15-24.5kg – 
2 tabs; 25-34.9kg 
– 3 tabs; 35kg+ - 
4 tabs 
4. Frequency: twice 
daily for AL and 
thrice daily for 
quinine 
5. Duration: any 
duration specified 
Very severe pneumonia: 
1. Drug: penicillin and 
gentamicin and 
oxygen 
2. Route: IV or IM 
3. Dose: Penicillin 
50,000iu/kg, 
gentamicin 7.5mg/kg 
(both +/- 20%) 
4. Frequency: Penicillin 
x4, Gentamicin x1, 
oxygen any specified 
5. Duration: any 
specified 
 
Severe pneumonia: 
1. Drug: Penicillin only 
(no gentamicin) 
2. Route: IV or IM 
3. Dose: 50,000iu/kg +/-
20% 
4. Frequency: x4 
5. Duration: any 
specified 
 
Non-severe pneumonia: 
1. Drug: Amoxicillin or 
cotrimoxazole 
2. Route: oral 
3. Dose: Amoxicillin 
25mg/kg, 
cotrimoxazole 
24mg/kg +/-20% 
4. Frequency: 
Amoxicillin x3, 
cotrimoxazole x2 
5. Duration: any 
specified 
Shock: 
1. Drug: normal saline or 
Ringer’s 
lactate/Hartmann’s 
solution 
2. Dose: volume/timex4 
within +/-20% of 20ml/kg 
3. Frequency: at least 1 in an 
hour 
 
Severe dehydration: 
1. Drug: Ringer’s or ORS 
2. Dose: total vol/time 
within +/- 20% of 
30ml/kg + 70mg/kg in 3 
hours for >1yr or in 6 
hours for < 1yr of 
Ringer’s or total vol/time 
within +/- 20% of 
100ml/kg in 6 hours. 
3. Frequency: step 1/2 used 
 
Some dehydration: 
1. Drug: ORS 
2. Dose: vol/timex4 within 
+/-20% of 75ml/kg 
3. Frequency: at least 1 in an 
24 hours 
 
No dehydration: 
1. Drug: ORS 
2. Dose: 10ml/kg +/-20% 
3. Frequency: any specified 
For the assessment domain, a list of signs and symptoms necessary to identify the 
disease and classify its severity were derived from the guidelines. The assessment score 
was the number of signs and symptoms documented by the admitting clinician. The 
diagnosis score was a binary indicator of whether the clinician made a valid 
classification of the severity of illness, that is, one of the recognised severity 
classifications in the guidelines. This is because it was not uncommon to find in practice 
a variety of other classifications which were neither meaningful within the context of 
the guidelines nor useful for determining the appropriate course of treatment. 
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An additional step would have been to consider the correctness of the diagnosis and its 
severity classification; however this was abandoned because it would have potentially 
led to a ‘double-penalty’ against less complete assessments whose correctness would 
have been difficult to ascertain. Furthermore, the judgement of illness severity given by 
the clinician who examined a sick child was considered to be more reliable and credible 
to other practitioners than the retrospective judgement of a third-party relying on 
documented signs and symptoms. This indicator of correctness of severity classification 
would have at best been subjective; it was therefore excluded from the set of score 
items. 
For the treatment domain, the guidelines explicitly set out recommendations for choice 
of drugs in each disease and severity classification, recommendations on dosages, route 
and frequency, and specifications for durations of treatment. Indicators for each of these 
recommendations were thus defined. Drug use (dose, route, frequency and duration) 
was scored conditional on drug choice since, just as it was difficult to objectively judge 
the correctness of a diagnosis, it was hard to definitively determine the appropriateness 
of treatment selection from the case record alone. It was nevertheless possible to 
determine whether the treatment was used correctly. Deviations of up to 20% of 
recommended dosages, which are within therapeutically safe dose ranges for all the 
drugs used, were considered to be correct to allow for small but clinically insignificant 
differences between prescribed and guideline recommended drug doses. 
Out of the 19 signs and symptoms necessary for identifying and classifying the severity 
of illness, only two signs – ability to drink or breastfeed and level of consciousness – 
were common across all three diseases considered. Five treatment indicators were 
defined to score the treatment of malaria and pneumonia but only three of these – drug 
choice, dose and frequency – were applicable to diarrhoea/dehydration since the other 
two (drug route and duration) were implicitly implied by the drug choice and frequency 
of dosing. 
The results were a 9-point (range 0 to 8) assessment score for all three diseases, a 2-
point (binary) diagnosis score and a 6-point (range 0 to 5) treatment score for malaria 
and pneumonia and a 4-point (range 0 to 3) treatment score for diarrhoea/dehydration. 
The overall process-of-care score – referred to as the basic score because it was an 
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arithmetic sum of the binary item scores – was a 15-point score (range 0 to 14) for 
malaria and pneumonia and a 13-point score (range 0 to 12) for diarrhoea/dehydration. 
5.2.3. Characteristics of the basic score 
Differences in the basic score between the intervention and control group were 
examined to establish the sensitivity of the score to changes in quality of care that have 
previously been documented. There was a wide variation in the proportion items 
achieved across the diseases and time points as shown in Table 5.2-3. At baseline this 
ranged from 0% for characterisation of pulse to 98.2% for documentation of the 
presence of diarrhoea in children diagnosed with diarrhoea or dehydration.  
In malaria, documentation of the presence of acidotic breathing was poorest at baseline 
(0.1%), and fever was the most documented sign (86.7%). Level of consciousness was 
the least documented sign in children with pneumonia (0.8%), and presence of a cough 
which is a key diagnostic sign of pneumonia was most documented with 88.1% of 
records having it recorded. At the main study end-point all indicators showed 
improvement, ranging from 0.4% increase in the frequency of administration of correct 
drugs for treatment of diarrhoea/dehydration to 79.6% improvement in documentation 
of the presence of sunken eyes. 
Distributions of the basic score across time and groups (Figure 5.2-1, Figure 5.2-2 and 
Figure 5.2-3) were consistent with what was expected in the presence of improvements 
in process of care and the heterogeneity across hospitals revealed in the tabulated 
results: the baseline scores were normally distributed; they were similar across groups 
as expected; there was also a notable shift towards higher scores in the endpoint score 
distributions, as would have been expected if the intervention resulted in clinicians 
undertaking more of the guideline-recommended processes of care. 
These confirmed findings which had been demonstrated previously using methods 
which examined a smaller number of item-specific process-of-care indicators than were 
included in this score [Ayieko et al. 2011]. 
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Table 5.2-3: Percentage of children for whom quality items from the basic score were achieved 
across all hospitals in the baseline and endpoint surveys 
Item in process-of-care score for disease  
Percentage of children in which item was achieved 
Malaria Pneumonia Diarrhoea/ 
Dehydration 
Baseline 
n=1,763 
End  
n=1,789 
Baseline  
n=902 
End  
n=1,194 
Baseline  
n=383 
End  
n=732 
Assessment       
Fever indicated as present or absent 86.73 95.42     
Convulsions indicated as present or absent 29.33 78.54     
Acidotic breathing indicated as present or 
absent 
0.11 69.70     
Degree of pallor indicated as ‘0’, ‘+’ or 
‘+++’ 
82.64 90.67     
Laboratory test for malaria requested 79.92 84.24     
Indrawing indicated as present or absent 7.77 72.61 14.19 86.85   
Cough indicated as present or absent   88.14 97.15   
Difficult breathing indicated as present or 
absent 
  52.44 89.03   
Central cyanosis indicated as present or 
absent 
  24.28 84.51   
Grunting indicated as present or absent   3.77 81.07   
Respiratory rate recorded   16.52 60.39   
Diarrhoea indicated as present or absent     98.17 98.91 
Vomiting indicated as present or absent     22.45 87.16 
Capillary refill indicated as ‘x’, ‘<2s’, ‘2-3s’ 
or ‘>3s’ 
    0.26 69.54 
Sunken eyes indicated as present or absent     5.48 85.11 
Return of skin pinch indicated as 
‘immediate’, ‘1-2s’ or ‘>2s’ 
    5.74 80.46 
Character of pulse indicated as ‘normal’ or 
‘weak’ 
    0.00 47.68 
Ability to drink or breastfeed reported in the 
affirmative or negative 
2.95 69.31 2.22 79.98 2.87 82.10 
Level of consciousness classified as ‘alert’, 
‘responsive to voice’, ‘responsive to pain’ or 
‘unconscious’ 
1.99 60.26 0.78 66.83 1.83 67.90 
       
Diagnosis       
Illness severity classification made 
consistent with guidelines 
7.32 65.18 9.87 81.41 24.28 62.70 
       
Treatment       
Choice of drug for treatment is consistent 
with illness severity as recommended in 
guidelines 
6.01 40.80 1.11 22.95 40.47 61.61 
Drug administered via recommended route* 0.23 44.89 8.20 63.74   
Dose of drug correct for child’s body weight 
according to dosing schedule 
1.25 12.86 3.99 45.73 26.89 44.26 
Drug administered at recommended daily 
frequency 
5.56 46.12 8.65 61.89 67.62 68.03 
Any duration of treatment specified* 6.01 31.86 7.76 54.10   
*Route of drug administration is implicit in the choice of drug for diarrhoea, and duration of treatment need not be explicitly specified 
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Figure 5.2-1: Distribution of the basic process-of-care score for malaria comparing baseline 
and main endpoint scores in the intervention and control hospitals 
 
 
Figure 5.2-2: Distribution of the basic process-of-care score for pneumonia comparing 
baseline and main endpoint scores in the intervention and control hospitals 
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Figure 5.2-3: Distribution of the basic process-of-care score for diarrhoea/dehydration 
comparing baseline and main endpoint scores in the intervention and control hospitals 
5.2.4. Shortfalls of the basic score 
The 15- and 13-point scales of the basic score failed to meet some desired properties of 
the process-of-care measure. First, the scales were heavily weighted towards the 
assessment domain, which contributed more than half of the items on the scale. 
Consequently it was possible to achieve a mid-range score, interpretable as ‘average’ 
care, by simply completing the clinical assessment even if diagnosis and treatment were 
not performed according to guideline recommendations. A case in point was a group of 
313 out of the 507 children with malaria and process-of-care scores of 8 out of 14 
(which was approximately at the median of the distribution) for whom all 8 assessment 
tasks were completed but neither was a valid severity classification of their illness made 
nor was there a record of any recommended treatment given. 
Secondly, there was a high degree of correlation between several items in this scale. 
This was assessed using tetrachoric correlation coefficients, which are the preferred 
measure of correlations between binary items, since Pearson correlation coefficients are 
valid only for normally distributed variables for reasons explained in section 4.4. 
Tetrachoric correlation coefficients between items in this scale are shown in Table 
5.2-4, Table 5.2-5, Table 5.2-6 and Table 5.2-7. Correlations at baseline – before the 
intervention had had a chance to change practice and potentially alter the relationships 
between items in the scale – were also examined and are presented in Appendix A.10.  
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Table 5.2-4: Tetrachoric correlation matrix of assessment items in the basic malaria process-of-
care score 
 fever convulsions acidotic breathing pallor 
(in)ability 
to drink 
level of 
consciousness indrawing 
malaria 
test 
fever 1.00        
convulsions 0.64 1.00       
acidotic 
breathing 0.64 0.94 1.00      
pallor 0.30 0.44 0.52 1.00     
(in)ability to 
drink 0.62 0.91 0.99 0.52 1.00    
level of 
consciousness 0.58 0.87 0.92 0.54 0.92 1.00   
indrawing 0.61 0.89 0.99 0.49 0.97 0.90 1.00  
malaria test 0.20 0.23 0.25 0.13 0.25 0.30 0.22 1.00 
 
Table 5.2-5: Tetrachoric correlation matrix of assessment items in the basic pneumonia process-
of-care score 
 cough difficult breathing 
central 
cyanosis 
(in)ability 
to drink 
level of 
consciousness grunting indrawing 
resp. 
rate 
cough 1.00        
difficult 
breathing 0.55 1.00       
central 
cyanosis 0.52 0.64 1.00      
(in)ability to 
drink 0.68 0.79 0.89 1.00     
level of 
consciousness 0.58 0.71 0.82 0.90 1.00    
grunting 0.65 0.80 0.92 0.98 0.91 1.00   
indrawing 0.59 0.78 0.86 0.95 0.87 0.97 1.00  
resp. rate 0.39 0.38 0.45 0.59 0.54 0.59 0.58 1.00 
 
Table 5.2-6: Tetrachoric correlation matrix of assessment items in the basic 
diarrhoea/dehydration process-of-care score 
 diarrhoea vomiting capillary 
refill 
level of 
consciousness 
(in)ability 
to drink 
sunken 
eyes 
skin 
pinch pulse 
diarrhoea 1.00        
vomiting 0.61 1.00       
capillary 
refill 0.36 0.91 1.00      
level of 
consciousness 0.37 0.84 0.86 1.00     
(in)ability to 
drink 0.42 0.94 0.93 0.88 1.00    
sunken eyes 0.46 0.91 0.94 0.88 0.97 1.00   
indrawing 0.42 0.91 0.94 0.87 0.95 0.97 1.00  
pulse 0.41 0.80 0.79 0.74 0.83 0.84 0.82 1.00 
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Table 5.2-7: Tetrachoric correlation matrix of treatment items in the basic process-of-care score 
  Malaria Pneumonia Diarrhoea/Dehydration 
  drug route dose freq. dur. drug route dose freq. dur. drug dose freq. 
M
a
la
ri
a
 
drug 1.00             
route 0.80 1.00            
dose 0.26 0.64 1.00           
freq. 0.85 0.93 0.75 1.00          
dur. 0.12 0.27 0.91 0.58 1.00         
Pn
eu
m
o
n
ia
 drug      1.00        
route      0.75 1.00       
dose      0.33 0.85 1.00      
freq.      0.68 0.97 0.90 1.00     
dur.      0.65 0.93 0.81 0.94 1.00    
D
n
D
 drug           1.00   
dose           0.66 1.00  
freq.           0.44 0.19 1.00 
The correlations between 10 pairs of assessment items for malaria, 11 pairs for 
pneumonia and 19 pairs for diarrhoea/dehydration were ‘very strong’ (tetrachoric 
correlation coefficients equal to or greater than 0.80) according to the criteria suggested 
by Evans (1996), as were half of the correlations between treatment item pairs for 
malaria and pneumonia. Furthermore the malaria assessment and treatment item 
tetrachoric correlation matrices were not positive (semi)definite: this means there was a 
high degree of linear dependency between multiple items. These characteristics implied 
that there was a lot of redundancy between these items: some items did not add any 
discriminative value to the score, and collapsing them into fewer items, preferably in a 
systematic process that maintained clinical relevance of the resulting items, could 
achieve a more balanced scale. 
Thirdly, differences in scale ranges across diseases (0–14 for malaria and pneumonia, 
0–12 for diarrhea/dehydration) also made it impossible to directly compare their process 
of care. Various forms of transformation or standardization of the original scores into 
new scales have been proposed to remedy this [Colman et al. 1997].  However these 
solutions also potentially introduce a new problem: a score produced from summation 
of indicator items is an ordered categorical outcome whose very intuitive interpretation 
or unit of measure – an important characteristic for reporting it to its end users – is a 
count of indicator items achieved. Mathematical transformations, which are only valid 
for continuous outcomes, would distort and obscure this meaning and therefore do not 
make for a suitable solution for obtaining a common scale that allows for the desired 
direct comparison across diseases while preserving the very specific meaning of the 
scale. 
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5.2.5. The modified score 
The assessment items in the basic score were modified by collapsing them into discrete 
clinical decision points that constitute the desired processes outlined in the guidelines. 
These items, listed in Table 5.2-8 and Table 5.2-9, were also designed with the aim of 
making them generic to the process of care of all three diseases considered, and 
arguably most other acute childhood illnesses. To this end, assessment items were 
grouped into three modified items: (1) primary assessment signs required to diagnose 
the disease of interest; (2) secondary assessment signs necessary to distinguish between 
disease severity classifications; (3) a third modified item representing complete 
documentation of all required assessment signs.  
For example, for malaria the primary assessment sign was fever. Secondary signs 
depended on severity. According to guidelines severe malaria was the correct diagnosis 
for a child who, in addition to fever, presented with at least one danger sign – 
convulsion, acidotic breathing, inability to drink or breastfeed, altered consciousness or 
pallor with respiratory distress indicated by grunting or indrawing. Fever in the absence 
of any danger sign was to be classified as non-severe malaria. A clinician was required 
to completely exclude the presence of a danger sign to correctly diagnose non-severe 
malaria. For this reason a complete secondary assessment for non-severe malaria meant 
documentation of all the danger signs, and this was a higher threshold of performance 
than was set for severe malaria where the clinician simply had to document fever and 
the presence of at least one danger sign. The indicator for complete assessment then 
distinguished between process of care that met the minimum threshold for good care 
from those that went the extra mile and undertook all tasks as recommended in the 
guidelines. This approach was extended across the various severity classifications of 
pneumonia and diarrhoea/dehydration. 
For diagnosis, the binary indicator of whether a relevant severity classification was 
made was retained unchanged. However for treatment two modified items were 
generated: (1) selection of any broadly relevant drug for treatment of the disease 
diagnosed, and (2) correct use of selected drug which included correct dose, appropriate 
route of delivery, frequency and duration where applicable. As with the basic score, the 
resulting process of care score – named the modified score because of its adaptation 
from the basic one – was a sum of the modified indicator scores for each individual. 
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Table 5.2-8: Items in the assessment and diagnosis domains of the modified process-of-care 
score 
Domain Disease 
Malaria Pneumonia Diarrhoea/dehydration 
Assessment 
 
Each grouped 
item scored 1 if 
all of its 
elements are 
documented 
(present, absent, 
quality or 
quantity) and 0 
otherwise 
 
1. Primary signs: fever 
2. Secondary signs: 
convulsions or 
acidotic breathing or 
(in)ability to 
drink/breastfeed or 
AVPU, or pallor in 
the presence of 
grunting or 
indrawing if severe, 
or convulsions and 
acidotic breathing 
and (in)ability to 
drink/breastfeed or 
AVPU, or pallor and 
grunting and 
indrawing if non-
severe 
3. Complete 
assessment: all signs 
documented 
1. Primary signs: cough 
or difficult breathing 
2. Secondary signs: 
central cyanosis or 
(in)ability to 
drink/breastfeed or 
AVPU or grunting or 
acidotic breathing  if 
very severe, or 
central cyanosis and 
(in)ability to 
drink/breastfeed or 
AVPU, and grunting 
and acidotic 
breathing  if severe, 
or central cyanosis 
and (in)ability to 
drink/breastfeed or 
AVPU, and grunting 
and acidotic 
breathing and 
respiratory rate if 
non-severe. 
3. Complete 
assessment: all signs 
documented 
  
1. Primary signs: diarrhoea 
and/or vomiting 
2. Secondary signs: 
capillary refill or AVPU 
or (in)ability to 
drink/breastfeed, and 
pulse if shock, or 
capillary refill and 
AVPU or (in)ability to 
drink/breastfeed and 
sunken eyes and skin 
pinch and pulse if 
severe, some or no 
dehydration 
3. Complete assessment: 
all signs documented 
Diagnosis 
 
Item score is 1 if 
a relevant 
severity 
classification is 
indicated, 0 
otherwise 
1. Classification: 
severe or non-severe 
1. Classification: very 
severe, severe or non-
severe 
1. Classification: shock, 
severe, some or none 
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Table 5.2-9: Items in the treatment domain of the modified process-of-care score 
Domain Disease 
Malaria Pneumonia Diarrhoea/dehydration 
Treatment 
 
‘Drug’ score is 1 
if correct (singly 
or in 
recommended 
combinations 
where 
applicable) 
according to 
guidelines for 
indicated severity 
classification 
 
‘Correct use’ 
scores 1 if dose, 
route, frequency 
and duration 
whichever 
applicable, of 
selected drug(s) 
are correct 
following 
guideline 
recommendations 
for their use, 0 
otherwise 
Severe malaria: 
1. Drug: quinine 
(loading and 
maintenance) 
2. Correct use: Route 
is IV or IM and 
dose is 20mg/kg 
loading, 10mg/kg 
maintenance +/- 
20% and frequency 
is twice daily and 
duration is stat for 
loading dose and 
any duration for 
maintenance dose 
 
Non-severe malaria: 
1. Drug: artemether-
lumefantrine or 
quinine 
2. Correct use: Route 
is oral and dose is 
5-14.9kg – 1 tab; 
15-24.5kg – 2 tabs; 
25-34.9kg – 3 tabs; 
35kg+ - 4 tabs, and 
frequency is twice 
daily for AL and 
thrice daily for 
quinine and 
duration is any 
duration specified 
Very severe pneumonia: 
1. Drug: penicillin and 
gentamicin and 
oxygen 
2. Correct use: Route is 
IV or IM and dose is 
penicillin 
50,000iu/kg, 
gentamicin 7.5mg/kg 
(both +/- 20%) and 
frequency is 
penicillin x4, 
gentamicin x1, 
oxygen any specified 
and duration is any 
specified 
 
Severe pneumonia: 
1. Drug: Penicillin only 
(no gentamicin) 
2. Correct use: Route is 
IV or IM and dose is 
50,000iu/kg +/-20% 
and frequency is x4 
and duration is any 
specified 
 
Non-severe pneumonia: 
1. Drug: Amoxicillin or 
cotrimoxazole 
2. Correct use: Route is 
oral and dose is 
Amoxicillin 
25mg/kg, 
cotrimoxazole 
24mg/kg +/-20% and 
frequency is 
Amoxicillin x3, 
cotrimoxazole x2 and 
duration is any 
specified 
Shock: 
1. Drug: normal saline or 
Ringer’s 
lactate/Hartmann’s 
solution 
2. Correct use: Dose is 
volume/timex4 within 
+/-20% of 20ml/kg and 
frequency is at least 1 in 
an hour 
 
Severe dehydration: 
1. Drug: Ringer’s or ORS 
2. Correct use: Dose is 
total vol/time within +/- 
20% of 30ml/kg + 
70mg/kg in 3 hours for 
>1yr or in 6 hours for < 
1yr of Ringer’s or total 
vol/time within +/- 20% 
of 100ml/kg in 6 hours 
and frequency is step 
1/2 used 
 
Some dehydration: 
1. Drug: ORS 
2. Correct use: Dose is 
vol/timex4 within +/-
20% of 75ml/kg and 
frequency: at least 1 in 
an 24 hours 
 
No dehydration: 
1. Drug: ORS 
2. Correct use: Dose is 
10ml/kg +/-20% and 
frequency is any 
specified 
5.2.6. Characteristics of the modified score 
The modified score was a 7-point score (range 0 – 6) across all three diseases, being the 
sum of six binary items contributing to it. It was therefore possible to directly compare 
process of care across the diseases using the same indicators. These items were grouped 
in the same three domains as in the basic score. The assessment domain was a 4-point 
score (range 0 – 3), diagnosis a binary score as in the basic score and the treatment 
domain a 3-point score (range 0 – 2). 
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There was a very wide variation in the proportion of modified score items achieved 
across the diseases at the various time points similar to the basic score (Table 5.2-10). 
At baseline this ranged from 0% complete assessment in all three diseases to 98.4% 
documentation of the primary signs of diarrhoea/dehydration. Documentation of 
primary signs of all diseases was over 85% both at baseline and at the main study end-
point; however secondary signs were poorly documented at baseline in all diseases. As 
with the basic score all indicators showed improvement, ranging from an absolute 
improvement of as low as 0.6% in the primary signs of diarrhoea to 63.6% improvement 
in documentation of secondary signs of pneumonia. 
Table 5.2-10: Percentages of children for whom quality items from the modified score were 
achieved across all hospitals in the baseline and endpoint surveys 
Item in process-of-care score 
for disease  
Percentage of children in which item was achieved 
Malaria Pneumonia Diarrhoea/ 
Dehydration 
 
Baseline 
n=1,763 
End  
n=1,789 
Baseline  
n=902 
End  
n=1,194 
Baseline  
n=383 
End  
n=732 
Primary signs/symptoms of 
illness documented 
 
86.73 95.42 93.90 98.16 98.43 99.04 
Secondary signs/symptoms of 
illness documented 
 
35.22 83.23 0.11 63.74 0.00 29.37 
Complete documentation of 
signs/symptoms 
 
0.00 47.12 0.00 41.79 0.00 37.98 
Illness severity classification 
made consistent with guidelines 
 
7.32 65.18 9.87 81.41 24.28 62.70 
Choice of drug for treatment is 
consistent with illness severity as 
recommended in guidelines 
 
6.01 40.80 1.11 22.95 40.47 61.61 
Selected drug used as 
recommended in guidelines 
 
0.17 29.40 32.26 60.97 32.64 44.81 
Despite the reduction in the range of its scale, distributions of the process of care scores 
were still normal, more so at baseline and post-intervention in the control group where 
there was little heterogeneity of the score across hospitals (Figure 5.2-4, Figure 5.2-5 
and Figure 5.2-6). The intervention hospitals had, as a group, higher scores than the 
controls, signalling an intervention effect similar to what was observed with the basic 
score. 
92 
 
 
Figure 5.2-4: Distribution of the modified process-of-care score for malaria comparing 
baseline and main endpoint scores in the intervention and control hospitals 
 
 
Figure 5.2-5: Distribution of the modified process-of-care score for pneumonia comparing 
baseline and main endpoint scores in the intervention and control hospitals 
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Figure 5.2-6: Distribution of the modified process-of-care score for diarrhoea/dehydration 
comparing baseline and main endpoint scores in the intervention and control hospitals 
Tetrachoric correlation coefficients of items in the same domain ranged between 0.34 to 
0.62 (‘weak’ to ‘moderate’ according to Evans’ criteria) showing much less of the co-
dependence between items in the basic score (Table 5.2-11). Between-domain 
correlation of items was also in this range. However there was a perfect correlation 
between the classification indicator and the drug choice indicator in malaria and 
pneumonia, and although this was expected – the choice of drug depended on severity 
classification – it may suggest that there still remained some redundancy between items. 
Table 5.2-11: Tetrachoric correlation matrix of items in the modified process-of-care score 
Complete assessment indicator has been excluded because it is perfectly correlated with the 
other two assessment items by design. ‘pri.’, ‘sec.’ and ‘class.’ are primary signs, secondary 
signs and illness severity classification indicator items respectively 
  Malaria Pneumonia Diarrhoea/Dehydration 
  pri. sec. class. drug use pri. sec. class. drug use pri. sec. class. drug use 
M
a
la
ri
a
 
pri. 1.00               
sec. 0.60 1.00              
class. 0.56 0.83 1.00             
drug 0.46 0.66 1.00 1.00            
use 0.24 0.49 0.48 0.45 1.00           
Pn
eu
m
o
n
ia
 pri.      1.00          
sec.      0.62 1.00         
class.      0.49 1.00 1.00        
drug      0.23 0.57 1.00 1.00       
use      0.15 0.28 0.28 0.51 1.00      
D
n
D
 
pri.           1.00     
sec.           0.34 1.00    
class.           0.15 0.87 1.00   
drug           0.11 0.24 0.27 1.00  
use           0.21 0.24 0.26 0.60 1.00 
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5.2.7. The combined score 
The basic and modified scores allowed for the measuring of process of care in each of 
the three diseases separately. However it was quite common for a child to be diagnosed 
with more than one disease at each episode of hospital admission. Specifically, of the 
12,036 admission episodes over the course of this study 6,150 (51.1%) had only one of 
the three diseases diagnosed, 4,188 (34.8%) had two and 446 (3.7%) had all three. The 
children represented by the remaining 1,252 admission episodes (10.4%) had other 
diseases than the three which were the focus of this thesis. 
Measuring the patient-level process of care for the 4,634 children with more than one 
disease thus required some suitable combination of the disease-specific scores. To 
maintain a consistent scale across the various possible co-morbidity patterns and to 
avoid reintroducing the problem of non-comparable scores, the combined score was 
structured around the modified score since the latter already had equivalent items in 
each domain across the three diseases. An intuitive approach to combining the item 
scores for an admission episode was to use the arithmetic mean of the disease-specific 
scores for each item. 
For example a child with all three diseases for whom the primary assessment score was 
1 in two diseases and 0 in the third had a combined primary assessment score of 2/3. 
Similarly a child with malaria and pneumonia for whom only the latter disease had a 
valid severity classification had a combined severity classification score of ½. As in the 
basic and modified scores the overall combined score was the sum of the item scores. 
However unlike the modified score this approach created non-integer scores which no 
longer represented a count of guideline-recommended process-of-care tasks completed 
by the clinician (Figure 5.2-7). Thus a score of 41/3, which implied four-and-a-third 
discrete assessment tasks completed for a child with all three diseases, could have 
instead been the result of an assessment score of 12/3, a diagnosis score of 1 and a 
treatment score of 12/3.   
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Figure 5.2-7: Distribution of the combined process-of-care score created from the arithmetic 
mean of disease-specific item scores, comparing baseline and main endpoint scores in the 
intervention and control hospitals 
Thus an alternative approach to combining item scores was based on defining combined 
items which depended on the diseases a child had been diagnosed with. In this approach 
a combined item was assigned a score of 1 if the equivalent items in each of the 
diagnosed diseases had scored 1, and zero otherwise – an all-or-none combination of 
disease-specific item scores. For example if a child had malaria and pneumonia then the 
combined primary assessment score was 1 if primary assessment items for both malaria 
and pneumonia (presence of fever documented, and presence of cough or difficult 
breathing documented) scored 1; if only one or none of them were documented then the 
combined score was zero. Although this approach made it more difficult to achieve each 
level of the score, it intuitively reflected the clinical reality that multiple diagnoses 
increased the number of guideline-recommended tasks required to effectively manage 
illness thereby increasing the difficulty in management of illness, and is often associated 
with higher risk of mortality [Fenn et al. 2005]. 
The combined score retained the main characteristics of the modified score: it was a 7-
point score (range 0 – 6); the assessment component was a 4-point score (range 0 – 3), 
the diagnosis one a binary score and the treatment domain a 3-point score (range 0 – 2). 
The proportion of items achieved across the diseases at the various time points also 
varied widely. At baseline it ranged between 0 to 15% in all but one item, but varied 
widely between 26% and 87% across all items at the endpoint (Table 5.2-12). 
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All indicators showed the expected change over time, ranging from an absolute increase 
of 9.8% in the documentation of primary signs of illness, to 50.3% improvement in 
documentation of illness severity classifications. Also worth noting was the increased 
denominator at each time-point, a consequence of the combined score now representing 
the process-of-care measure of a child’s admission episode rather than being a disease-
specific measure. 
Table 5.2-12: Percentage of children for whom quality items from the combined score were 
achieved across all hospitals in the baseline and endpoint surveys 
Item in process-of-care score for disease  
Percentage of children in which item 
was achieved 
Baseline (n=2,450) End (n=2,714) 
Primary signs/symptoms of illness documented 77.59 87.36 
Secondary signs/symptoms of illness documented 15.02 51.69 
Complete documentation of signs/symptoms 0.00 33.86 
Illness severity classification made consistent with guidelines 7.80 58.14 
Choice of drug for treatment is consistent with illness severity 
as recommended in guidelines 
4.65 26.23 
Selected drug used as recommended in guidelines 5.22 28.26 
Its distribution also had a similar appearance and changes over time to those of disease-
specific scores in Figure 5.2-4, Figure 5.2-5 and Figure 5.2-6, namely approximately 
normal, superimposed distributions of the two groups at baseline followed by a shift in 
the intervention group of hospitals towards higher scores at the main end-point. This is 
illustrated in Figure 5.2-8. 
 
Figure 5.2-8: Distribution of the combined process-of-care score created from an all-or-none 
combination of disease-specific item scores, comparing baseline and main endpoint scores in 
the intervention and control hospitals 
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5.3. Measuring agreement between basic and modified scores through 
cluster level variability 
The 7-point modified score mirrored the response of the basic 15-point score to 
hypothesised changes in process of care in the study hospitals across group and time. 
Nevertheless it was likely that some loss of variability of the score – and consequently 
ability to discriminate between clinically important differences in process of care – 
which was not apparent when comparing the distributions, could have occurred as a 
consequence of collapsing and grouping of indicators. In fact a number of studies have 
highlighted such losses occurring as a consequence of not only collapsing an ordered 
categorical measure into fewer categories as has been done between the 16- and 7-point 
scores [Srinivasan & Basu 1989] but also due to categorizing a continuous measure 
[Bennette & Vickers 2012, Naggara et al. 2011, Altman 2005] or using a categorical 
outcome to measure a continuous latent construct [Rhemtulla et al. 2012, Naggara et al. 
2011]. 
In recognising loss of variability as a potential weakness of the described approach to 
score design, the amount of agreement between the 15-point basic score and the 7-point 
modified score was quantified by estimating the variability in the basic score that could 
be explained by the modified score alone at hospital and clinician level. Variations of 
two estimation models of the family of generalised linear models were fitted reflecting 
different assumptions about the level of measurement of the score: a linear model 
treating the score as a continuous measure, and an ordered categorical model assuming 
an ordered categorical measure. First a model of the basic score, Yi, with the modified 
score, Xi, as the only covariate was fitted: 
E[g(Yijk)] = α + βXijk + uj + ujk 
uj represents clinician-level random variation which was assumed to be normally 
distributed with a mean of zero and variance represented by σuj2, conditional on 
hospital-level variation represented by ujk and also assumed to be normally distributed 
with a mean of zero and variance represented by σujk2. The link function, g, was the 
identity link which assumed normally distributed scores for the linear regression 
models, and probit link for the ordered logistic regression models. A ‘null’ model of the 
basic score alone was then fitted: 
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E[g(Yijk(null))] = α(null) + uj(null) + ujk(null) 
The increase in hospital and clinician-level variances in the null model compared to the 
calibration model represented the amount of variability in the basic score explained by 
the modified score alone, which was then calculated as: 
ρVWXY  *&Z5[\\  *&Z*&Z5[\\  
for variability at the hospital level and: 
ρ]\%5  *&5[\\  *&*&5[\\  
for variability at the clinician level. The 95% confidence intervals for these estimates 
were obtained by bootstrapping: this involved repeated re-sampling with replacement 
from the estimation sample followed by re-estimation; the 95% confidence intervals 
was the range of values which included 95% of the repeated sample estimates. 
Table 5.3-1: Cluster-level agreement between the basic and modified scores across the three 
diseases 
Method 
Percentage of variability in the basic score explained by 
the modified score (bootstrap 95% confidence intervals) 
Malaria 
n=6,356 
Pneumonia 
n=4,128 
Diarrhoea/ 
dehydration 
n=1,910 
Hierarchical linear regression to estimate 
hospital level variances 
93.8% 
(92.4 – 95.3) 
  
91.6% 
(88.1 – 95.1) 
72.3% 
(66.1 – 78.7) 
Hierarchical linear regression to estimate 
clinician level variances 
95.3% 
(94.5 – 96.1) 
 
90.0% 
(88.3 – 91.8) 
51.8% 
(48.2 – 53.4) 
Hierarchical ordered logistic regression to 
estimate hospital level variances 
65.2% 
(56.2 – 74.3) 
  
76.8% 
(64.3 – 89.2) 
39.5% 
(18.1 – 60.9) 
Hierarchical ordered logistic regression to 
estimate clinician level variances 
73.8% 
(68.0 – 79.5) 
73.6% 
(66.2 – 81.0) 
14.5% 
(5.6 – 34.5) 
There was some loss of information as a consequence of the score transformation. 
Assuming a normal distribution, the loss of variability was less than 10% at both 
hospital and clinician level for malaria and pneumonia, but comparatively larger for 
diarrhoea/dehydration, with close to 50% of clinician level variability lost in the 
transformation. The greater loss of variability in the diarrhoea score was most probably 
attributable to the fact that almost twice as many pairs of items in the disease-specific 
basic score were very strongly correlated (Table 5.2-6). When the score was treated as 
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an ordered categorical outcome, the amounts of variability explained in both levels 
across all three diseases were comparatively lower, ranging between 39.5% and 65.2% 
at hospital level and 14.5% to 73.8% at clinician level. Nevertheless in all cases, except 
the ordinal assumption on the diarrhoea score, the amount of explained variability was 
still ‘large’ according to Cohen’s criteria (in the latter it was ‘medium’) [Cohen 1992]. 
It was thus concluded that despite the inevitable loss of variability upon collapsing the 
basic score items into fewer groups, there was still a good level of agreement between 
the basic and modified scores.  
5.4. Summary 
A score to measure process of care has been described in this Chapter, starting with the 
identification of items that represent key process-of-care recommendations from clinical 
practice guidelines. Binary scores of compliance with recommendations have been 
defined for each of these items, and a basic score has been constructed by summing up 
the binary scores. The score possesses good face-validity as a measure of adherence to 
good care practices and is potentially useful in its own right. However a major 
shortcoming is its inability to cater for direct comparison of the process of care across 
multiple diseases. Thus a second approach to scoring, a modification of the basic score, 
has been described, which has produced a score with this feature. The modification has 
come at the cost of some loss of variability in the score, a known consequence of 
collapsing continuous or categorical measures into fewer categories. Some validation of 
the proposed measure has also been undertaken in this Chapter. Content validity has 
been ensured through the selection from clinical practice guidelines of items describing 
how care ought to be provided. Face-validity has been explored by graphically 
examining the sensitivity of the score to changes in quality of care previously reported 
in the Kenyan district hospitals study. A shift has been observed in the distribution of 
the score between intervention and control hospitals at baseline and at the main study 
endpoint which is consistent with an improvement in quality of care. Further validation 
is presented in the next Chapter. 
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Chapter 6 – Further Validation 
6.1. Introduction 
In this Chapter three new aspects of the validity of the measure are examined in addition 
to those highlighted in Chapter 5, namely construct validity, criterion-related validity 
and external validity. Construct validity is tested by examining the extent to which items 
of the measure aggregate into domains which are consistent with generic phases of the 
clinical process. Criterion-related validity is assessed in terms of the association of the 
measure with an outcome of care. External validity is investigated by exploring how the 
measure works in situations different from those in which it has been designed and 
tested. 
6.2. Construct validity: do the modified score items aggregate into the 
proposed domains? 
Items of the modified and combined scores have been grouped into three domains, 
namely: assessment, which constitutes the indicators of documentation of the primary 
and secondary signs of illness; diagnosis, which is a single-item domain of an indicator 
of illness severity classification; and a treatment domain of indicators of correct choice 
of medical intervention (drug, intravenous fluids or oral fluids) and their correct use in 
terms of dose, frequency and duration of administration. This conceptual grouping of 
items into domains allows for measurement at the distinct stages of the process of care 
represented by the proposed domains, a key objective of this work. It is also consistent 
with the sequence of clinical process and is therefore arguably a sensible approach to 
measuring and reporting quality of care. What is still unclear at this stage is whether 
there is any statistical evidence that supports these conceptual groupings. 
To address this question structural equation modelling (SEM) was used to explore the 
extent to which these conceptual groupings were consistent with patterns of correlations 
between observed items in the data across each of the three diseases of interest. Some 
statistical principles underlying CFA/SEM and generalised linear modelling (GLM, 
‘regression’) have been described in sections 4.2 and 4.5 respectively. 
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6.2.1. Specification of a structural equation model of the modified score 
The model specification was based on the expected association between the observed 
items and the latent factors that represent the conceptualised groupings. The first 
assumption was that the primary and secondary assessment indicators were the 
observable partial manifestations of a latent factor named ‘assessment’. For this reason 
they were expected to be highly correlated with each other. Similarly, the indicators of 
correct drug choice and use were thought to be manifestations of a latent factor named 
‘treatment’ and expected to be highly correlated with each other. The degree to which 
‘assessment’ and ‘treatment’ manifested themselves through the items in those domains 
was measured through their factor loadings. These were symbolised by λ subscripted by 
an initial identifying the item. A ‘diagnosis’ domain was not included as a factor in this 
model because there was only one indicator item for this domain and a factor would not 
be identifiable from it for reasons explained in detail in section 4.2.3. 
It was also assumed that the score items were partial manifestations of the latent factors, 
and there remained some quantities of the latent factors unmeasured by them. These 
residuals, symbolised by ε subscripted by an initial identifying the factor, were assumed 
to be normally distributed with a mean of zero and some variance σ2ε. The third 
assumption was that the items were completely unassociated with each other except 
through the latent factors. For example, any association between the indicator of 
assessment for primary signs of illness and that of correct drug use was through the 
association between the assessment and treatment factors by the correlation of the 
variances of their residuals. These three assumptions underlie the confirmatory factor 
analysis, described in section 4.2.4, which is considered the measurement component of 
the model. 
The structural part of the model was the component to adjust for the independent 
associations between indicator items and exogenous variables; the latter were variables 
assumed to exert their effect on the indicators solely through the latent factors. 
Time/survey and intervention/group were included as exogenous variables since their 
effects on quality of care, therefore on ‘assessment’ and ‘treatment’ have been 
demonstrated previously [Ayieko et al. 2011]. These effects, analogous to regression 
coefficients, were represented by β subscripted with identifiers of the variables and the 
latent factors they affected. 
 A path diagram (Figure 
between items, factors and residuals
McArdle's reticular action model [
exogenous variables
variances by circles. 
points from the assumed causative factor, item or residual towards the effected one
bi-directional arrow represent
Figure 6.2-1: Path diagram of the 
scores 
6.2.2. Estimation of parameters
The measurement part 
probabilities of the observed indicator item
factors. It is given by:
where Φ{.} is the cumulative normal distribution [StataCorp 2013]. The
of the model shows the effect of exogenous variables on the latent factors
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assessment = αassessment + [group]βg assessment + [survey]βh assessment + εa 
treatment = αtreatment + [group]βg treatment + [survey]βh treatment + εt 
Model parameters were estimated using Mplus software version 5.1 [Muthén & 
Muthén]. An iterative robust weighted least-squares procedure – which is suitable for 
categorical items such as the process indicators in this model – was used for parameter 
estimation. This procedure assumes that residuals are normally distributed with very 
few extreme values. Estimation begins by fitting estimates of the measurement part of 
the model using weighted least squares, which involves identifying values of λ and the 
latent factors that solve the simultaneous equations expressing the probabilities of the 
observed indicator values for iteratively set values of the latent factors. The λ of the first 
item on each factor is fixed at 1 with a standard error of 0 to scale all other item 
loadings. This is followed by calculation of regression coefficients in the measurement 
part of the model and the standardised adjusted residuals. Robust weights are then 
estimated as a function of these residuals and applied to re-weight the estimates and the 
cycle repeated until convergence is achieved. 
Although these data were clustered within hospital, this non-hierarchical model was 
preferred for two reasons. First, it was the more parsimonious option, since the 
alternative approach of fitting a model of 11 parameters using only 8 hospitals –
effectively 8 observations – would have led to imprecise estimates. A minimum of 10 
observations per parameter has been recommended to ensure precision of estimates 
[Schreiber et al. 2006]. Secondly, in these data the number of admissions for each 
disease varied across the 8 hospitals, and the hospital-level ICC was 0.17 [Opondo et al. 
2011]. Simulation studies have shown that in such circumstances (i.e. unequal cluster 
sizes, few clusters, or very small or very large ICC) the assumption of independent and 
identically distributed variables in a hierarchical model is likely to be violated leading to 
unreliable between-group estimates [Hox & Maas 2001].  
Listwise deletion was the preferred method of handling missing data in all analyses 
undertaken in this work. It is valid for data missing completely at random (MCAR). 
Data collection procedures followed in the district hospitals study made this the most 
likely mechanism for missingness. This is because all missing information in case 
record forms were coded ‘E’ (‘empty’) in the data collection tool and recoded to ‘0’ in 
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the indicators, and these implied poor quality of care. True missingness, which was 
most likely MCAR, occurred in the form of indicators for which either the actual 
observation made by the clinician or the explicit coding for the absence of such 
information was not done at data collection or lost during data entry. 
6.2.3. Results of the structural equation model of the modified score 
Table 6.2-1, Table 6.2-2 and Table 6.2-3 present the parameter estimates from the 
structural equation models of the modified score for malaria, pneumonia and 
diarrhoea/dehydration respectively. Each disease-specific model was limited to cases 
which had been diagnosed with that disease alone. This was done to exclude any 
potential effect of multiple diagnoses, since a number of the signs and symptoms of 
illness (e.g. level of consciousness, inability to drink/breastfeed, indrawing) were 
relevant to two or three diseases. For this reason only 2,930 cases of malaria, 1,409 of 
pneumonia and 529 of diarrhoea/dehydration were used to estimate these parameters 
and assess the model’s goodness of fit. 
The suitability of the proposed conceptual groupings was assessed through factor 
loadings – the parameters represented by the λ’s – and model fit indices. All factor 
loadings across all three diseases were significantly greater than zero, except the 
secondary assessment indicator for the diarrhoea/dehydration model (which was the 
smallest model by sample size). Comparative Fit Index (CFI) and Tucker-Lewis Index 
(TLI) were large and Root Mean Square Error of Approximation (RMSEA) small, 
indicative of good to marginal fit according to the suggested interpretation of fit indices 
in Table 4.2-2. 
Modifications to the proposed factor model in an attempt to improve fit, including a 
one-factor model which assumed that all indicators loaded onto a single factor, and for 
diarrhoea/dehydration, a model replacing the secondary assessment indicator with the 
diagnosis indicator, resulted in poorer fitting models (Appendix A.11). For this reason 
the proposed aggregation of items into three domains was adopted as the most preferred 
conceptual grouping of indicators within the score since it was the one best supported 
by the patterns observed in these data and most likely to be intuitive to the intended 
audiences. 
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Table 6.2-1: Parameter estimates of the two-factor structural equation model of the modified 
score for malaria quality of care 
Parameter Estimate (standardised) Standard error p-value 
λp 1.000 (0.534) _ _ 
λs 1.958 (0.976) 0.250 < 0.001 
λd 1.000 (0.706) _ _ 
λu 0.886 (0.644) 0.055 < 0.001 
βg assessment 0.216 (0.196) 0.039 < 0.001 
βh assessment 0.183 (0.394) 0.025 < 0.001 
βg treatment 0.770 (0.466) 0.046 < 0.001 
βh treatment 0.423 (0.605) 0.023 < 0.001 
var(εa) 0.246 0.039 < 0.001 
var(εt) 0.310 0.043 < 0.001 
cov(εa,εt) 0.229 (0.829) 0.031 < 0.001 
    
n = 2,930; fit indices: χ25 = 88.254, p-value < 0.001; CFI = 0.948; TLI = 0.874; RMSEA = 0.075 
 
Table 6.2-2: Parameter estimates of the two-factor structural equation model of the modified 
score for pneumonia quality of care 
Parameter Estimate (standardised) Standard error p-value 
λp 1.000 (0.650) _ _ 
λs 1.614 (0.918) 0.254 < 0.001 
λd 1.000 (1.050) _ _ 
λu 0.516 (0.580) 0.064 < 0.001 
βg assessment 0.518 (0.358) 0.087 < 0.001 
βh assessment 0.378 (0.587) 0.057 < 0.001 
βg treatment 0.630 (0.273) 0.082 < 0.001 
βh treatment 0.304 (0.296) 0.043 < 0.001 
var(εa) 0.286 0.093     0.002 
var(εt) 1.125 0.160 < 0.001 
cov(εa,εt) 0.287 (0.506) 0.053 < 0.001 
    
n = 1,409; fit indices: χ25 = 11.151, p-value = 0.0485; CFI = 0.992; TLI = 0.980; RMSEA = 0.030 
 
Table 6.2-3: Parameter estimates of the two-factor structural equation model of the modified 
score for diarrhoea/dehydration quality of care 
Parameter Estimate (standardised) Standard error p-value 
λp 1.000 (0.360) _ _ 
λs 2.091 (0.709) 2.199 0.341 
λd 1.000 (0.795) _ _ 
λu 0.847 (0.685) 0.154 < 0.001 
βg assessment 0.260 (0.354) 0.278 0.349 
βh assessment 0.105 (0.333) 0.112 0.351 
βg treatment 0.501 (0.297) 0.105 < 0.001 
βh treatment 0.174 (0.241) 0.045 < 0.001 
var(εa) 0.095 0.102 0.349 
var(εt) 0.585 0.124 < 0.001 
cov(εa,εt) 0.105 (0.444) 0.112 0.349 
    
n = 529; fit indices: χ25 = 13.093, p-value = 0.0108; CFI = 0.941; TLI = 0.822; RMSEA = 0.066 
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The two-factor model of the combined score further supported the proposed structure of 
the quality of care measure (Table 6.2-4). The fit indices were indicative of good fit. 
Additionally, factor loadings were all significantly greater than zero, with standardised 
loadings between 0.59 and 0.80. There was also a high correlation of 0.66 between the 
‘assessment’ and ‘treatment’, conditional on group and survey (this was between 0.44 
and 0.83 for the disease-specific scores), confirming that although the domains were 
distinct dimensions of the process of care they were still closely related as is expected of 
the dimensions of a construct. 
Table 6.2-4: Parameter estimates of the two-factor structural equation model of the combined 
score for malaria, pneumonia and diarrhoea/dehydration 
Parameter Estimate (standardised) Standard error p-value 
λp 1.000 (0.617) _ _ 
λs 1.347 (0.801) 0.091 < 0.001 
λd 1.000 (0.771) _ _ 
λu 0.738 (0.591) 0.034 < 0.001 
βg assessment 0.369 (0.283) 0.031 < 0.001 
βh assessment 0.224 (0.401) 0.016 < 0.001 
βg treatment 0.517 (0.305) 0.029 < 0.001 
βh treatment 0.304 (0.419) 0.015 < 0.001 
var(εa) 0.317 0.031 < 0.001 
var(εt) 0.516 0.033 < 0.001 
cov(εa,εt) 0.266 (0.657) 0.020 < 0.001 
    
n = 8,476; fit indices: χ25 = 187.008, p-value < 0.001; CFI = 0.980; TLI = 0.948; RMSEA = 0.039 
6.3. Criterion-related validity: is the score associated with mortality? 
Outcomes of care are not only intrinsic to the meaning of quality of care 
[Hammermeister et al. 1995] but are also the ultimate validation of quality of care 
[Donabedian 1966]. Mortality (or, more specifically, survival) is arguably the most 
relevant and objective outcome of care. As such, the demonstration of a favourable 
association between processes of care and mortality is a key step in validating this 
quality of care measure. Although indicators contributing to the proposed process of 
care measure should, at least in theory, be associated with outcomes such as 
death/survival, individual indicators can lack sufficient variability and power to show 
such associations or intervention effects except in very large samples and/or for very 
strong associations. 
A case in point is a study exploring whether process indicators of care for elderly 
patients with pneumonia were associated with lower 30-day mortality which showed 
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improved survival with only 2 of the 4 processes examined [Meehan et al. 1997]. A 
similar finding in the Kenyan district hospitals study was that 6 of the 18 indicators used 
to compare performance between the intervention and control hospitals at the main 
study endpoint showed weak or no evidence of intervention effect [Ayieko et al. 2011], 
and only 1 of 3 key indicators of the process of care for malaria, pneumonia and 
diarrhoea/dehydration were associated with mortality, as shown in Table 6.3-1.  
Table 6.3-1: Estimates of association between mortality and process of care based on a 
hierarchical logistic regression model of death on key process indicators adjusting for age, sex, 
group and survey. 
Indicator n Adjusted odds 
ratio for death 
95% confidence 
intervals p-value 
Quinine loading dose in severe malaria 1,792 1.32* 0.82 – 2.13 0.258 
Correct dose of gentamicin in very 
severe pneumonia 
434 0.70 0.38 – 1.27 0.239 
Correct dose  of IV fluids in severe 
dehydration 
674 0.57 0.34 – 0.94 0.027 
*Although not statistically significant, an increased odds of death associated with quinine loading dose could be due to poor 
management of harmful side effects of quinine, e.g. hypoglycaemia 
Specifically, there was no evidence that the use of quinine loading dose in severe 
malaria and the correct dose of gentamicin in very severe pneumonia were associated 
with lower odds of death even though they are recommended best-practice for what 
ought to be good care, whereas there was strong evidence that correct use of IV fluids in 
dehydration was associated with a 43% reduction in odds of death. 
To test the comparative efficiency of the score in detecting changes in the process of 
care, a hierarchical logistic regression model of the odds of death across the range of the 
combined score was fitted. The analysis was limited to data from children with at least 
one of the three diseases of interest to this work. The model adjusted for variables 
representing study design factors – group (intervention) and time (survey) and their 
interaction – and age and sex which were thought of a priori as possible confounders in 
the hypothesised association between the selected process and outcome measures. There 
was also adjustment for the nature, number and severity of disease all of which were 
known to increase the odds of death. 
Proportions and associations of outcome and exposure variables with the combined 
score are presented in Table 6.3-2. There was evidence of association between the 
combined score and almost all the other exposure variables to be included in the model. 
There was also evidence of association between the all exposure variables and 
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mortality, as shown in Table 6.3-3. A number of variables had missing values. Potential 
causes and treatment of missing values is briefly discussed in section 6.2.2. 
Table 6.3-2: Proportions (%) and associations of outcome and exposure variables with the 
combined score 
Combined score 0 1 2 3 4 5 6 n p-value 
Outcome          
Alive 4.66 27.09 18.66 13.23 18.56 12.23 5.56 8,210 0.051 Dead 4.78 23.23 17.30 17.30 17.46 14.00 5.93 
          
Age          
< 12 months 5.05 28.40 18.17 14.19 17.64 11.57 4.97 
8,476 <0.001 
12 – 23 months 5.26 27.93 18.20 12.77 19.24 11.60 5.00 
24 to 35 months 3.78 22.34 20.45 13.23 18.38 14.43 7.39 
36 to 47 months 2.73 22.12 20.76 12.88 20.45 13.94 7.12 
48 to 59 months 4.73 26.72 18.68 13.53 18.43 12.32 5.59 
          
Sex          
Male 4.16 21.42 18.45 14.52 20.43 14.55 6.48 7,040 0.355 Female 3.75 22.80 18.89 15.01 20.58 12.92 6.04 
          
Number of diseases 
diagnosed 
         
1 3.27 20.87 20.62 12.76 18.30 15.90 8.28 
8,476 <0.001 2 6.85 34.55 14.26 15.02 19.25 7.93 2.14 
3 5.29 35.29 33.24 10.29 12.35 3.24 0.29 
          
Severity          
Lowest 5.12 25.71 19.30 13.91 21.02 11.70 3.23 
5,812 <0.001 Intermediate 1.83 9.56 17.69 21.20 28.52 13.52 7.68 
Highest 0.65 2.66 6.73 18.29 30.25 28.19 13.22 
          
Identity of disease          
Diarrhoea/dehydration 0.38 10.96 30.06 16.82 21.17 8.70 11.91 
8,476 <0.001 Malaria 6.06 27.85 20.08 10.39 15.83 13.54 6.25 
Pneumonia 4.06 27.70 15.93 16.00 20.47 11.65 4.18 
          
Group          
Control 6.65 33.85 25.30 14.57 12.49 5.87 1.26 8,476 <0.001 Intervention 3.17 20.92 13.29 12.69 23.26 17.57 9.11 
          
Survey          
Baseline 11.33 61.56 21.12 4.25 1.74 0.00 0.00 
8,476 <0.001 1
st
 follow-up 1.96 13.31 16.07 17.50 26.78 17.92 6.47 
2nd follow-up 2.08 13.16 15.97 17.22 26.38 18.16 7.02 
End-point 3.06 16.69 20.60 15.85 20.65 14.40 8.75 
          
Overall 4.73 26.72 18.68 13.53 18.43 12.32 5.59   
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Table 6.3-3: Proportions (%) and associations of exposure variables with mortality 
Variable Proportion of children 
who died (%) 
Crude odds 
ratio n p-value 
Combined score     
0 7.57 1.00 
8,210 0.051 
1 6.41 0.84 
2 6.89 0.90 
3 9.45 1.27 
4 6.99 0.92 
5 8.37 1.12 
6 7.84 1.04 
     
Age     
< 12 months 9.99 1.00 
8,210 < 0.001 
12 – 23 months 5.65 0.54 
24 to 35 months 4.14 0.39 
36 to 47 months 4.69 0.44 
48 to 59 months 5.56 0.53 
     
Sex     
Male 7.06 1.00 6,814 0.050 Female 8.32 3.83 
     
Number of diseases diagnosed     
1 7.51 1.00 
8,210 0.023 2 6.85 0.91 
3 10.94 1.51 
     
Severity     
Lowest 5.34 1.00 
5,626 < 0.001 Intermediate 8.85 1.72 
Highest 9.70 1.91 
     
Identity of disease     
Diarrhoea/dehydration 8.01 1.00 
8,210 < 0.001 Malaria 5.66 0.69 
Pneumonia 7.39 1.12 
     
Group     
Control 6.51 1.00 8,210 0.006 Intervention 8.10 1.27 
     
Survey     
Baseline 5.82 1.00 
8,210 0.007 1
st
 follow-up 7.27 1.27 
2nd follow-up 8.37 1.48 
End-point 8.12 1.43 
     
Overall 7.39  8,210  
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Although the three diseases considered in this analysis are often associated with illness 
of relatively short duration, it was not unusual to observe admission episodes lasting 
more than a few days. Adjustment was made of the duration of admission, but since 
admissions lasting more than a month were relatively rare – 2.56% of all cases – they 
were all collapsed into a single group. Excluding admission episodes lasting more than 
7 days did not change the conclusions from the model (Appendix A.12). The presence 
and nature of clinical signs and symptoms and treatments were excluded from the model 
since they were either components of either the characteristics of the illnesses diagnosed 
– and already adjusted for – or the score itself. The model also adjusted for the clustered 
nature of observations by admitting clinician and hospital. Quadratic terms of 
statistically significant continuous predictor variables were fitted and retained in the 
model if they were significant and did not worsen model fit. 
If Yijk is the outcome of patient i who was attended to by clinician j in hospital k, x1 is the 
effect of the score or any indicator on mortality, and xl are other covariates and 
quadratic terms associated with the outcome to be adjusted for, the model is: 
E[logit(Yijk)] = α  + β1x1ijk + Σl βl xlijk + uj + ujk 
with normally-distributed clinician-level random-effects uj assumed to have a mean of 
zero and variance of σuj2 conditional on the normally-distributed hospital-level random 
effects ujk, whose variance is σujk2. These assumptions are examined graphically in 
Appendix A.13. 
Estimates from the model are presented in Table 6.3-4. They show strong evidence of a 
14% reduction in adjusted odds of death per unit increase in the score. There were other 
notable findings as well. The odds of death decreased by 31% with each extra disease 
diagnosed. Although this may seem counterintuitive, it was probably a reflection of the 
guideline recommendation that clinicians should identify and treat all illnesses 
consistent with clinical signs and symptoms. It may also mean that children diagnosed 
with more than one disease were more likely to be admitted to hospital regardless of the 
severity of their illness. 
Lastly, there was no difference in the adjusted odds of death comparing intervention and 
control groups across time. This was most probably due to the intervention exerting its 
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effect through improved process of care measured by the score which, once adjusted 
for, likely muted any direct group and time effects on mortality. 
Table 6.3-4: Adjusted effect of quality of care measured using the combined score on death 
 
Adjusted odds 
ratio for death 
95% confidence 
interval p-value 
Combined score 0.86 0.77 – 0.95    0.005 
Age (years) 0.63 0.55 – 0.72 <0.001 
Sex (female vs. male) 1.13 0.91 – 1.40   0.283 
Number of diseases diagnosed 0.69 0.54 – 0.87   0.002 
Severity (3=highest, 2=intermediate, 1=lowest) 1.49 1.27 – 1.75 <0.001 
    
Identity of disease    
Diarrhoea/dehydration 1.00  
< 0.001 Malaria 0.83 0.54 – 1.29 
Pneumonia 1.57 1.02 – 2.42 
    
Duration of admission (days) 0.95 0.92 – 0.98 < 0.001 
    
Group    
Control 1.00   
Intervention 1.20 0.41 – 3.50    0.733 
    
Survey    
Baseline 1.00  
   0.942 1
st
 follow-up 0.95 0.44 – 2.04 
2nd follow-up 1.12 0.51 – 2.44 
End-point 1.06 0.50 – 2.24 
    
Group-survey interaction    
Intervention x 1st follow-up 1.50 0.55 – 4.12 
   0.741 Intervention x 2nd follow-up 1.14 0.42 – 3.12 
Intervention x End-point 1.45 0.55 – 3.85 
    
Random effects Variance   
Clinician (i=391) 0.19 0.07 – 0.52  
Hospital (j=8) 0.17 0.05 – 0.59  
    
n =  4,732, died = 386 |  Goodness of fit test: Hosmer-Lemeshow χ28 = 13.12, p = 0.1077,  ROC AUC = 0.7535 
6.4. External validity: can the score be systematically replicated in 
routine data? 
The primary data used in the design of the score arose from a cluster randomised trial 
designed to mirror routine care as much as possible, but some characteristics of the trial 
were not typical of a routine care setting. Most notably, the use of the paediatric 
admission record (PAR) form – a central component of the intervention – probably 
increased the extent, content and detail of documentation of the process of clinical care. 
This could have made it comparatively easier to obtain case record data and calculate a 
process of care score. The provision of guidelines and work-aids along with supervision 
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and feedback could have also created an enabling environment for the completion of the 
processes represented by the indicators contributing to the score. Absolute scores at 
clinician and hospital level, and variations between and within these levels were likely 
affected by these factors, possibly influencing the observed characteristics of the score.  
Systematic replication was therefore necessary to explore whether: (1) it was possible to 
calculate the score using data collected in non-intervention and routine quality 
assessment work, and (2) the score’s domains and association with mortality observed 
in the trial data were generalisable to a non-trial setting. The pneumonia trial 
observation data and the Ministry of Health survey data, introduced and described in 
detail in section 2.3, are different from the Kenyan district hospitals study in a number 
of ways that make them suitable for external validation. 
First, the pneumonia study focused on treatment of children with acute illnesses not 
randomised to either arm of a trial; there was therefore potentially no group 
(intervention) effect on the quality of care for these children. Secondly there was no 
survey effect in the pneumonia trial observational data because they were collected 
continuously over an 18-month period. This is in contrast with the staggered design of 
the district hospitals study where although data spanned the entire study period 
including the inter-survey periods, data collection followed ‘waves’ of supervision, 
instances of regular feedback and other substantive support activities designed to 
change the process of care. 
Thirdly, although outcome assessment was undertaken at individual level in all three 
studies, the intervention was delivered at individual level in the pneumonia trial unlike 
the district hospitals study where the hospital (cluster) was the level of intervention. 
Any between-hospital differences in care in the observation study were therefore more 
likely to be due to hospital-level random variation, unlike the district hospitals study 
where there was likely an additional hospital-level effect due to the intervention. Lastly, 
observations were not linked to an identifier for the admitting clinician. 
The Ministry of Health survey data were collected in a single cross-sectional study as 
part of a routine quality assessment exercise. Like the pneumonia trial observation 
dataset this survey involved neither group allocations nor multiple surveys. The hospital 
was the unit of interest in reporting of processes and outcomes, and the number of 
observations per hospital – between 16 and 55 – was comparatively smaller than those 
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in the pneumonia trial observation and district hospitals study. The data extraction and 
score calculation steps described in Chapter 5 were repeated on each of these two 
datasets. Next, a structural equation model to examine whether items contributing to the 
combined score aggregated in the proposed conceptual groupings were fitted on the 
replication data according to the path diagram in Figure 6.2-1. The results are presented 
in Table 6.4-1 and Table 6.4-2.  
Table 6.4-1: Parameter estimates of the two-factor CFA model of the combined score for 
malaria, pneumonia and diarrhoea/dehydration in the Ministry of Health survey dataset 
Parameter Estimate (standardised) Standard error p-value 
λp 1.000 (0.249) _ _ 
λs 4.010 (0.998) 2.794 0.151 
λd 1.000 (1.469) _ _ 
λu 0.115 (0.169) 0.096 0.229 
var(εa) 0.062 0.058 0.287 
var(εt) 2.157 1.658 0.193 
cov(εa,εt) 0.145 (0.398) 0.102 0.152 
    
n = 802; fit indices: χ25 = 182.375, p-value < 0.001; CFI = 1.000; TLI = 1.026; RMSEA < 0.001 
 
Table 6.4-2: Parameter estimates of the two-factor CFA model of the combined score for 
malaria, pneumonia and diarrhoea/dehydration in the pneumonia trial observation dataset 
Parameter Estimate (standardised) Standard error p-value 
λp 1.000 (0.331) _ _ 
λs 1.606 (0.531) 0.334 <0.001 
λd 1.000 (0.886) _ _ 
λu 0.434 (0.384) 0.064 <0.001 
var(εa) 0.109 0.037   0.003 
var(εt) 0.784 0.117 <0.001 
cov(εa,εt) 0.170 (0.581) 0.034 <0.001 
    
n = 7,479; fit indices: χ25 = 632.226, p-value < 0.001; CFI = 0.994; TLI = 0.968; RMSEA = 0.023 
Validation on the Ministry of Health survey data showed a very good fit on CFI, TLI 
and RMSEA fit indices. However, none of the item loadings was significantly greater 
than zero. This may mean that variations in the items in these data is poorly linked to 
the underlying factors (domains), but could also reflect confounding by unidentified 
exogenous variables or item response patterns unique to the data. Validation on the 
pneumonia trial observation data also showed good fit on the same three fit indices and, 
unlike the former, significant factor loadings on all items. Correlations between the 
latent factors were estimated as 40% in the Ministry of Health survey data and 58% in 
the pneumonia trial observation data. These findings suggested that the observed 
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relationships between items and factors/domains were similar to those observed in the 
Kenyan district hospitals trial. 
The final step was to investigate the score’s association with mortality. The results are 
shown in Table 6.4-3. Unlike in the Kenyan district hospitals data, there was no 
evidence of a crude association of the combined score with mortality in each of the 
validation datasets. 
Table 6.4-3: Proportions (%) and associations of exposure variables with mortality 
Variable 
Proportion of 
children who 
died (%) 
Crude odds 
ratio 
Trend odds 
ratio n 
p-value 
(trend 
p-value) 
Combined score in the 
pneumonia observation 
data 
     
0 6.25 1.00 
0.95 7,058 0.062 (0.184) 
1 5.32 0.84 
2 5.79 0.92 
3 6.88 1.11 
4 4.36 0.68 
5 5.64 0.90 
6 3.85 0.60 
      
Combined score in the 
Ministry of Health survey 
data 
     
0 0.00 _ 
0.96 783 0.149 (0.732) 
1 1.89 1.00 
2 6.54 3.64 
3 5.15 2.82 
4 9.28 5.32 
5 2.67 1.42 
6 5.49 1.81 
      
Nevertheless adjusted estimates association were obtained from logistic regression 
models analogous to those in section 6.3 appropriately modified to accommodate the 
differences between the datasets. For example, neither model included a group 
(intervention) or time (survey) variable, nor was there any adjustment for clustering 
within clinician. Both models were first attempted with adjustment for clustering within 
hospitals. Treating hospitals as random effects – an exact replication of the model of the 
district hospitals study data – and as fixed effects resulted in poorly fitting models even 
though the estimated association of the score with mortality remained consistent with 
previous findings (Appendix A.14). The best fitting models of the validation data did 
not include any adjustment for clustering. Estimates from these models are presented in 
Table 6.4-4 and Table 6.4-5. They are consistent with previous findings about the 
adjusted associations between each of the variables and death. The estimated reduction 
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in the odds of death per unit increase in the score was 22% in the pneumonia trial 
observation and 39% in the Ministry of Health survey, and the confidence intervals 
around these estimates overlapped with those from the district hospitals study. The 
greater uncertainty about the association in the Ministry of Health survey was likely 
attributable to the comparatively smaller size of the study. 
Table 6.4-4: Adjusted effect of quality of care measured using the combined score on death 
estimated by a logistic regression model of the pneumonia trial observation data 
 Adjusted odds 
ratio for death 
95% confidence 
interval p-value 
Combined score 0.78 0.70 – 0.88 < 0.001 
Age (years) 0.92 0.85 – 0.98    0.014 
Sex (female vs. male) 1.05 0.84 – 1.32    0.653 
Number of diseases diagnosed 0.83 0.58 – 1.18    0.302 
Severity (3=highest, 2=intermediate, 1=lowest) 2.64 2.11 – 3.30 < 0.001 
    
Identity of disease    
Diarrhoea/dehydration 1.00  
< 0.001 Malaria 0.39 0.23 – 0.66 
Pneumonia 1.09 0.75 – 1.58 
    
Duration of admission (days) 1.00 0.99 – 1.01    0.785 
    
n =  5,924, died = 324 |  Goodness of fit test: Hosmer-Lemeshow χ28 = 12.70, p = 0.1226; ROC AUC = 0.6704 
 
Table 6.4-5: Adjusted effect of quality of care measured using the combined score on death 
estimated by a logistic regression model of the Ministry of Health survey data 
 Adjusted odds 
ratio for death 
95% confidence 
interval p-value 
Combined score 0.61 0.42 – 0.88    0.008 
Age (years) 0.64 0.43 – 0.96    0.033 
Sex (female vs. male) 1.03 0.49 – 2.18    0.933 
Number of diseases diagnosed (omitted – varies very little with the outcome) 
Severity (3=highest, 2=intermediate, 1=lowest) 5.34 2.53 – 13.26 < 0.001 
    
Identity of disease    
Diarrhoea/dehydration 1.00  
   0.162 Malaria 0.18 0.03 – 1.11 
Pneumonia 0.29 0.07 – 1.17 
    
Duration of admission (days) 0.94 0.86 – 1.04    0.210 
    
n = 540, died = 32 | Goodness of fit test: Hosmer-Lemeshow χ28 = 6.52, p = 0.5890 | ROC AUC = 0.7689 
More formally, similarity across estimates was tested by calculating a chi-squared 
statistic for heterogeneity based on how different each estimate was from the average 
relative to the variance of the estimate, as described in section 4.5.3 [Higgins et al. 
2002, Thompson & Sharp 1999, Thompson 1994]. The statistic is a sum of the inverse 
variance-weighted differences between each study’s estimate of effect and the overall 
pooled estimate of effect. For these three studies Q was estimated as 3.87 with 2 degrees 
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of freedom corresponding to a p-value of 0.144, meaning that there was no evidence of 
heterogeneity. The proportion of variability across studies attributable to heterogeneity, 
I2, was 48.4%. This was a ‘moderate’ amount of variability which did not weaken the 
suggestion of a common effect especially in light of the consistency in magnitude and 
direction of association of the score with mortality [Higgins et al. 2003]. 
It was further assumed that the true effect of process of care – measured by the score – 
on mortality varied randomly across the studies. This was a fair assumption considering 
the possibility of confounding in the association between care and mortality caused by 
factors unidentifiable from the hospital record of the admission episode, such as socio-
economic status of the patient or promptness of with which care was given, among 
others. Nevertheless this assumption did not change any conclusions about 
heterogeneity, estimates of effect, or strength of evidence for (or against) the hypotheses 
examined.  
Figure 6.4-1 is a graphical comparison of the individual study effects along with the 
pooled effect which was estimated as a 20.1% reduction in the odds of death per unit 
increase in the score (95% confidence intervals 29.1% reduction to 9.9% reduction, p-
value < 0.001). It shows very strong evidence of an association between the score and 
mortality which is consistent and of similar magnitude across the three datasets. 
 
Figure 6.4-1: Study-specific and pooled estimates of the strength of association between the 
process of care score and mortality 
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6.5. Summary 
There is evidence that items making up the score naturally aggregate into domains that 
are not only consistent with the clinical process encompassing assessment, diagnosis 
and treatment, but that are also measures of a common underlying construct. There is 
also strong evidence that the score is associated with mortality. Higher scores, 
representing better care, are associated with lower odds of mortality, and this suggests 
that the score as a measure of process of care is linked to an objective outcome, as 
expected. All these findings, first observed in data arising from a trial, have been 
replicated on external data from a prospective observation and those from a 
retrospective cross-sectional survey, albeit with lower-strength evidence of item 
groupings in one dataset. Nevertheless when put together with the results of initial 
validation in Chapter 5, there is sufficient evidence to conclude that the proposed score 
is a good measure of the process of care. Chapter 7 presents some practical applications 
of the score. 
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Chapter 7 – Applications of the Proposed Measure as a 
Process-based Outcome 
7.1. Introduction 
This Chapter demonstrates how the score could work in real life. The combined score is 
presented in the context of two common uses of quality measures. The first is an 
example of routine quality of care assessment and reporting similar to what would 
normally be undertaken in quality assurance and improvement programmes. In this 
example, alternative contemporary approaches to reporting summary measures are 
briefly discussed with the aim of selecting the most suitable one for reporting this score. 
Use of the score is demonstrated with data from the Ministry of Health survey which 
was the type of quality assessment exercise envisaged in the design of the proposed 
score. The second situation is an application of the score as a trial outcome measure for 
an intervention to improve quality of care. This is demonstrated through estimation of 
the effect of the intervention in the Kenyan district hospitals study using score as an 
outcome measure. An approach to the analysis is suggested, along with an appropriate 
sample size calculation for the study.  
7.2. Example 1: reporting and monitoring quality of care 
Once standards of process of care are in place, and an objective way of measuring 
whether care is provided according to these standards has been developed, then the next 
logical step is to work out an effective strategy for communicating the metric to its 
target audience. Three approaches to reporting metrics of quality of care for quality 
assurance and improvement and comparing hospitals are commonly encountered in 
literature, and these are cumulative sum (CUSUM) charts league tables and funnel plots.  
CUSUM charts are plots of the cumulative number of successes or failures against the 
total number of patients, procedures or events [Williams et al. 1992]. They have been 
used to monitor clinical outcomes in routine clinical data such as low APGAR scores 
[Sibanda & Sibanda 2007], binary surgical outcomes [Steiner et. al 2001], assessment 
of organ transplant failure rates [Biswas & Kalbfleisch 2008], and even competency in 
conducting medical procedures [Sivaprakasam & Purva 2010, Sims et al. 2013]. They 
are designed for use with binary outcomes or measures that can be dichotomised, and 
for this reason are not applicable to the score. 
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League tables are listings, tabulations or graphical presentations of the institutions 
against their value of a measure of an attribute of interest. They are popular because 
they are easy to interpret and understand. They are often used when a standard against 
which performance on the measure is to be compared is not set [Noyez 2009]. They 
assume that the institutions being compared are inherently similar, and any variations 
between them are due to true differences in the attribute being measured. A league table 
comparing the quality of care in the 22 hospitals in the Ministry of Health survey of 
2012 as measured by the combined score is presented in Figure 7.2-1.  
 
Figure 7.2-1: League table of the 22 hospitals in the Ministry of Health survey of 2012 
The dots and capped vertical lines represent the hospital mean combined scores and their 
95% confidence intervals respectively (numbers are hospital IDs), and the horizontal line is 
the overall mean for all hospitals. 
League tables are suitable for identification of institutions in need of improvement. For 
example, hospitals 2, 5, 9, 10, 12, 14, 15, 18 and 19 in Figure 7.2-1 exhibit poor quality 
of care compared to their peers because they have mean scores below the overall mean 
and their 95% confidence intervals do not include the overall mean. However, the ranks 
implied by league tables are themselves sensitive to sampling variation just like the 
mean scores. This has been a source of great controversy and scepticism [Pandey et al. 
2007, Jacobs et al. 2005, Gibberd et al. 2004, Botha et al. 2001] not least because the 
variability in ranking is not properly accounted for [Goldstein & Speigelhalter 1996]. 
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Funnel plots, unlike CUSUM plots, can be applied to binary, categorical and continuous 
outcomes, and unlike league tables, they handle various sources of variability 
satisfactorily and do not explicitly rank institutions [Benneyan et al. 2003, Woodall & 
Montgomery 1999, Wheeler & Chambers 1992]. The principles underlying funnel plots 
are derived from statistical process control of product variation in manufacturing. Two 
sources of variation in a measurement are identified. One is chance which manifests 
itself through sampling variation. It is referred to as common cause variation and is 
expected in all measurement. The other – arguably the most important in institutional 
comparison but which league tables do not explicitly distinguish – is systematic 
differences, referred to in statistical process control terminology as special cause 
variation. Special cause variation can be attributed to an assignable cause such as a true 
improvement or deterioration, and if an assignable cause is not patent then special cause 
variation warrants further investigation. 
Funnel plots have a series of points representing the units being compared, with a line 
indicating their mean on one axis. These are bound by contour lines representing control 
limits beyond which deviations in the metric are attributed to special cause variation. 
Precision is measured by the denominators of the metric and are plotted on the second 
axis [Spiegelhalter 2005, Spiegelhalter 2002]. For example, the measure of precision of 
the hospital mean quality of care scores is the number of case records sampled to 
estimate the mean score. Typically the control limits are set at 2 and 3 standard 
deviations above and below the overall quantity means. They are analogous to the 95% 
and 99.5% confidence intervals in the league tables, but are calculated differently: 
whereas the confidence intervals in the league tables are estimated around each 
hospital’s mean score, those in the funnel plots are based on the overall mean of all the 
hospitals. The assumption behind this approach is that all hospitals are performing at the 
same level, and the funnel plot simply aims to establish a range of values within which 
their performance could still be characterised as ‘average’ within the limits of chance. It 
is a formal test of the null hypothesis that each of the hospital mean scores is not 
different from the overall mean score. If the mean of n scores in hospital i is i and the 
mean score of all hospitals is µ with standard deviation σ, then:  
x32   µ
σ √!_  
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3`aM µ
σ √5_  is assumed to be normally distributed. The control limits are a function of n and are 
set at µ ± bc σ√! where zα is the cumulative normal distribution at level α. Figure 7.2-2 is 
a funnel plot of same 22 hospitals in Figure 7.2-1. 
 
Figure 7.2-2: Funnel plot of the 22 hospitals in the Ministry of Health survey of 2012 
Dots represent the hospital mean scores (numbers are the hospital IDs), the vertical line is 
the overall mean for all hospitals, and the dotted contour lines represent the range of values 
2 (inner) and 3 (outer) standard deviations around the mean 
A larger number of hospital mean scores are compatible with the overall mean 
compared to the league table. The funnel plot suggests that 7 hospitals have mean scores 
which are less than the lower 95% confidence limit of overall mean of about 3.6, 
another 6 greater than the upper 95% confidence limit, and 9 are within the 95% 
confidence limits of the overall mean. This is in contrast to the league table where only 
hospitals 6, 7, 8 and 11 are not different from the overall mean while all other hospitals 
have mean scores higher or lower than the overall mean. 
Although the score is in fact an ordinal outcome, the assumption that its mean is 
asymptotically normally distributed underlies the construction of the control limits. This 
assumption may be problematic for means close to the lower and upper bounds of the 
range of the score since it may lead to control limits falling outside these bounds. To 
avoid this anomaly the items of the score are assumed to be a series of independent but 
not necessarily identically distributed Bernoulli experiments. The sum of successes of n 
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binary process of care indicators each with a distinct probability of success, pij in each 
hospital j has a Poisson-binomial distribution. The corresponding hospital mean scores, 
µj, are given by: 
µd $,+d!+1  
and are equivalent to the arithmetic hospital means of a normally distributed score. 
Hospital standard deviations, σj, are given by: 
σd   $,+d1  ,+d!+1  
The standard deviation is equal to that of a normally distributed score at its median; it 
reaches a maximum when each of the Bernoulli experiments – the indicator items – has 
a probability of 50%, but tends towards zero for values greater or less than the median 
Figure 7.2-3, which is a funnel plot of the 22 hospitals in Figure 7.2-2, shows the 
narrowed control limits resulting from this assumption about the score distributions. 
 
Figure 7.2-3: Funnel plot of the 22 hospitals in the Ministry of Health survey of 2012 with 
Poisson-binomial based 95% and 99.5% confidence bounds (‘control limits’) 
A grading system can then be applied to report these mean scores (Table 7.2-1). 
Grading provides standardised descriptors of each hospital’s performance relative to the 
group: hospitals with higher scores will on average have better grades, and vice-versa, 
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even when there’s a change in the mean score of all hospitals. The grades may be 
reported alongside the absolute scores to communicate both absolute and relative 
changes in quality of care. 
Table 7.2-1: Suggested 5-grade system for interpreting the funnel plots 
Grade Range of mean scores Hospitals in this grade 
A Equal to or greater than the upper 99.5% confidence 
limit 
3, 4, 13, 16, 21 
B Equal to or greater than the upper 95% confidence 
limit but less than the upper 99.5% limit 
1, 17, 22 
C Equal to or greater than the lower 95% confidence 
limit but less than the upper 95% limit 
5, 6, 7, 8, 11, 20 
D Equal to or greater than the lower 99.5% confidence 
limit but less than the lower 95% limit 
9 
E Less than lower 99.5% confidence limit 2, 10, 12, 14, 15, 18, 19 
Grades B and D refer to the region between the 95% and 99.5% confidence limits, 
which is small compared to the rest of the funnel-plot, and likely to include few 
hospitals especially when there is little variability between them. For example, although 
there is a wide variability of hospital mean scores in Figure 7.2-3, only 4 out of 22 
hospitals fall in this region. A 3-grade system which considers ‘average’ performance to 
be within either 95% or 99.5% confidence limits – thus excluding this narrow range of 
performance – may be preferred (Table 7.2-2). 
Table 7.2-2: Suggested 3-grade system with ‘average’ performance set at mean scores within 
the overall 95% confidence limits 
Grade Range of mean scores Hospitals in this grade 
A (‘above average’) Equal to or greater than the upper 95% confidence 
limit 
1, 3, 4, 13, 16, 17, 21, 22 
B (‘average’) Equal to or greater than the lower 95% confidence 
limit but less than the upper 95% limit 
5, 6, 7, 8, 11, 20 
C (‘below average’) Less than the lower 95% confidence limit 2, 9, 10, 12, 14, 15, 18, 19 
Other than comparing hospitals, funnel plots can be used to compare clinicians within a 
hospital, quality of care across a variety of diseases using disease-specific scores, or 
even showing how quality compares to a pre-set level of performance. Further examples 
of their uses are presented in Appendix A.15. 
7.3. Example 2: estimating the effect of a quality improvement 
intervention 
The proposed score can be used as a trial outcome measure in studies estimating the 
effect of quality improvement interventions. Group mean scores may be compared using 
parametric and non-parametric tests or regression models when adjustment for 
covariates is required. For example, in the Kenyan district hospitals study where a 
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quality improvement intervention was delivered to hospitals over an 18-month period, 
the effectiveness of the intervention could be assessed as follows. 
The trial outcome measure, Yi, is the score of process of care for patient i. The patient’s 
group allocation is x1 such that x1=0 for a patient in the control group and x1=1 for a 
patient in the intervention group. The surveys are represented by x2 (x2=0 at baseline, 
x2=1 at first follow-up, x2=2 at second follow-up and x2=3 at the primary end-point), and 
x3 is the interaction of group and survey. A generalised linear regression model for Y is: 
g(Yi) = α + β1x1i + β2x2i + β3x3i + ei  
where g is the link function for the outcome. The intervention effect on the score at 
baseline is the difference between the expressions of the outcome when x1=1 and x1=0 
respectively, with x2 held at 0:  
{α + β1 + β3x3i + ei } – {α + β3x3i + ei } 
which is β1. The score at any time T is predicted by: 
g(Yi) = α + β1x1i + β2T + β3T x1i + ei 
which when rearranged to: 
g(Yi) = α + x1i(β1+ β3T) + β2T + ei 
shows that the intervention effect on the score is the slope β1+ β3T. The baseline-
adjusted intervention effect is the difference between the intervention effect at baseline 
and that at any other time point:  
{β1+ β3T } – {β1} = β3T 
Therefore the intervention effect at time T is the coefficient of the interaction term for 
the intervention and time. 
Table 7.3-1 shows the intervention effect on the score estimated by two generalised 
linear models both with adjustment for clustering within hospital: a linear model which 
assumes that the score is continuous and normally distributed as suggested by the 
histograms in Figure 5.2-7 and Figure 5.2-8, and an ordered logistic regression model 
which acknowledges the ordered categorical nature of the score and assumes 
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proportionality of odds between levels of the score. The model results were very 
similar. There was no evidence of a difference in scores between the groups at baseline. 
Scores in the control group at the first and second follow-up surveys and at the main 
end-point were 1.57, 1.31 and 1.09 units respectively greater than baseline scores, with 
a trend of decline over time (χ2 test for trend p-value <0.001). In the ordered logistic 
model the odds ratio for a unit increase in control group scores followed the same trend: 
the odds of a unit increase in the score at the three time points were 9.32, 6.67 and 4.58 
times those at baseline. Scores in the intervention group were progressively higher in 
successive surveys according to the linear model; the score was on average 0.96, 1.33 
and 1.55 units higher at the second, third and fourth surveys respectively than baseline. 
Similarly in the ordered logistic model the odds ratio for a unit increase in the score 
were 3.90, 6.07 and 8.85 times higher than baseline in each of the three successive 
surveys. The largest effect was observed in the study’s main end-point, with strong 
evidence of a linear trend (χ2 test for trend p-value <0.001). 
Table 7.3-1: Effect of the intervention on the process of care score in the Kenyan district 
hospitals study 
 Linear model (n=8,453) Ordered logistic model (n=8,476) 
Effect coef. 95% CI p-value OR 95% CI p-value 
Group       
Control 1.00   1.00   
Intervention 0.10 -0.26 – 0.47 0.591 0.90 0.50 – 1.63 0.724 
       
Survey       
Baseline 1.00  
<0.001 
1.00  
<0.001 1
st
 follow-up 1.57 1.46 – 1.68 9.32 5.77 – 15.05 
2nd follow-up 1.31 1.20 – 1.43 6.67 3.15 – 14.14 
End-point 1.09 0.98 – 1.20 4.58 1.32 – 15.83 
       
Group-survey interaction       
Intervention x 1st follow-up 0.96 0.80 – 1.11 
<0.001 
3.90 2.11 – 7.22 
<0.001 Intervention x 2nd follow-up 1.33 1.17 – 1.48 6.07 2.80 – 13.12 
Intervention x End-point 1.55 1.40 – 1.69 8.85 2.78 – 28.18 
An important consideration for the use of the score as a trial outcome is a sample size 
calculation. Unlike indicator outcomes where sample size calculations and effect sizes 
are based on an estimated or desired proportion of successes, sample size calculations 
when the score is the main outcome can be set as the change in the mean number of 
process of care tasks undertaken. Trials of this nature will almost invariably be of a 
cluster design due to the effect of higher-level clustering variables, such as the clinician 
or hospital, on the outcome. Assuming equal-sized clusters with m observations in each 
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cluster, the minimum required number of clusters per arm, n, for a two-arm trial to 
detect a difference in mean scores, d, between the arms is: 
!   2beO + bf g{1 +   1i}   
where α and β are the required level of significance and 1-power respectively, zα/2 and 
zβ are the cumulative normal distribution corresponding to α/2 and β respectively, and 
σ2 is the overall variance [Hayes & Bennett 1999]. The intraclass correlation 
coefficient ρ is estimated from the between (σ2b) and within (σ2w) cluster variances of 
previous similar studies as σ2b/{σ2b + σ2w}. Poisson-binomial variances described in 
section 7.2 may be used if success probabilities of each of the indicator items 
contributing to the score are known. If the clusters are of different sizes, as is wont to be 
in many studies, then the sample size is adjusted by a coefficient of variation, c, which 
is the ratio of the standard deviation of cluster sizes to the mean of cluster size, m 
[Eldridge et al. 2006, Kang et al. 2003]. The required number of clusters per arm of 
uneven sizes with a known coefficient of variation is: 
!   2beO + bf g{1 + kA1 + lF  1i} k  
One likely difficulty with this adjustment is that very few studies report intraclass 
correlation coefficients and coefficients of variation of their main measures of interest 
[Rutterford et al. 2011]. It is also not unusual to find a difference between values used 
in sample size calculations prior to the study and those calculated with actual data from 
the study [Eldridge et al. 2006]. Figure 7.3-1 is a simulation of sample sizes (number of 
clusters per arm, n) across a range of between-arm mean score differences, d, assuming 
clusters of different mean sizes of 20 and 200, coefficients of variation of 0, 0.5 and 1, 
and ρ of 0.2 (low clustering) and 0.8 (high clustering). In each simulation α is 0.05, β is 
90%, and σ2 is assumed to be 1.5 which is the Poisson-binomial variance for six binary 
indicators each with a 50% probability. It shows that larger samples are required for 
smaller between group differences in the score (smaller d), higher clustering (larger ρ), 
smaller average cluster sizes (smaller m) and higher variability between cluster sizes 
(larger c) when all else are held constant. For example, a sample of 8 clusters per arm is 
required to demonstrate a difference of 1 between the groups if clusters have an average 
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size of 200, coefficient of variation of 0.5 and intraclass correlation of 0.2, but this 
shoots up to 32 for an intraclass correlation of 0.8, and to 50 with a coefficient of 
variation of 1 and an intraclass correlation of 0.8. For any combination of c, m and ρ, 
the n quadruples for any 50% reduction in d. 
 
Figure 7.3-1: Sample size calculations for a range of between-group score differences, 
average cluster sizes, coefficients of variations and intraclass correlation coefficients 
For ease of presentation the legends are listed in the same vertical order of the lines they 
represent on the graph 
7.4. Summary 
A variety of tools for summarising and presenting the score are available. Funnel plots 
are the preferred method of presenting hospital, clinician or other cluster-level mean 
scores because they appropriately deal with the various sources of variability in 
measurement. A qualitative interpretation of cluster mean scores below, around and 
above the overall mean provides a promising way of grading scores, an additional 
approach to reporting them. 
The utility of the score as a trial outcome has also been demonstrated in two regression 
models of data from the Kenyan district hospitals trial. The models reflect different 
assumptions about the distribution of the score. They have been compared to explore the 
sensitivity of conclusions on quality of care to non-normality through the modelling of 
the score as a discrete, ordered categorical outcome. Both models have led to 
conclusions which are consistent with each other, and with traditional outcomes such as 
single indicators which have previously been used to analyse these data. 
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Chapter 8 – Summary and Conclusion 
The aim of this work was to construct and validate a measure of the quality of care for 
children with acute illnesses admitted to hospitals in a low income country. A review of 
the literature highlighted a lack of quality of care measures relevant for routine use in 
this setting. This can be partly attributed to a lack of well-established reference 
standards and guidelines on which to base quality measurements and, even when 
guidelines have been available, a lack of effective dissemination and use in setting 
minimum standards of care [English et al. 2004, Nolan et al. 2001]. There are however 
several examples of studies illustrating the development of measures of quality of care 
for a variety of illnesses, mostly in high income countries. These examples provided 
guidance on the development of the measure of quality of care. The process began with 
a selection of a perspective of measurement (Chapter 1), followed by data selection 
(Chapter 2) and an exploration of approaches to analysis (Chapter 3 and Chapter 4), 
reliability and validity testing of the measure (Chapter 5), and culminated in exploration 
of it links to related measures and a brief presentation of examples of its application 
(Chapter 6 and Chapter 7). This was thought to be an objective and transparent 
approach to setting up and validating the measure. 
The Donabedian framework which considers the overall quality of health care in terms 
of resources that support health service delivery (‘structure’), the appropriateness of 
what is actually done by the providers of care (‘process’) and the results of care 
(‘outcomes’) was adopted in conceptualising quality of care and selecting a suitable 
perspective for its measurement [Donabedian 1988]. While each of these aspects is 
important in its own right, there is evidence that failure to translate evidence of good 
care into practice – weaknesses in the process of care according to Donabedian’s 
framework – is a limiting factor to the achievement of good outcomes in many low 
income settings, including Kenya [Peabody et al. 2006]. For this reason this thesis 
adopted process of care as the perspective of measurement, with initial focus on 
children admitted with malaria, pneumonia and diarrhoea since these diseases are 
responsible for the majority of under-5 deaths in this setting [Liu et al. 2012, Black et 
al. 2010]. Measuring quality of care in terms of process by contrasting what was 
documented to have been undertaken in the process of care – or the lack of 
documentation of process, an indicator of poor practice – with guideline 
recommendations is admittedly a narrow perspective for measuring what is obviously a 
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multi-faceted concept; it is nevertheless a very important one considering the central 
role of clinical processes in providing the means by which health inputs are converted to 
desirable outcomes. Ideally, this approach should be applicable to quality of care 
measurement in other diseases as well as settings beyond what has been presented in 
this thesis, and also allow for direct comparison of quality of care across diseases. 
Data for the initial development of the measure came from the case records of 12,036 
children admitted with acute illnesses to 8 Kenyan district hospitals during a cluster-
randomised trial [Ayieko et al. 2011, Gathara et al. 2011, English et al. 2009]. In 
Kenya, what constitutes good care is defined by clinical practice guidelines for 
paediatric care [MoH 2010, MoH 2007, MoH 2006]. Items representing specific 
recommendations on how to provide care were identified from these evidence-based 
guidelines. These items were then summarised into a basic score which was a count of 
the number of recommended tasks undertaken by the admitting clinician during each 
child’s treatment. The use of score for quality of care measurement is not without 
precedence since a number of other measures of health related constructs, such as 
quality of life measures [Burckhardt & Anderson 2003, Hunt et al. 1985, Gilson et al. 
1975] and prognostic scores in critical care [Knaus et al. 1985, Teasdale & Jennet 1974] 
take a similar approach to measurement. 
This patient-level score focused on processes of care in the first 48 hours of an 
admission episode, a critical period for treatment of acute illnesses when there is 
sufficient opportunity to intervene and restore health [Couto et al. 2013, Adeboye et al. 
2010, Campbell et al. 2004, Berkley et al. 2003, Sodemann et al. 1997, Commey et al. 
1994]. Patient-level measurement provides the flexibility to adjust for characteristics 
such as age, sex, severity of illness, co-morbidity in statistical models, while allowing 
for aggregation at higher levels such as clinician, department and hospital level, and 
adjustment for factors at each of those levels that may affect quality of care.  
Items making up the basic score were very specific to each of the three diseases. There 
was also redundancy between several items and lack of direct comparability of disease-
specific scores resulting from differences in their scale ranges. Modifications to the 
basic score items produced generic items which eliminated redundancy by grouping 
items representing similar tasks. These generic items allowed the same scoring approach 
to be applied to all three diseases, and for this reason the modified score was similar in 
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scale and directly comparable across all three diseases. It also allowed the aggregation 
of scores for multiple treatment needs into a unified score – the combined score. This 
approach can be extended to other diseases by identifying equivalent domains of clinical 
process, since the principle underlying the three domains of clinical process is almost 
universal in medicine. The absence of a hypothetical fourth domain of items relating to 
diagnostic testing is a weakness worth noting. Perhaps this reflects on the low-resource 
nature of this setting where the use of such technologies is not widespread or 
emphasised as important for the delivery of care [Mabey et al. 2004]. Future work could 
explore adding this domain in settings where such elements of process are clearly part 
of the standards of admission care. 
Structural equation modelling of the disease-specific modified scores and the combined 
score provided evidence that this conceptual aggregation of score items into domains 
was supported by observed patterns of correlations between items, and was therefore a 
valid representation of the construct being measured. It is possible that better fitting 
factor models could have been obtained through changes to the proposed groupings of 
items and relationships between domains. However, this was not the aim of the analysis, 
especially considering the known difficulty in fitting models with only two items per 
domain, and the sensitivity of model fit to unique patterns across datasets [Costello & 
Osborne 2005, Raubenheimer 2004]. Instead the focus was on establishing whether the 
proposed model was theoretically and practically sound while exhibiting a statistically 
acceptable fit to the data – these key aims of the analysis were met. 
Association of the score with mortality was explored to test the theory that process of 
care should be associated with outcomes. Strong evidence that higher scores are 
associated with lower odds of mortality was found. This confirms that the score works 
well as a measure of quality of care, since better care – represented by higher process of 
care scores – should be associated with lower odds of mortality. It also strengthens the 
face-validity of the score, and will likely reassure policymakers and practitioners. 
However, as quality of care improves over time – resulting in less variability in scores – 
this measure is likely to start to fail to predict mortality. In the same way it may not be 
possible to link such scores with outcomes in high income settings.  
The score was easily reproduced with case record data from a longitudinal observational 
study and a cross-sectional survey of hospitals which were broadly representative of the 
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varied characteristics of hospitals in a low income country. Successful replication of the 
score was important because it demonstrated the broad applicability of the score across 
a variety of circumstances. Key characteristics of the score were consistent with those 
observed during its development on data from the district hospitals study. Association 
of the score with mortality was similar in magnitude and direction to that observed in 
the trial data, sufficiently to assume a common effect across the three datasets 
examined, and possibly more generally. In addition, fit indices in structural equation 
model of the main data and both validation datasets confirmed that the proposed 
aggregation of items into domains was a good fit to the data. Although other domains 
may exist which could better explain item aggregation into groups that are different 
from those proposed in this thesis – as rigorous testing of the structure of many 
measures often reveals [Kupeli et al. 2013, van Prooijen & van der Kloot 2001] – all of 
the evidence established in this work supports the conclusion that the items in this score 
are good measures of the proposed domains. These include the well-fitting disease-
specific and combined score models in two of the datasets, and a sound theoretical basis 
of this grouping of items. 
A graphical and a semi-quantitative method for effective communication of the score to 
its target audiences were suggested. Funnel plots for graphing score summaries at 
clinician, department, hospital or group level (or any other desired level of clustering) 
allow for effective handling of the various sources of variability within and between 
groups [Benneyan et al. 2003, Woodall & Montgomery 1999]. They are good for 
showing such groups summaries and the differences between them, including 
differences that are unlikely to arise by chance alone. Grading of scores provides an 
additional layer of reporting which enables the descriptive presentation of group scores 
relative to other groups. Application of the score as a trial outcome measure was also 
demonstrated by estimating effect of the quality improvement intervention in the 
Kenyan district hospitals study. The observed effect of the intervention was consistent 
with the findings of previous analyses, showing the suitability of the score as a trial 
outcome and its efficiency in terms of the numbers required to test an intervention 
[Ayieko et al. 2011]. For this purpose a sample size calculation for clustered group 
comparison has been suggested which addresses some important considerations. 
A number of statistical approaches and considerations underlie the score design process, 
including the identification of a suitable level of measurement, factor analysis to explore 
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the aggregation of items into domains, approaches to comparing agreement between 
measures and generalised linear modelling to estimate the association between the score 
and other variables. Some challenges were encountered in the course of applying these 
methods. In factor analysis, it is often assumed that the items thought to measure the 
underlying construct are continuous and normally distributed. This was not the case in 
this work. Items were binary, and a modification to the factor analysis involving the use 
of a polychoric correlation matrix was necessary for the estimation of factors. 
Difficulties were also encountered in interpreting factor analysis fit indices because 
recommendations in the literature vary widely. An approach examining the consistency 
of evidence for or against model fit from multiple indices and different datasets was 
adopted. It relied on qualitative interpretations of ranges of multiple fit indices rather 
than fixed thresholds which, according to literature, were least affected adversely by 
model peculiarities such as sample size and model complexity. 
In measuring agreement between candidate scores it was necessary to consider the 
likely effect of clustering on scores. Specifically, scores of children attended to by the 
same clinician or in the same hospital were likely to be more similar than those not, 
thereby creating a false impression of higher agreement. To work around this problem 
an R2 statistic was estimated at both clinician and hospital level to measure agreement 
between candidate scores in terms of the amount of variability in one score explained by 
the other. A theoretical distribution of this statistic was unknown. It was therefore not 
possible to derive estimates of uncertainty around these measures of agreement, and for 
this reason bootstrap 95% confidence intervals were calculated. 
Estimates of R2 were obtained by modelling the score as both a continuous and an 
ordinal measure. This involved the use of GLMs which assumed a Gaussian and an 
ordered logit distribution respectively of the dependent variable. These were plausible 
assumptions, since the score was observed to be normally distributed, but also known to 
be an ordered categorical measure. A Poisson-binomial distribution was an alternative 
plausible approach to modelling the score, since the score could have also been 
considered to be the number of successes in a series of independent binary items. 
Poisson-binomial means and standard errors were manually calculated when exploring 
and graphing variations in the score across hospitals and over time because none of the 
major statistical analysis software provided estimation routines using this approach. 
This is a gap for future software development.  
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In conclusion, this work shows how a score of process of care can be set up, used and 
presented in quality of care measurement. The initial focus has been on quality of care 
for three acute illnesses, and future work will be required to explore whether the 
methods that have been developed are suitable in other clinical settings, including non-
paediatric care, non-medical care and non-communicable diseases. This work also 
demonstrates the link between process and an objective outcome of care, and shows the 
relevance of clinical processes in quality of care assessment. 
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Appendices 
A.1. Search terms in the literature review 
No. Search strings Number of hits 
1 "design" OR "develop" OR "build" OR "theory" OR "construct" OR 
"create" 
1,384,314 
2 "Quality of Health Care"[Mesh] 4,230,882 
3 "Process Assessment (Health Care)"[Mesh] 2,578 
4 "score" OR "scale" OR "index" OR "measure" OR ("composite" AND 
"indicator") 
1,218,431 
5 "child, preschool"[Mesh] OR "Infant, Newborn"[Mesh] 1,025,427 
6 #1 AND #2 AND #3 AND #4 AND #5 9 
7 #1 AND #2 AND #3 AND #4 138 
8 "Outcome Assessment (Health Care)"[Mesh] 565,146 
9 "Inpatients"[Mesh] 10,569 
10 #3 OR #8 565, 306 
11 #1 AND #9 AND #10 277 
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A.2. Explanations of suggested steps for constructing a composite 
measure 
Proposed step Explanation 
Perspective of quality 
measurement 
Whether the measure is a structure, process or outcome measure or 
a combination 
Data selection, sample size Source data for the development of the measure including 
considerations for sampling and sample size calculation 
Handling of missing data Discussion on whether missing data is encountered, mechanism of 
missingness and solutions e.g. imputation, complete-case analysis 
Multivariate analysis Statistical methods to study the data structure and dimensions, to 
identify grouping scales or domains 
Weighting, aggregation, 
generation of a summary measure 
Identify weighting and aggregation procedures relevant to the data 
properties and clinical application 
Assessment of robustness and 
sensitivity analysis 
Exploring changes to the measure under different scenarios e.g. 
methods of  aggregation, handling of missing data, summary 
generation 
Reliability and validity Using a validation sample or new data to test reliability and validity 
of the measure 
Links to other indicators and 
measures 
Comparing performance of new measure with existing ones 
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A.3.  Summary of articles included in the review 
Authors Title Description 
Saloojee et al. 
2009 
Development of a 
measure of family-
centred care for 
resource-poor South 
African settings: the 
experience of using a 
modified version of the 
MPOC-20 
• objective: to adapt the Measure of Process of Care 
(MPOC) and develop a measure of family-centred care in 
a disadvantaged South African setting 
• setting: all public hospitals in two SA provinces with 
established rehabilitation services for children with 
cerebral palsy 
• population: caregivers of children aged 1-18 diagnosed 
with cerebral palsy living in poorly resourced areas in two 
provinces in South Africa 
• sampling: sample size based on Nunnally’s (1978) 
suggested criterion for validating a scale (a minimum of 
10 participants for each scale item). Convenience sample 
of 267 used. 
• statistical methods: 
• exploratory factor analysis 
• reliability: internal consistency (Cronbach’s alpha 
>0.7 based on Nunnally’s recommendation, very 
high = item redundancy Streiner & Norman 2003) 
and test-retest reliability (re-interviewing 
respondents by same interviewer then calculate 
ICC, 10% sample required) 
• validity: convergent and discriminant validity 
using multi-trait scaling (Stewart et al. 1988); 
Kaiser-Meyer-Olkin measure of item sampling 
adequacy and content validity (Kaiser 1974), 
Bartlett’s test of sphericity to ascertain whether 
factor analysis was appropriate (Sitzia 1999); 
concurrent validity by correlating scale scores with 
other variables it was hypothesised to be related to 
using Pearson correlation coefficients 
• PCA to examine dimensions of the MPOC-SA 
• findings: modified MPOC did not work in new setting 
although underlying constructs were similar; a further 
revised 8-item version with 2 factors appears useful 
• key refs: King et al. 1995, 1996; King et al. 2004b (original 
MPOC); Rosenbaum et al. 1990; Ketelaar et al. 1998; 
Streiner & Norman 2003 (psychometric properties). Also 
lookup the Gross Motor Function Classification System 
(GMFCS) (Palisano et al. 1997) 
Klassen et al. 
2009 
Evaluating family 
centred service in 
paediatric oncology 
with the measure of 
process of care 
(MPOC-20) 
• objective: to evaluate the psychometric properties of the 
20-item MPOC in parents of children undergoing 
treatment for cancer at 5 paediatric oncology centres in 
Canada 
• setting: 5 Canadian paediatric oncology centres 
• population: parents of children with cancer 
• sampling: convenient sample of 513 parents whose 
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Authors Title Description 
children were on active treatment at least 2 months post-
diagnosis not on palliative care. 412 of 501 who agreed 
completed questionnaire (80% response rate) 
• statistical methods: 
• exploratory factor analysis to determine how to 
group the questions (ML-FA without rotation, scree 
test to determine number of factors) 
• score generated by summation 
• reliability: internal consistency – Cronbach’s alpha 
(random error in score due to intercorrelations 
among items); item scale correlations (Nunnally & 
Bernstein 1994) 
• validity: within-scale construct validity – item-own 
scale correlations corrected for overall exceeding 
item-other scale correlations by at least 2 SDs; 
scale inter-correlation r=0.3-0.7 Cano et al. 2004 
• ability of scale to differentiate between groups 
known to differ (King et al. 2004b) 
• findings: EFA yielded 2 factors; little missing data; scale 
scores spanned entire scale range; no notable floor or 
ceiling effects nor skewing; mean scale score nearer to 
high end than midpoint; scales exceeded criteria for 
internal consistency reliability; intercorrelations between 
scales showed related constructs; Spearman’s rho 
correlations between the scales ranged 0.72-0.85 
suggesting one concept was being measured 
• key refs: King et al. 1996; King et al. 2004b; Costello & 
Osborne 2005 (EFA); Scientific Advisory Committee of 
the Medical Outcomes Trust 2002; Streiner & Norman 
2003; Cano et al. 2004 (psychometric tests and criteria – 
e.g. criterion for scale-level data quality is less than 5% 
missing, mean is near midpoint, floor according to Cano 
et al. 2004) 
Siebes et al. 
2008 
A family-specific use 
of the Measure of 
Process of Care for 
Service Providers 
(MPOC-SP) 
• objective: to examine the validity and utility of the 
MPOC-SP as a family specific measure 
• setting: paediatric rehab in the Netherlands 
• population: professionals providing rehabilitation and 
educational services to children with cerebral palsy 
• sample size: 5-10 subjects per variable/item 
• statistical methods: 
• to explore appropriateness of parametric statistics: 
skewness and kurtosis 
• reliability: 
• validity: construct validity – Pearson’s product-
moment correlation coefficient between scales and 
comparable multidimensional structure on FA 
(general vs. family-specific MPOC-SP); ability of 
providers to discriminate between scales explored 
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Authors Title Description 
by absolute difference scores 
• findings: construct validity satisfactory (providers can 
distinguish family-specific and general ratings), Pearson’s 
correlations not significant. 
• key refs: King et al. 2004b; King et al. 1996; Nunnally & 
Wilson 1975; Streiner & Norman OUP 1995 
Wierenga et al. 
2011 
Quality indicators for 
in-hospital 
pharmaceutical care of 
Dutch elderly patients: 
development and 
validation of an 
ACOVE-based quality 
indicator set 
• objective: develop and validate a set of explicitly-
phrased QIs to measure efficiently the quality of 
pharmaceutical care of elderly hospitalized patients in 
the Netherlands by selecting and adapting ACOVE 
criteria 
• setting: a tertiary university hospital in the Netherlands 
• population: elderly hospitalized patients 
• sampling: NR 
• methods: 
• expert opinion used to select QIs using a Delphi 
technique 
• selected QIs tested against records of 10 
preselected patients experiencing long-term 
hospital stay 
• inter-rater reliability: using 3 raters’ assessments of 
10 randomly-selected patients using Fleiss κ values 
if all 3 raters or ICC if any two raters 
• face and content validity – expert opinion 
• final QIs categorized in 4 ‘domains’ based on 
important aspects of pharmaceutical care described 
by Higashi et al. 
Chen et al. 2011 Diabetes 
Empowerment Process 
Scale: development and 
psychometric testing of 
the Chinese version 
• objective: to develop and test the psychometric 
properties of the Chinese version of the Diabetes 
Empowerment Process Scale 
• setting: China 
• population: outpatients living with diabetes 
• sample size: 211 outpatients; calculation not reported 
• statistical methods: stages – item generation and content 
validity testing (through concept analysis of literature 
and expert opinion respectively), item analysis 
(sampling – 10 participants per item, item analysis to 
check correlation of each item with total score) , 
validity testing (EFA, CFA, concurrent validity using 
similar tools), reliability testing (Cronbach’s alpha for 
each scale – internal consistency; re-administration of 
tool to new sample then calculating ICC – test-retest 
reliability) 
• findings: satisfactory reliability and validity; no ‘floor’ 
or ‘ceiling’ effects; scale and subscales correlated with 
global self-care behaviours 
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Authors Title Description 
• key refs: Bear 1990 (Theoretical basis of measurement); 
Bentler & Chou 1986, MacCallum et al. 1996 (sample 
size); DeVellis 1991, Ferketich 1991 (item selection) 
Bamm et al. 
2010 
Validation of the 
measure of process of 
care for adults: a 
measure of client-
centred care 
• objective: to assess psychometric properties of MPOC-
A 
• setting: regional orthopaedic service of a university-
affiliated hospital in Canada 
• population: patients and their families who had joint 
replacement surgery in Jan-Aug 2007 
• sample size: convenient sample of all patients treated at 
the time; exclusion was lack of fluency in English. 
• statistical methods (expectations): 
• internal consistency – Cronbach’s alpha > 0.8 
• reliability: inter-rater reliability correlation – ICC 
of 0.5-0.7 between patients’ and families’ scores on 
MPOC-A; high test-retest reliability– ICC 0.7-0.9 
(both by comparing time 1 vs. time 2 scores) 
• validity: cross-sectional – MPOC-A vs. CSQ 
(client satisfaction questionnaire) scores; 
convergent construct. 
• findings: high internal consistency, ‘moderate to good’ 
correlation between scales, inter-rater agreement; high 
test-retest reliability 
Suhonen et al. 
2010 
Individualized care 
scale – nurse version: a 
Finnish validation 
study 
• objective: develop the ICS-nurse and ensure its validity 
and reliability 
• design: methodological design 
• setting: inpatient wards in one university, two regional 
hospitals, two psychiatric hospitals and four health 
centres in Finland 
• population: Finnish nursing staff 
• sample size: not reported 
• statistical methods:  
• sum scores by averaging 
• internal consistency reliability: Cronbach’s alpha 
and item analysis including inter-tem, average 
inter-item and item-to-total correlations 
• validity: content validity – producing the measure 
from a concept analysis including expert analysis; 
construct validity – PCA with Kaiser-Meyer-Olkin 
measure of sampling adequacy for FA; Spearman’s 
rho correlations between subscales to check 
associations, SEM? 
• findings: good evidence of content validity, few missing 
data, satisfactory reliability, some ICCs high; PCA 
supported 3 component structure 
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Authors Title Description 
• key refs: Suhonen et al. 2000, Suhonen et al. 2005 
Mael et al. 2010 Development of a 
model and measure of 
process-oriented 
quality of care for 
substance abuse 
treatment 
• objective: to develop and validate a model of QoC for 
substance abuse treatment 
• setting: the US 
• population: substance abuse treatment staff 
• sample size: ‘representative’ sample of 51 substance 
abuse treatment agencies purposively selected 
• methods:  
• development of the model and QoC scale using a 
critical incident technique (CIT) – staff describe 
incidents they have been involved in that affected 
organizational outcomes; these are sorted and 
categorized iteratively into a performance model 
(consensus based Delphi-like process) 
• QoC scale based on 15 dimensions created above 
made up of 100 Likert-type items (5-10 per scale) 
• Validation – internal reliability, confirmatory factor 
analysis, inter-rater reliability 
Chevat et al. 
2009 
Development and 
psychometric 
validation of a self-
administered 
questionnaire assessing 
the acceptance of 
influenza vaccination: 
the Vaccinees’ 
Perception of Injection 
(VAPI) questionnaire 
• objective: to develop and validate a self-administered 
questionnaire for use in clinical trials to assess subjects’ 
perception and acceptance of influenza vaccination and 
injection site reactions 
• design: NR 
• setting: US, Germany, Switzerland; validation in 
France, Belgium, Germany, Italy and UK 
• population: adult subjects receiving IM influenza 
vaccination 
• sample size: NR 
• statistical methods:  
• PCA with Varimax rotation and Kaiser-Guttman 
criterion to retain factors 
• Final VAPI structure confirmed using Multitrait 
analysis based on item-scale Spearman 
correlations; item discriminant validity... floor and 
ceiling effects; scale-scale correlation using 
Spearman coefficients 
• Clinical validity – comparing questionnaire ISR 
score vs. description in CRFs using Mann-
Whitney-Wilcoxon and Kruskal-Wallis tests. 
• Internal consistency reliability – Cronbach’s alpha 
> 0.7 
• findings: PCA and MA resulted in deletion of 23 items; 
final PCA with 521 subjects; all items except one met 
convergent validity criterion for 4 dimensions; 
Cronbach’s alpha > 0.7 indicating good internal 
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consistency (but low for one dimension in one setting; 
clinical validity - scores higher on average for those 
with more severe reactions in CRF 
• key refs: Campbell et al. 1959 
Najjar-Pellet et 
al. 2008 
Quality assessment in 
intensive care units: 
proposal for a scoring 
system in terms of 
structure and process 
• objective: to develop a score for assessing quality of 
ICU care in terms of structure and process based on 
literature review, expert opinion, field tests and analysis 
• design: feasibility observational study 
• setting: a French regional clinical research project 
• population: ICUs with focus on members of the ICU 
teams 
• sample size: 40; no report of how this was arrived at  
• methods:  
• bibliographic review (including brainstorming to 
define ‘quality’) > expert consideration (Delphi 
type) > field test (in 2 ICUs) > descriptive analysis 
()frequency tables, correlations etc) > final 
consensus to determine which variables to retain 
• grouping into ‘dimensions’ of variables thought to 
be discriminating, uncorrelated, non-redundant and 
representative of QoC 
• summarised by simple addition (total score) 
• levels of performance measured by percentage 
achievement of maxima 
• relationships between scores tested using Pearson’s 
correlation matrix 
• findings: adherence to methodology, use of Delphi 
technique, direct observations, elimination of 
subjectivity, coverage of components of quality in 
intensive care, independence of dimensions, 
feedback of participating ICUs, and equivalence to 
some available standards all support this score as a 
useful one 
Llewellyn et al. 
2007 
An index of 
orthodontic treatment 
complexity 
• objective: to develop an index for measuring treatment 
complexity with input factors related to complexity and 
output being a score reflecting the degree of treatment 
complexity 
• design: NR 
• setting: 2 dental hospitals in the UK 
• population: (dental casts and records of) patients treated 
for dental problems between June 1996 and December 
2003 
• sample size: 120 – determination not stated. 
• methods (steps):  
1. scoring of the study casts using unweighted peer 
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assessment rating (PAR) 
2. grading perceived treatment complexity on a 6-
point scale 
3. selection of up to 3 occlusion factors contributing 
to complexity from a pre-set list 
4. multiple regression to assess relationship between 
complexity grade and occlusion factors – partial 
regression coefficients used to derive weightings 
for occlusion factors 
5. orthodontic treatment complexity = occlusion 
component score x weighting 
6. summing up of component score 
7. Spearman ranked correlation coefficients to study 
relationship between calculated and perceived 
complexity 
• key refs: Brook and Shaw 1989; Richmond et al., 1992; 
DeGuzman et al., 1995; Hamdan and Rock, 1999; 
Daniels and Richmond, 2000 
Siebes et al. 
2006 
Family-centred services 
in The Netherlands: 
validating a self-report 
measure for paediatric 
service providers 
• objective: to validate the Dutch translation of the 
Canadian Measure of Processes of Care for Service 
Providers questionnaire MPOC-SP 
• setting: paediatric rehab in the Netherlands 
• population: service providers representing 7 children’s 
rehab centres and affiliated schools 
• sample size: 163 service providers based on 5-10 
subjects per item 
• statistical methods: 
• face-validity: service providers to add or omit what 
they found most or least important 
• test-retest reliability: rerunning questionnaire to a 
subset of initial sample 
• skweness/kurtosis to check suitability of 
parametric statistics 
• validity: construct validity – Spearman’s rank 
correlations to confirm original factor structure and 
examine correlations between item and scale 
scores; 
• content and face validity: qualitative and 
quantitative data from additional 26-item 
questionnaire given to subsample 
• findings: good evidence of content and construct 
validity, internal consistency and moderate-to-good 
reliability 
• key refs: King et al. 2004b; King et al. 1996; Nunnally 
& Wilson 1975; Streiner & Norman OUP 1995 
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Sixma et al. 
2000 
Quality of care from 
the perspective of 
elderly people: the 
QUOTE-elderly 
instrument 
• objective: to develop an instrument to measure quality 
of care for elderly people from their own expectations 
and experiences 
• setting: the Netherlands 
• population: non-institutionalized elderly people of 65 
years or older who have used general practice services 
in last 2 months 
• sample size: 13 for FGD; 961 for questionnaire 
• statistical methods: 
• 59 items answered on 4-point Likert scale 
• Likert responses transformed to standardised z-
scores ranging 0-10 
• Response categories dichotomised 
• Data analysis: non-response, skewness, 
correlations 
• EFA with Varimax rotation and Kaiser 
normalization, CFA, reliability analysis 
• Reliability and stability checked using sub-sample 
Ashton et al. 
1999 
An empirical 
assessment of the 
validity of explicit and 
implicit process-of-care 
criteria for quality 
assessment 
• setting: the US 
• population: men treated between 1987 and 1989 at 
southern VA hospitals 
• sample size: 12 hospitals for the case-control study and 
159 hospitals for the readmission study 
• methods: 
• QoC assessed using chart reviews by an 
administrative and a quality reviewer 
• Quality reviewer used a large set of 
disease specific explicit process-of-care 
criteria marked as met or not met 
• Inter-rater reliability assessed be 
comparing ratings of two assessors 
• Adherence score = number of met criteria 
divided by number of applicable criteria, 
expressed as a percentage 
• Categories = ‘domains’ 
• Differential weightings assigned by panel 
of experts 
• Validation: convergence with measures of 
same construct, divergence with different 
construct – Spearman rank correlations; 
association of process with outcome 
• findings: weighting did not make a 
difference in score’s outcome predictive 
ability (predictive validity) but samples 
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too small to show important differences; 
apparent dose-response relationship – 
worse outcomes in lower percentiles of 
score 
Symmons et al. 
1995 
Development and 
preliminary assessment 
of a simple measure of 
overall status in 
rheumatoid arthritis 
(OSRA) for routine 
clinical use 
• objective: to develop and assess a simple measure of 
overall status for rheumatoid arthritis 
• setting: the UK 
• population: patients receiving care of rheumatoid 
arthritis in routine clinical settings 
• sample size: NR 
• methods: 
• score has 4 components: demographic info, disease 
activity, damage score and treatment category 
• items in the activity and damage scores selected 
using a heuristic approach 
• overall status is indicated by a sequence of 
categorical scores for each components e.g. 
M50B.8.2.C is a 50y old man in second decade of 
disease with active disease but little cumulative 
damage on second-line therapy. 
• validation: content and construct validity – 
Spearman rank correlation between different scales 
to demonstrate some independence; criterion 
validity – longitudinal studies proposed; 
discriminant validity – comparison of OSRA to 
actual outcomes 
• key refs: Apgar 1953 
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A.4.  Assessment score vs. expanded criteria set for measuring 
adherence to malaria guidelines for the first 20 patients in the 
Kenyan district hospitals study data 
Patient ID No. of assessment 
tasks performed 
(assessment score) 
Illness severity 
recorded (1) 
and correct (2) 
No. of correct 
treatment tasks 
(correct drug, dose, 
route, frequency, 
duration) 
Total number of 
correctly completed 
tasks 
(expanded criteria set) 
1 6 1 2 9 
2 1 0 2 3 
3 6 0 0 6 
4 6 1 3 10 
5 5 0 3 8 
6 6 1 1 8 
7 6 2 1 9 
8 6 0 2 8 
9 6 2 3 11 
10 6 1 0 7 
11 2 1 3 6 
12 6 1 1 8 
13 4 2 3 9 
14 6 2 2 10 
15 6 0 2 8 
16 6 1 1 8 
17 6 1 3 10 
18 6 1 3 10 
19 2 1 1 4 
20 5 2 2 9 
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A.5. The paediatric data abstraction form 
Hosp ID.  HW 
code  
Questionnaire 
No.  IP NO.  QID  
Name 
(First, Last) 
 Age yrs mths 
Adm Date     /       / 20 Wt (kg)  Ht (cm) 
 
WHZ 
 
Sex M   /   F  /  E Temp (0C)          
             
Vaccines PCV10     X....../E 
M’sles      
Y / N / E 
DTP/ Penta           
X....../E 
Is there a hospital folder with an IP number? 
 
     Y /  N 
History  
 
Examination 
Length of illness days Airway Clear Stridor 
Needs active support 
to open E 
Fever Y  E  Breathing Respiratory Rate                     /min / E 
Cough Y N E 
 
 
Oxygen saturation _ _ % SpO2 
    Central Cyanosis Y N E 
Cough > 3 weeks Y N E Indrawing Y N E 
Difficulty 
breathing Y N E Grunting Y N E 
 
 
 
Acidotic breathing Y N E 
Wheeze Y N E 
Crackles Y N E 
Circulation Pulse  Weak Norm E /min 
 
 
Cap Refill X <2 2-3 >3 E 
Skin 
temp 
Not 
cold hand 
fore-
arm 
elbow 
E 
Pallor / Anaemia 0 + +++ E 
Diarrhoea Y  E  Dehydration Sunken eyes Y N E 
Diarrhoea > 14d Y N E  Skin pinch (sec) 0 1 2 E 
Diarrhoea bloody Y N E Disability AVPU A V P U E 
Convulsions Y N E  
 
Can drink / breastfeed? Y N E 
If yes, no of fits    Bulging fontanelle Y N E 
Difficulty feeding Y N E   
 
Visible severe wasting Y N E 
 
 
 
 
 Oedema  none foot knee face E 
Admission Diagnoses 
Malaria □ Severe           □ Non-sev  □  No classif’n Anaemia □  Sev   □  Non-sev 
 
Pneumonia □ V. Sev           □ Sev          □  Non-sev   Meningitis  
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Diarrhoea □ Non-bloody    □ Bloody   
Dehydration □  Shock    □  Sev     □  Some      □  No classif’n   
HIV / AIDS □ previous diagnosis          □  Clinical suspicion    
Malnutrition □  Kwash        □   Marasm □   M. Kwash             
Other 1  
 Investigations ordered 
 Ordered? Results documented same 
day 
Result (give units) 
Malaria Slide Y  /  N Y  /  N / E Pos   /   Neg 
Hb / HCT / PCV Y  /  N Y  /  N / E  
HIV test Y  /  N Y  /  N / E Pos   /   Neg 
Glucose Y  /  N Y  /  N / E  
Lumbar Puncture Y  /  N Y  /  N / E      (microscopy) Pos   /   Neg 
HIV test 
(inpatient) Y  /  N Y  /  N / E Pos   /   Neg 
Other tests    
Oxygen and Blood Transfusion – Record data only about the immediate admission events 
 Ordered? Describe how prescribed (flow rate, device) 
Oxygen Y  /  N    □  No detail  Flow rate  =   Ncath   /    NP   / mask   /   Oth 
Transfusion Y  /  N    □  No detail Volume of Blood (mls) = Duration prescribed (hrs) 
Treatment – Record only the initial treatment prescribed for the admission episode  
 Was drug 
prescribed? 
Drug prescription 
 Route Dose Units Freq Days 
Antibiotics 
Penicillin Yes  /  No iv  /  im   mg  /  iu   
Gentamicin Yes  /  No iv  /  im   mg   
Amoxicillin Yes  /  No po   mg / mls / tabs   
ceftriaxone Yes  /  No iv  /  im  mg / mls / tabs   
chloramphenical Yes  /  No iv  /  im     
Metronidazole Yes  /  No iv / po   mg / mls / tabs   
Antimalarials 
Quinine (Load) Yes  /  No iv  /  im   mg stat  
Quinine (Maint) Yes  /  No iv  /  im  / po  mg   
Artemether - load Yes  /  No iv  /  im   mg stat  
Artemether - maint Yes  /  No iv  /  im   mg   
Coartem Yes  /  No po   tabs   
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Supportive Care 
Paracetamol Yes  /  No im / po   mg / mls / tabs   
Others       
       
Did the child have a prescription for fluids to treat dehydration.  Yes   /   No   
A. Was the child given fluids using iv route? Yes   /   No If No, skip to part B, if yes continue 
Fluid prescribed 
Fluid prescription for Step 1 and 2 (up to 6 hours) 
Step 1 / Step 2 
plan used Total Vol. Time (hrs)  
Ring  /  NSal  /  HS Darr  /  Other Yes  /  No     
B. Was the child given fluids using oral or ng route? Yes   /   No If No, then skip this section, if yes 
continue. 
Fluid prescribed 
Fluid prescription for first 4 hours 
Ng tube used Total Volume 
Time  
(hrs) 
OR Volume with 
each stool 
ORS  /  Ring  /  NSal  /  HSD  /  
Other Yes  /  No     Mls/Not indicated 
Was the child prescribed any feeds? Yes   /   No If No, then skip this section, if yes 
continue. 
Feed prescribed 
Feed prescription for first 24 hours 
Route Feed vol  Freq / 24hrs 
F75  / F100 /  Sp Milk  /  HPD  /  
Other   ngt  /  po  mls /  E               /  E 
Fluid and Feed Monitoring   
Is there a feed/fluid monitoring chart for the first 24 hrs Yes  /  No 
Were feeds/fluids monitored as prescribed for the first 24 hrs Yes  /  No 
Ward rounds 
 
 
No of documented ward rounds  
No of documented major (consultant) ward rounds 
 
 
 
Vital signs chart 
 Is there a vital signs chart? Y            N 
 What parameters are 
recorded? 
Temperature  Respiratory rate Pulse rate  Oxygen saturation 
No of times documented 
in 48 hrs. 
    
Is there a discharge/Death summary in the case record?             Y          N  
Discharge Date         /           /2001 Outcome Alive  /  Dead  /  Refer’d  /  Absc’d 
Discharge Diagnoses: Select ONE primary diagnosis (tick 1) and secondary diagnoses (tick 2)  
Is there a clear primary diagnosis   Y          N  
Malaria 1 2 □ Severe      □ Non-sev   □  No classif’n Meningitis 1 2 
Pneumonia 1 2 □ V. Sev      □ Sev           □  Non-sev    
Diarrhoea 1 2 □ Non-bloody                  □  Bloody Other diagnosis (name) 1 2 
Dehydration 1 2 □  Sev          □  Some       □  No classif’n  
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HIV / AIDS 1 2 □ previous   □  clinical suspicion  
   diagnosis  
Malnutrition 1 2 □  Kwash     □   Marasm  □  M. Kwash           
Anaemia 1 2 □  Sev          □  Non-sev  
Last weight 
recorded  Date recorded  
Follow Up Not arranged Hospital Disp / H. Centre 
Did the child have a diagnosis of malaria or meningitis?  Yes   /   No   
Were there convulsions Yes   /   No If No, skip to part B, if yes continue 
               
How many convulsions in 24 hrs □ 1 -2         □ 3 -4      □>5 
Type of convulsion experienced  □Generalized   □ Focal    □ Empty 
 Was Lumber puncture done Yes   /   No If No, then skip this section, if yes 
continue. 
 Bed side exam of CSF □ dry tap       □ under pressure  
□ turbid         □ bloody        □ clear      □ not done 
  CSF investigations  
 
 Test done Test results 
CSF microscopy Yes   /   No  
CSF Biochemistry Yes   /   No  
CSF culture Yes   /   No □ no growth    □ growth (list)……………………………... 
What was the outcome? 
                       □ Died     □ Alive no sequelae     □ Alive with sequelae     □ Referred     □ Absconded     □ empty  
 If sequelae please give details 
  
 
  
 A.6. Overlap between hospitals in the Kenyan district hospitals study, 
the pneumonia trial observation and the Ministry of Healthsurvey
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Kenyan district 
hospitals study
(8 hospitals)
Ministry of Health 
survey
(22 hospitals)
Pneumonia trial 
observation
(7 hospitals)
6 hospitals 
4 
hospitals 
1 hospital 
none 
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A.7. Reliability and validity as conceptualised in this work 
Reliability 
The reliability of a measure refers to its consistency on repeated use. According to the 
classical test theory an observed measure is made up of two components, namely the 
‘true’ level of the underlying trait being measures and some random error. Reliability is 
formally defined as 1 minus the ratio of error variance to observed-measure variance. 
Correlation coefficients are often used to estimate reliability of a measure; this 
coefficient quantifies the amount of variance attributable to differences in a measure on 
repeated use. 
A measure’s reliability can be tested in a number of ways. Internal consistency 
reliability, alternatively referred to as the coefficient of internal consistency, is the 
correlation between items that make up a measure. It is investigated by calculating the 
average correlation between pairs of items measuring the same domain of a construct 
(average inter-item correlation) or the average correlation between measurements from 
two halves of items contributing to a measure (split-half reliability). Internal consistency 
is related to the number of items making up the measure since it tends to decrease for 
measures made up of fewer items. This is because more items in a measure increase its 
ability to better characterise the underlying construct, and this is consistent with the 
domain sampling theory which attempts to explain the relationship between a construct, 
items and measure. 
Other tests of reliability are: inter-item consistency which quantifies the degree to which 
items in a measure correlate to each other; test-retest reliability, also known as the 
coefficient of stability, which measures the correlation between two sets of measures on 
the same entity; alternate-forms reliability, also called the coefficient of equivalence or 
parallel-forms reliability, which is the correlation between two versions of measures of 
a construct when applied to the same entity; and inter-rater or inter-scorer reliability 
which measures the correlation between measurements by different users of the same 
measure on an entity. Differences in a construct across time, differences between items 
in a measure, and differences between users introduce variability to a measure. For this 
reason no measure is perfectly reliable, and the play of error in measurement must be 
recognized when interpreting a measure. Nevertheless reliability can be improved by 
minimizing these sources of error whenever possible.  
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Validity 
The validity of a measure is how well it quantifies the construct it is intended to. A 
measure’s validity is what determines the truth of inferences made on a construct based 
on the use of measure. Similar to reliability there are a number of ways in which the 
validity of a measure can be conceptualised but unlike reliability it is a rather subjective 
concept.  
Construct validity, as the name implies, is the association between the measure and the 
construct it is intended to measure to the exclusion of other constructs. Face validity 
defines the credibility of a measure to its potential audience and users. Content validity 
refers to the suitability of the items making up the measure in sufficiently covering the 
construct. Construct validity, content validity and face validity of a measure can be 
assessed and improved by incorporating the opinions of experts and potential users of a 
measure in its design. 
Convergent and discriminant validity define how similar a measure is to others it should 
theoretically be related to, and dissimilar to those pertaining to unrelated constructs, 
respectively. Closely aligned with this is criterion-related validity which is the 
correlation between a measure and other methods of quantifying a construct. The 
measure may be able to predict those other methods, in which case it possesses 
predictive criterion-related validity; alternatively it may only concur with related 
measurements made at the same time, and this is referred to as concurrent criterion-
related validity. Since this form of validity is a quantitative concept suitable statistical 
techniques may be applied to investigate it. 
Validity may also relate to the use of a measure to steer progress towards desired 
outcomes. This is called formative validity and it refers to the ability of a measure to 
provide the information necessary to improve the construct it measures. It can only be 
realised when the measure is put to use; for this reason it constitutes a form of post-hoc 
validation. 
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A.8. Levels of measurement 
The units of all measures belong to fundamental levels of measurement, also referred to 
as measurement scales. These are, in increasing order of complexity: (1) the nominal 
level which represents measurements that take on the same numeric value if they share 
the same value of an attribute; in a sense it represents ‘labels’ rather than ‘quantities’ 
implied by measurement; (2) the ordinal level where measurements reflect an order on 
the defined attribute; (3) the interval level which is similar to the ordinal level but 
additionally differences between assigned numbers reflect equal differences of an 
attribute; (4) the ratio level where both differences and ratios of assigned numbers 
reflect differences and ratios of attributes; and (5) the absolute level in which all 
properties of the assigned numbers are analogous to properties of the attributes of 
interest. 
In each of these levels (except the nominal level) there exist transformations which 
preserve relevant relationships of the measurement process. Linear transformations 
preserve relevant relationships on interval or higher levels; an example of a linear 
transformation is the conversion of temperature measurements from degrees Celsius to 
Fahrenheit by multiplying by 9/5 and adding 32. Only monotone increasing 
transformations preserve relationships on the ordinal level [Stevens 1946, Killeen 
1976]. A monotone increasing relationship is one in which whenever an attribute value 
of the construct increases, associated values of the item(s) used to measure them 
increase or stay the same (contrast this with affine relationships where the values of 
items measuring a construct would necessarily increase whenever attribute values of the 
construct do). Monotone increasing transformations leave a scale form-invariant: this 
means that the relative order of the elements of the scale is unaffected by a 
transformation. For example, the linear transformation of [1, 2, 3, 4] to [1, 3, 5, 7], and 
the non-linear transformation of the same to [4, 5, 13, 20], are monotone increasing 
transformations because they do not affect the order of relationships between the 
elements of this matrix. 
Some authors have disagreed with this classification of levels of measurement. 
Velleman (1993) argued that it was too strict to apply to real-world data. Indeed a 
measure may lie squarely at any one of these levels, be a mixture of more than one 
level, lie somewhere between any two levels or even be too arbitrarily defined to 
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correspond to any of the levels originally proposed by Stevens. Other authors have gone 
further to suggest alternative, less restrictive classifications. For example Mosteller and 
Tukey (1977) listed levels of measurement in increasing order of complexity as follows: 
(1) names; (2) grades and ordered labels; (3) ranks starting at 1 (smallest) to largest; (4) 
counted fractions, including percentages, bounded by zero and one; (5) counts of non-
negative integers; (6) amounts represented by non-negative real numbers; (7) balances 
which are unbounded positive or negative values. 
Three distinct tiers of scale become apparent from these classifications. At the lowest 
tier is the simplest level of measurement in both classifications which can only assign 
named identities to attributes of a construct. Above this is an intermediate tier 
corresponding to measurement of discrete quantities of the construct of interest; at this 
tier are the ordinal and interval levels of measurement in Stevens’ classification, and 
grades, ranks, counted fractions and counts in Mosteller and Tukey’s classification. 
Many measures of complex constructs such as human intelligence and academic ability, 
and many academic grading systems often correspond to this tier of scale. At the highest 
tier are continuous quantities, represented by the ratio and absolute levels of 
measurement in Stevens’ classification, and amounts and balances in Mosteller and 
Tukey’s classification. Normality, approximate normality or normality upon 
transformation of a measure is only achievable with measures at the level of 
measurement at or above the intermediate tier of scale. 
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A.9. Drug dosage charts from the Basic Paediatric Protocols 
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A.10. Tetrachoric correlation matrices of score items at baseline 
Table A.10-1: Tetrachoric correlation matrix of assessment items in the basic malaria process-
of-care score at baseline 
 
fever convulsions acidotic breathing pallor 
(in)ability 
to drink 
level of 
consciousness indrawing 
malaria 
test 
fever 1.00        
convulsions 0.38 1.00       
acidotic 
breathing 1.00 0.16 1.00      
pallor 0.15 0.14 1.00 1.00     
(in)ability to 
drink 0.08 0.13 -1.00 0.15 1.00    
level of 
consciousness 0.18 0.41 0.62 0.10 0.42 1.00   
indrawing 0.12 0.19 0.43 0.09 -0.07 0.25 1.00  
malaria test 0.12 0.03 1.00 0.05 0.15 0.15 0.01 1.00 
 
Table A.10-2: Tetrachoric correlation matrix of assessment items in the basic pneumonia 
process-of-care score at baseline 
 
cough difficult breathing 
central 
cyanosis 
(in)ability 
to drink 
level of 
consciousness grunting indrawing 
resp. 
rate 
cough 1.00        
difficult 
breathing 0.06 1.00       
central 
cyanosis 0.02 0.03 1.00      
(in)ability to 
drink -0.15 -0.08 0.29 1.00     
level of 
consciousness -0.37 -0.22 0.05 0.37 1.00    
grunting -0.17 0.22 0.32 -1.00 0.27 1.00   
indrawing 0.00 0.25 0.01 -0.09 0.33 0.29 1.00  
resp. rate 0.09 -0.31 -0.38 0.06 0.15 0.02 -0.23 1.00 
 
Table A.10-3: Tetrachoric correlation matrix of assessment items in the basic 
diarrhoea/dehydration process-of-care score at baseline 
 diarrhoea vomiting capillary 
refill 
level of 
consciousness 
(in)ability 
to drink 
sunken 
eyes 
skin 
pinch pulse
*
 
diarrhoea 1.00        
vomiting 0.12 1.00       
capillary 
refill 1.00 -1.00 1.00      
level of 
consciousness 1.00 0.08 -1.00 1.00     
(in)ability to 
drink 1.00 0.47 -1.00 0.58 1.00    
sunken eyes 1.00 -0.06 1.00 0.23 -1.00 1.00   
indrawing 1.00 0.07 -1.00 0.22 -1.00 0.54 1.00  
pulse* _ _ _ _ _ _ _ 1.00 
*does not vary 
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Table A.10-4: Tetrachoric correlation matrix of treatment items in the basic process-of-care 
score at baseline 
  Malaria Pneumonia Diarrhoea/Dehydration 
  
drug route dose freq. dur. drug route dose freq. dur. drug dose freq. 
M
a
la
ri
a
 
drug 1.00             
route 1.00 1.00            
dose 1.00 -1.00 1.00           
freq. 1.00 1.00 0.92 1.00          
dur. 1.00 1.00 1.00 1.00 1.00         
Pn
eu
m
o
n
ia
 drug 
     1.00        
route 
     0.83 1.00       
dose 
     0.19 1.00 1.00      
freq. 
     0.82 1.00 0.96 1.00     
dur. 
     0.83 0.99 0.96 0.99 1.00    
D
n
D
 drug 
          1.00   
dose 
          0.43 1.00  
freq. 
          0.76 0.28 1.00 
 
Table A.10-5: Tetrachoric correlation matrix of items in the modified process-of-care score at 
baseline 
Complete assessment indicator has been excluded because it is perfectly correlation with the 
other two assessment items by design. ‘pri.’, ‘sec.’ and ‘class.’ are primary signs, secondary 
signs and illness severity classification indicator items respectively 
  Malaria Pneumonia Diarrhoea/Dehydration 
  pri. sec. class. drug use pri. sec. class drug use pri. sec.* class drug use 
M
a
la
ri
a
 
pri. 1.00               
sec. 0.31 1.00              
class. 0.21 0.08 1.00             
drug 0.26 0.11 1.00 1.00            
use 1.00 0.25 -1.00 -1.00 1.0           
Pn
eu
m
o
n
ia
 pri.      1.00          
sec.      1.00 1.00         
class.      -0.20 1.00 1.00        
drug      -0.27 -1.00 1.00 1.00       
use      -0.06 -1.00 0.21 0.36 1.00      
D
n
D
 
pri.           1.00     
sec.*           _ 1.00    
class.           0.11 _ 1.00   
drug           -0.10 _ 0.09 1.00  
use           0.20 _ -0.05 0.25 1.00 
 
 A.11. One-factor structural equation model of the modified and combined 
process of care scores
Figure A.11-1: Path diagram of the one
combined scores 
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-factor structural equation model
 
 
 of the modified and 
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Table A.11-1: Parameter estimates of a one-factor structural equation model of the modified 
score for malaria quality of care 
Parameter Estimate (standardised) Standard error p-value 
λp 1.000 (0.555) _ _ 
λs 1.422 (0.745) 0.119 < 0.001 
λc _ _ _ 
λd 1.520 (0.785) 0.127 < 0.001 
λu 1.187 (0.643) 0.113 < 0.001 
βg 0.431 (0.365) 0.042 < 0.001 
βh 0.259 (0.520) 0.022 < 0.001 
var(εq) 0.216 0.033 < 0.001 
    
n = 2,930; fit indices: χ27 = 163.888, p-value <0.001; CFI = 0.901; TLI = 0.831; RMSEA = 0.087 
 
Table A.11-2: Parameter estimates of a one-factor structural equation model of the modified 
score for pneumonia quality of care 
Parameter Estimate (standardised) Standard error p-value 
λp 1.000 (0.543) _ _ 
λs 2.084 (0.962) 0.275 < 0.001 
λc 2.195 (0.994) 0.293 < 0.001 
λd 1.424 (0.731) 0.198 < 0.001 
λu 0.751 (0.418) 0.116 < 0.001 
βg 0.376 (0.326) 0.058 < 0.001 
βh 0.281 (0.548) 0.037 < 0.001 
var(εq) 0.203 0.052 < 0.001 
    
n = 1,409; fit indices: χ211 = 129.204, p-value <0.001; CFI = 0.937; TLI = 0.908; RMSEA = 0.087 
 
Table A.11-3: Parameter estimates of a one-factor structural equation model of the modified 
score for diarrhoea/dehydration quality of care 
Parameter Estimate (standardised) Standard error p-value 
λp 1.000 (0.261) _ _ 
λs 4.039 (0.961) 1.306 0.002 
λc 3.059 (0.757) 0.904 0.001 
λd 1.846 (0.474) 0.589 0.002 
λu 1.455 (0.376) 0.500 0.004 
βg 0.152 (0.290) 0.053 0.004 
βh 0.060 (0.266) 0.021 0.005 
var(εq) 0.056 0.033 0.093 
    
n = 529; fit indices: χ216 = 383.026, p-value <0.001; CFI = 0.817; TLI = 0.707; RMSEA = 0.113 
Item loadings on the single factor were significant and positive in all three diseases. 
Despite a 0.047 rise in the CFI of the malaria model indicative of a slightly better fit, all 
model fit indices indicate poorer fit compared to the two-factor model. 
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A.12. Hierarchical logistic regression model in section 6.3 on admission 
episodes lasting up to 7 days 
Table A.12-1: Adjusted effect of quality of care measured using the combined score on death in 
admission episodes lasting up to 7 days 
 Adjusted odds ratio 
for death 
95% confidence 
interval 
p-value 
Combined score 0.87 0.78 – 0.98 0.026 
Age (years) 0.56 0.48 – 0.65 <0.001 
Sex (female vs. male) 1.19 0.92 – 1.52 0.170 
Number of diseases diagnosed 0.79 0.60 – 1.04 0.097 
Severity (3=highest, 2=intermediate, 
1=lowest) 
1.59 1.32 – 1.91 <0.001 
    
Identity of disease    
Diarrhoea/dehydration 1.00  
< 0.001 Malaria 0.81 0.48 – 1.35 
Pneumonia 1.52 0.91 – 2.55 
    
Duration of admission (days) 0.53 0.48 – 0.57 < 0.001 
    
Group    
Control 1.00   
Intervention 1.72 0.46 – 6.40 0.416 
    
Survey    
Baseline 1.00  
0.610 1
st
 follow-up 1.30 0.48 – 3.56 
2nd follow-up 1.64 0.59 – 4.52 
End-point 1.71 0.64 – 4.58 
    
Group-survey interaction    
Intervention x 1st follow-up 1.25 0.36 – 4.32 
0.697 Intervention x 2nd follow-up 0.83 0.24 – 2.84 
Intervention x End-point 0.78 0.26 – 2.80 
    
    
Random effects Variance   
Clinician (i=391) 0.21 0.07 – 0.69  
Hospital (j=8) 0.25 0.07 – 0.85  
    
n =  4,119, died = 332 |  Goodness of fit test: Hosmer-Lemeshow χ28 = 7.63, p = 0.4706 | ROC AUC = 0.8106 
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A.13. Fit diagnostic test for the hierarchical logistic regression model in 
section 6.3 
 
Figure A.13-1: Plot of predicted clinician-level random effects versus their rank for logistic 
regression model in section 6.3 
The sigmoid shape of the scatter of random effects estimates implies that the assumption of 
normal distribution is not violated  
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Figure A.13-2: Plot of predicted hospital-level random effects versus their rank for logistic 
regression model in section 6.3 
The small number of hospitals makes it difficult to identify the same sigmoid shape of the scatter 
of random effects as seen in the clinician-level estimates. However there are no signs of extreme 
values 
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Figure A.13-3: Receiver operating characteristics (ROC) curve for logistic regression model in 
section 6.3 
The area under the curve (AUC) of 0.7535 implies to an ‘acceptable’ model fit [Hosmer & 
Lemeshow 2000]  
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A.14. Hierarchical logistic regression models of the association between 
the 7-point combined score and mortality on the validation data 
Table A.14-1: Adjusted effect of quality of care measured by the combined score on death in the 
pneumonia trial observation data 
 Adjusted odds 
ratio for death 
95% confidence 
interval 
p-value 
Combined score 0.72 0.64 – 0.81 < 0.001 
Age (years) 0.95 0.89 – 1.02    0.167 
Sex (female vs. male) 1.06 0.84 – 1.34    0.602 
Number of diseases diagnosed 0.79 0.55 – 1.14    0.211 
Severity (3=highest, 2=intermediate, 1=lowest) 2.53 2.01 – 3.19 < 0.001 
    
Identity of disease    
Diarrhoea/dehydration 1.00  
< 0.001 Malaria 0.29 0.16 – 0.51 
Pneumonia 0.86 0.59 – 1.29 
    
Duration of admission (days) 1.00 0.99 – 1.01    0.267 
    
Random effects Variance   
Hospital (j=7) 0.59 0.19 – 1.86  
    
n= 5,924 |  Goodness of fit for logistic regression model: Hosmer-Lemeshow χ28 = 85.45, p < 0.0001 | ROC AUC = 0.7552 
 
Table A.14-2: Adjusted effect of quality of care measured by the combined score on death in the 
Ministry of Health survey data 
 Adjusted odds 
ratio for death 
95% confidence 
interval 
p-value 
Combined score 0.55 0.36 – 0.84 0.006 
Age (years) 0.63 0.40 – 0.98 0.041 
Sex (female vs. male) 0.98 0.44 – 2.17 0.957 
Number of diseases diagnosed (omitted – varies very little with the outcome) 
Severity (3=highest, 2=intermediate, 1=lowest) 3.88 1.44 – 10.49 0.007 
    
Identity of disease    
Diarrhoea/dehydration 1.00  
0.118 Malaria 0.11 0.01 – 0.94 
Pneumonia 0.21 0.04 – 1.08 
    
Duration of admission (days) 0.95 0.87 – 1.05 0.338 
    
Random effects Variance   
Hospital (j=22) 1.12 0.21 – 5.89  
    
n= 592 |  Goodness of fit for logistic regression model: Hosmer-Lemeshow χ28 = 17.84, p = 0.0224 | ROC AUC = 0.8842 
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A.15. Further examples of application of funnel plots for comparing 
mean quality of care scores across clinicians, diseases and time 
Figure A.15-1: Funnel plot comparing clinician performance (mean scores) in one hospital 
Numbered dots are clinician IDs. This plot illustrates a wide variability in clinician performance 
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Figure A.15-2: Funnel plots showing disease-specific quality of care scores for malaria (top), 
pneumonia (middle) and diarrhoea/dehydration (bottom) in the seven Pneumonia 
observational study hospitals 
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Figure A.15-3: Funnel plots charting changes in quality of care in the intervention (2, 3, 7 and 
8) and control (1, 4, 5 and 6) hospitals in the Kenyan district hospitals study at baseline (top), 
first and second follow-up, and main end-point (bottom) surveys respectively 
At baseline all hospitals had low mean scores. One control and one intervention hospital had 
means above the overall average, one intervention and two control hospitals had means below 
the average, and the remaining three hospitals were within the average. After baseline, all 
control hospitals had means below the overall average and all intervention hospitals had means 
above the average, and this pattern was maintained all through the study until the main end-
point. 
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A.16.  Stata commands for main analyses 
Obtaining patient-level basic, modified and combined scores from case record data 
1. *Create indicator variables 
2. *Malaria 
3. local loop = 1 
4. while `loop' < 8 { 
5. foreach sign_symptom of varlist fever convulsions acidotic__breathing 
pallor can_drink avpu indrawing { 
6. gen mal_assess_`loop' = 0 
7. replace mal_assess_`loop' = 1 if `sign_symptom' != "E" & `sign_symptom' 
!= "" 
8. label var mal_assess_`loop' "`sign_symptom'" 
9. local loop = `loop' + 1 
10. } 
11. } 
12. gen mal_assess_8 = 0 
13. replace mal_assess_8 = 1 if mal1_order == "Y" 
14. label var mal_assess_8 "BS for MPS" 
15. *Pneumonia 
16. local loop = 1 
17. while `loop' < 9 { 
18. foreach sign_symptom of varlist cough diff_breath c_cyanosis can_drink 
avpu grunting indrawing resp_rate { 
19. gen pneum_assess_`loop' = 0 
20. replace pneum_assess_`loop' = 1 if `sign_symptom' != "E" & 
`sign_symptom' != "" 
21. label var pneum_assess_`loop' "`sign_symptom'" 
22. local loop = `loop' + 1 
23. } 
24. } 
25. *Diarhoea/dehydration 
26. local loop = 1 
27. while `loop' < 9 { 
28. foreach sign_symptom of varlist diarrhoea vomits cap_refill avpu 
can_drink sunk_eyes skin_pinch pulse{ // recode if cold hands and 
restlessness/irritability known 
29. gen dnd_assess_`loop' = 0 
30. replace dnd_assess_`loop' = 1 if `sign_symptom' != "E" & `sign_symptom' 
!= "" 
31. label var dnd_assess_`loop' "`sign_symptom'" 
32. local loop = `loop' + 1 
33. } 
34. } 
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35. Assessment score type 1 
36. gen mal_assess_sum1 = 
mal_assess_1+mal_assess_2+mal_assess_3+mal_assess_4+mal_assess_5+mal_ass
ess_6+mal_assess_7+mal_assess_8 
37. gen pneum_assess_sum1 = 
pneum_assess_1+pneum_assess_2+pneum_assess_3+pneum_assess_4+pneum_assess
_5+pneum_assess_6+pneum_assess_7+pneum_assess_8 
38. gen dnd_assess_sum1 = 
dnd_assess_1+dnd_assess_2+dnd_assess_3+dnd_assess_4+dnd_assess_5+dnd_ass
ess_6+dnd_assess_7+dnd_assess_8 
39. Assessment score type 2 
40. *Malaria 
41. gen mal_assess_1_primary = fever != "E" & fever != "" 
42. label var mal_assess_1_primary "fever" 
43. replace dx1_malaria = "Non-severe" if strmatch(dx1_malaria, "*Non*sev*") 
44. replace dx1_malaria = "No classification" if strmatch(dx1_malaria, 
"*No*clas*") 
45. gen mal_assess_1_secondary = 
((mal_assess_2+mal_assess_3+mal_assess_5+mal_assess_6>0) | 
(mal_assess_4==1 & mal_assess_7==1) & dx1_malaria=="Severe") | 
((mal_assess_2+mal_assess_3+(mal_assess_5 | mal_assess_6)==3) | 
(mal_assess_4+mal_assess_7==2)) 
46. label var mal_assess_1_secondary "convulsion or acidosis or inability to 
drink or AVPU <A or pallor with resp. distress" 
47. gen mal_assess_1_complete = mal_assess_sum==8 
48. label var mal_assess_1_complete "complete assessment for malaria" 
49. *Pneumonia 
50. gen pneum_assess_1_primary = (cough != "E" & cough != "") | (diff_breath 
!= "E" & diff_breath != "") 
51. label var pneum_assess_1_primary "cough or difficult breathing" 
52. replace dx1_pneum = "Very severe" if strmatch(dx1_pneum, "*V. Sev*") 
53. replace dx1_pneum = "Non-severe" if strmatch(dx1_pneum, "*Non*sev*") 
54. replace dx1_pneum = "No classification" if strmatch(dx1_pneum, 
"*No*clas*") 
55. destring resp_rate, force replace 
56. gen pneum_assess_1_secondary = 
((pneum_assess_3+pneum_assess_4+pneum_assess_5+pneum_assess_6>0 & 
dx1_pneum=="Very severe") | (pneum_assess_3+(pneum_assess_4 | 
pneum_assess_5)+pneum_assess_6+pneum_assess_7==4 & dx1_pneum=="Severe") 
| (pneum_assess_3+(pneum_assess_4 | 
pneum_assess_5)+pneum_assess_6+pneum_assess_7==4 & resp_rate != . & 
(age_years != . | age_mths != . | age_days != .) & dx1_pneum=="Non-
severe")) 
57. label var pneum_assess_1_secondary "at least one of cyanosis, inability 
to drink, AVPU, grunting or acidotic breathing for very severe 
pneumonia, OR all of the above plus indrawing for severe pneumonia, OR 
all of the above cumulatively plus respiratory rate for non-severe 
pneumonia" 
58. gen pneum_assess_1_complete = pneum_assess_sum == 8 
59. label var pneum_assess_1_complete "complete assessment for pneumonia" 
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60. *Diarrhoea/dehydration 
61. gen dnd_assess_1_primary = dnd_assess_1 | dnd_assess_2 
62. label var dnd_assess_1_primary "diarrhoea or vomiting" 
63. replace dx1_dehydrat = "Shock" if dx1_other_1 == "Shock" | dx1_other_2 
== "Shock" 
64. replace dx1_dehydrat = "Severe" if dx1_dehydrat == "Sev" 
65. replace dx1_dehydrat = "No classification" if strmatch(dx1_dehydrat, 
"*No*clas*") 
66. gen dnd_assess_1_secondary = ((dnd_assess_3 | dnd_assess_4 | 
dnd_assess_5) & dnd_assess_8 & dx1_dehydrat == "Shock") | 
(dnd_assess_3+(dnd_assess_4 | 
dnd_assess_5)+dnd_assess_6+dnd_assess_7+dnd_assess_8==5 & (dx1_dehydrat 
== "Severe" | dx1_dehydrat == "Some" | dx1_dehydrat == "No 
classification")) 
67. label var dnd_assess_1_secondary "capillary refill or AVPU, plus weak 
pulse for shock OR these plus sunken eyes and skin pinch for all other 
categories" 
68. gen dnd_assess_1_complete = dnd_assess_sum == 8 
69. label var dnd_assess_1_complete "complete assessment for 
diarrhoea/dehydration" 
70. Diagnosis score 
71. *Malaria 
72. gen mal_diag_id_guide = fever == "Y" & mal1_order == "Y" 
73. gen mal_diag_id_clin = dx1_malaria == "No classification" | dx1_malaria 
== "Non-severe" | dx1_malaria == "Severe" 
74. gen mal_diag_id_corr = mal_diag_id_clin == 1 & mal_diag_id_guide == 1 
75. gen mal_diag_sev_guide = fever == "Y" & (convulsions == "Y" | 
acidotic__breathing == "Y" | (pallor == "+++" & indrawing == "Y") | 
can_drink == "N" | avpu == "V" | avpu == "P" | avpu == "U") 
76. gen mal_diag_sev_clin = dx1_malaria == "Severe" 
77. gen mal_diag_nonsev_guide = fever == "Y" & convulsions == "N" & 
acidotic__breathing == "N" & (pallor == "0" | pallor == "+") & 
(can_drink == "Y" | avpu == "A") 
78. gen mal_diag_nonsev_clin = (dx1_malaria == "Non-severe" | dx1_malaria == 
"Non-sev") 
79. gen mal_diag_noclass_clin = dx1_malaria == "No classif'n" 
80. gen mal_diag_class_corr = (mal_diag_sev_clin == 1 & mal_diag_sev_guide 
== 1) | (mal_diag_nonsev_clin == 1 & mal_diag_nonsev_guide == 1) 
81. gen mal_diag_any_class = mal_diag_sev_clin + mal_diag_nonsev_clin 
82. *Pneumonia 
83. gen pneum_diag_id_guide = cough == "Y" | diff_breath == "Y" 
84. gen pneum_diag_id_clin = dx1_pneum == "No classification" | dx1_pneum == 
"Non-severe" | dx1_pneum == "Severe" | dx1_pneum == "Very severe" 
85. gen pneum_diag_id_corr = pneum_diag_id_clin == 1 & pneum_diag_id_guide 
== 1 
86. gen pneum_diag_very_sev_guide = (cough == "Y" | diff_breath == "Y") & 
(c_cyanosis == "Y" | can_drink == "N" | avpu == "V" | avpu == "P" | avpu 
== "U" | grunting == "Y" | acidotic__breathing == "Y") 
87. gen pneum_diag_very_sev_clin = dx1_pneum == "Very severe" 
88. gen pneum_diag_sev_guide = (cough == "Y" | diff_breath == "Y") & 
c_cyanosis == "N" & can_drink == "Y" & avpu == "A" & grunting == "N" & 
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acidotic__breathing == "N" & indrawing == "Y" 
89. gen pneum_diag_sev_clin = dx1_pneum == "Severe" 
90. gen pneum_diag_nonsev_guide = (cough == "Y" | diff_breath == "Y") & 
c_cyanosis == "N" & can_drink == "Y" & avpu == "A" & grunting == "N" & 
acidotic__breathing == "N" & indrawing == "N" & ((age_years < 1 & 
age_mths > 1 & age_mths < 12 & resp_rate >= 50) | (age_years > 0 & 
resp_rate >= 40)) 
91. gen pneum_diag_nonsev_clin = dx1_pneum == "Non-severe" 
92. gen pneum_diag_noclass_clin = dx1_pneum == "No classification" 
93. gen pneum_diag_class_corr = (pneum_diag_very_sev_clin == 1 & 
pneum_diag_very_sev_guide == 1) | (pneum_diag_sev_clin == 1 & 
pneum_diag_sev_guide == 1) | (pneum_diag_nonsev_clin == 1 & 
pneum_diag_nonsev_guide == 1) 
94. gen pneum_diag_any_class = pneum_diag_very_sev_clin + 
pneum_diag_sev_clin + pneum_diag_nonsev_clin 
 
95. *Diarrhoea/dehydration 
96. gen dnd_diag_id_guide = diarrhoea == "Y" | vomits == "Y" 
97. gen dnd_diag_id_clin = dx1_diarrhoea == "Bloody" | dx1_diarrhoea == 
"bloody" | dx1_diarrhoea == "Non-bloody" | dx1_diarrhoea == "No 
classification" 
98. gen dnd_diag_id_corr = dnd_diag_id_clin == 1 & dnd_diag_id_guide == 1 
99. gen dnd_diag_shock_guide = pulse == "Weak" & (cap_refill == ">3" | avpu 
== "V" | avpu == "P" | avpu == "U") 
100. gen dnd_diag_shock_clin = dx1_dehydrat == "Shock" 
101. gen dnd_diag_sev_guide = (can_drink == "N" | avpu == "V" | avpu == "P" | 
avpu == "U") & sunk_eyes == "Y" & skin_pinch == "2" // recode if cold 
hands known 
102. gen dnd_diag_sev_clin = dx1_dehydrat == "Severe" 
103. gen dnd_diag_some_guide = can_drink == "Y" & sunk_eyes == "Y" & 
(skin_pinch == "1" | skin_pinch == "2") // recode if 
restlessness/irritability known 
104. gen dnd_diag_some_clin = dx1_dehydrat == "Some" 
105. gen dnd_diag_none_clin = dx1_dehydrat != "Shock" & dx1_dehydrat != 
"Severe" & dx1_dehydrat != "Some" 
106. gen dnd_diag_none_guide = pulse == "Normal" & (cap_refill == "<2" | 
cap_refill == "X") & (avpu == "A" | can_drink == "Y") & sunk_eyes == "N" 
& skin_pinch == "0" // recode if cold hands and 
restlessness/irritability known 
107. gen dnd_diag_class_corr = (dnd_diag_shock_clin == 1 & 
dnd_diag_shock_guide == 1) | (dnd_diag_sev_clin == 1 & 
dnd_diag_sev_guide == 1) | (dnd_diag_some_clin == 1 & 
dnd_diag_some_guide == 1) | (dnd_diag_none_clin == 1 & 
dnd_diag_none_guide == 1) 
108. gen dnd_diag_any_class = dnd_diag_shock_clin + dnd_diag_sev_clin + 
dnd_diag_some_clin 
109. Treatment score 
110. *Malaria 
111. gen mal_trt_sev_drug = quinl1_pres == "Y" | quinm1_pres == "Y" 
112. gen mal_trt_sev_route = (quinl1_route == "im" | quinl1_route == "iv") & 
(quinm1_route == "im" | quinm1_route == "iv") 
113. gen mal_trt_sev_dose = (quinl1_dose <= 20*i_weight & quinl1_dose >= 
20*i_weight & quinl1_unit == "mg") & (quinm1_dose <= 10*i_weight & 
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quinm1_dose >= 10*i_weight & quinm1_unit == "mg") 
114. gen mal_trt_sev_freq =  quinm1_freq == 2 
115. gen mal_trt_sev_dur = (quinl1_freq == "stat" | quinl1_freq == "STAT" | 
quinl1_freq == "1") & (quinm1_days != "E" | quinm1_days != "") 
116. gen mal_trt_nonsev_drug = (coart1_pres == "Y" | quinm1_pres == "Y") & 
quinl1_pres == "N" 
117. gen mal_trt_nonsev_route = coart1_route == "po" | quinm1_route == "po" 
118. gen mal_trt_nonsev_dose = (((coart1_dose == "1" & i_weight >= 5 & 
i_weight < 15) | (coart1_dose == "2" & i_weight >= 15 & i_weight < 25) | 
(coart1_dose == "3" & i_weight >= 25 & i_weight < 35) | (coart1_dose == 
"4" & i_weight >= 35)) & coart1_unit == "tabs") | (quinm1_dose <= 
10*i_weight & quinm1_dose >= 10*i_weight & quinm1_unit == "mg") 
119. gen mal_trt_nonsev_freq = coart1_freq == "2" | quinm1_freq == 3 
120. gen mal_trt_nonsev_dur = (coart1_days != "E" | coart1_days != "") | 
(quinm1_days != "E" | quinm1_days != "") 
121. replace mal_trt_sev_route = 1 if mal_trt_nonsev_drug & 
mal_trt_nonsev_route 
122. replace mal_trt_nonsev_route = 1 if mal_trt_sev_drug & mal_trt_sev_route 
123. replace mal_trt_sev_dose = 1 if mal_trt_nonsev_drug & 
mal_trt_nonsev_dose 
124. replace mal_trt_nonsev_dose = 1 if mal_trt_sev_drug & mal_trt_sev_dose 
125. replace mal_trt_sev_freq = 1 if mal_trt_nonsev_drug & 
mal_trt_nonsev_freq 
126. replace mal_trt_nonsev_freq = 1 if mal_trt_sev_drug & mal_trt_sev_freq 
127. replace mal_trt_sev_dur = 1 if mal_trt_nonsev_drug & mal_trt_nonsev_dur 
128. replace mal_trt_nonsev_dur = 1 if mal_trt_sev_drug & mal_trt_sev_dur 
129. gen mal_trt_drug = (mal_diag_sev_clin==1 & mal_trt_sev_drug==1) | 
(mal_diag_nonsev_clin==1 & mal_trt_nonsev_drug==1) 
130. gen mal_trt_route = (mal_diag_sev_clin==1 & mal_trt_sev_route==1) | 
(mal_diag_nonsev_clin==1 & mal_trt_nonsev_route==1) 
131. gen mal_trt_dose = (mal_diag_sev_clin==1 & mal_trt_sev_dose==1) | 
(mal_diag_nonsev_clin==1 & mal_trt_nonsev_dose==1) 
132. gen mal_trt_freq = (mal_diag_sev_clin==1 & mal_trt_sev_freq==1) | 
(mal_diag_nonsev_clin==1 & mal_trt_nonsev_freq==1) 
133. gen mal_trt_dur = (mal_diag_sev_clin==1 & mal_trt_sev_dur==1) | 
(mal_diag_nonsev_clin==1 & mal_trt_nonsev_dur==1) 
134. gen mal_trt_use = (mal_trt_sev_route==1 & mal_trt_sev_dose==1 & 
mal_trt_sev_freq==1 & mal_trt_sev_dur==1) | (mal_trt_nonsev_route==1 & 
mal_trt_nonsev_dose==1 & mal_trt_nonsev_freq==1 & mal_trt_nonsev_dur==1) 
135. treatment score type 1 (sum of appropriate drug(s), dose, route, 
frequency and duration for severity classification) 
136. gen mal_trt_sum1 = 0 
137. replace mal_trt_sum1 = mal_trt_sev_drug + mal_trt_sev_route + 
mal_trt_sev_dose + mal_trt_sev_freq + mal_trt_sev_dur if 
mal_diag_sev_clin == 1// severe 
138. replace mal_trt_sum1 = mal_trt_nonsev_drug + mal_trt_nonsev_route + 
mal_trt_nonsev_dose + mal_trt_nonsev_freq + mal_trt_nonsev_dur if 
mal_diag_nonsev_clin == 1 // non-severe 
139. treatment score type 2 (appropriate drug + correct use) 
140. gen mal_trt_sum2 = mal_trt_drug + mal_trt_use 
141. *Pneumonia 
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142. gen pneum_trt_very_sev_drug = (oxy_order == "Y" &  
strmatch(clinician_oxy, "*linician*1*")) & (pen_pres == "Y") & 
(gent1_pres == "Y") 
143. gen pneum_trt_very_sev_route = (pen1_route != "E" & pen1_route != "") & 
(gent1_route != "E" & gent1_route != "") 
144. gen pneum_trt_very_sev_dose = (pen1_dose <= 50000*i_weight*1.2 & 
pen1_dose >= 50000*i_weight*0.8 & pen1_unit == "iu") & (gent1_dose <= 
7.5*i_weight*1.2 & gent1_dose >= 7.5*i_weight*0.8 & gent1_unit == "mg") 
145. gen pneum_trt_very_sev_freq = (pen1_freq == 4) & (gent1_freq == 1) // & 
(oxy_prescr != "No detail" & oxy_prescr != "") 
146. gen pneum_trt_very_sev_dur = (pen1_days != "E" & pen1_days != "") & 
(gent1_days != "E" & gent1_days != "") 
147. gen pneum_trt_sev_drug = (pen_pres == "Y") & (gent1_pres != "Y") 
148. gen pneum_trt_sev_route = pen1_route != "E" & pen1_route != "" 
149. gen pneum_trt_sev_dose = pen1_dose <= 50000*i_weight*1.2 & pen1_dose >= 
50000*i_weight*0.8 & pen1_unit == "iu" 
150. gen pneum_trt_sev_freq = pen1_freq == 4 
151. gen pneum_trt_sev_dur = pen1_days != "E" & pen1_days != "" 
152. gen pneum_trt_nonsev_drug = amox1_pres == "Y" | sept1_pres == "Y" 
153. gen pneum_trt_nonsev_route = (amox1_pres == "Y" & amox1_route == "po") | 
(sept1_pres == "Y" & sept1_route == "po") 
154. gen pneum_trt_nonsev_dose = (amox1_pres == "Y" & ((amox1_dose <= 
25*i_weight*1.2 & amox1_dose >= 25*i_weight*0.8 & amox1_unit == "mg") | 
(((amox1_dose == 5 & i_weight < 7) | (amox1_dose == 7.5 & (i_weight >= 7 
& i_weight < 10)) | (amox1_dose == 10 & (i_weight >= 10 & i_weight < 
14)) | (amox1_dose == 15 & (i_weight >= 14 & i_weight < 19)) | 
(amox1_dose == 20 & (i_weight >= 19 & i_weight < 21))) & amox1_unit == 
"mls") | (((amox1_dose == 0.5 & i_weight < 9) | (amox1_dose == 1 & 
(i_weight >= 9 & i_weight < 14)) | (amox1_dose == 2 & (i_weight >= 14 & 
i_weight < 21))) & (amox1_unit == "tabs" | amox1_unit == "caps")))) | 
(sept1_pres == "Y" & ((sept1_dose <= 24*i_weight*1.2 & sept1_dose >= 
24*i_weight*0.8 & sept1_unit == "mg") | (((sept1_dose == 2.5 & (i_weight 
>= 2 & i_weight < 4)) | (sept1_dose == 5 & (i_weight >= 4 & i_weight < 
11)) | (sept1_dose == 7.5 & (i_weight >= 11 & i_weight < 16)) | 
(sept1_dose == 10 & (i_weight >= 16 & i_weight < 21))) & sept1_unit == 
"mls") | (((sept1_dose == 0.25 & (i_weight >= 2 & i_weight < 4)) | 
(sept1_dose == 0.5 & (i_weight >= 4 & i_weight < 16)) | (sept1_dose == 1 
& (i_weight >= 16 & i_weight < 21))) & (sept1_unit == "tabs" | 
sept1_unit == "caps")))) 
155. gen pneum_trt_nonsev_freq = (amox1_pres == "Y" & amox1_freq == 3) | 
(sept1_pres == "Y" & sept1_freq == 2) // recheck this 
156. gen pneum_trt_nonsev_dur = (amox1_pres == "Y" & amox1_days != "E" & 
amox1_days != "") | (sept1_pres == "Y" & sept1_days != "E" & sept1_days 
!= "") 
157. replace pneum_trt_very_sev_route = 1 if (pneum_trt_sev_drug & 
pneum_trt_sev_route) | (pneum_trt_nonsev_drug & pneum_trt_nonsev_route) 
158. replace pneum_trt_sev_route = 1 if (pneum_trt_very_sev_drug & 
pneum_trt_very_sev_route) | (pneum_trt_nonsev_drug & 
pneum_trt_nonsev_route) 
159. replace pneum_trt_nonsev_route = 1 if (pneum_trt_very_sev_drug & 
pneum_trt_very_sev_route) | (pneum_trt_sev_drug & pneum_trt_sev_route) 
160. replace pneum_trt_very_sev_dose = 1 if (pneum_trt_sev_drug & 
pneum_trt_sev_route) | (pneum_trt_nonsev_drug & pneum_trt_nonsev_dose) 
161. replace pneum_trt_sev_dose = 1 if (pneum_trt_very_sev_drug & 
pneum_trt_very_sev_route) | (pneum_trt_nonsev_drug & 
pneum_trt_nonsev_dose) 
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162. replace pneum_trt_nonsev_dose = 1 if (pneum_trt_very_sev_drug & 
pneum_trt_very_sev_route) | (pneum_trt_sev_drug & pneum_trt_sev_dose) 
163. replace pneum_trt_very_sev_freq = 1 if (pneum_trt_sev_drug & 
pneum_trt_sev_route) | (pneum_trt_nonsev_drug & pneum_trt_nonsev_freq) 
164. replace pneum_trt_sev_freq = 1 if (pneum_trt_very_sev_drug & 
pneum_trt_very_sev_route) | (pneum_trt_nonsev_drug & 
pneum_trt_nonsev_freq) 
165. replace pneum_trt_nonsev_freq = 1 if (pneum_trt_very_sev_drug & 
pneum_trt_very_sev_route) | (pneum_trt_sev_drug & pneum_trt_sev_freq) 
166. replace pneum_trt_very_sev_dur = 1 if (pneum_trt_sev_drug & 
pneum_trt_sev_route) | (pneum_trt_nonsev_drug & pneum_trt_nonsev_dur) 
167. replace pneum_trt_sev_dur = 1 if (pneum_trt_very_sev_drug & 
pneum_trt_very_sev_route) | (pneum_trt_nonsev_drug & 
pneum_trt_nonsev_dur) 
168. replace pneum_trt_nonsev_dur = 1 if (pneum_trt_very_sev_drug & 
pneum_trt_very_sev_route) | (pneum_trt_sev_drug & pneum_trt_sev_dur) 
169. gen pneum_trt_drug = (pneum_diag_very_sev_clin==1 & 
pneum_trt_very_sev_drug==1) | (pneum_diag_sev_clin==1 & 
pneum_trt_sev_drug==1) | (pneum_diag_nonsev_clin==1 & 
pneum_trt_nonsev_drug==1) 
170. gen pneum_trt_route = (pneum_diag_very_sev_clin==1 & 
pneum_trt_very_sev_route==1) | (pneum_diag_sev_clin==1 & 
pneum_trt_sev_route==1) | (pneum_diag_nonsev_clin==1 & 
pneum_trt_nonsev_route==1) 
171. gen pneum_trt_dose = (pneum_diag_very_sev_clin==1 & 
pneum_trt_very_sev_dose==1) | (pneum_diag_sev_clin==1 & 
pneum_trt_sev_dose==1) | (pneum_diag_nonsev_clin==1 & 
pneum_trt_nonsev_dose==1) 
172. gen pneum_trt_freq = (pneum_diag_very_sev_clin==1 & 
pneum_trt_very_sev_freq==1) | (pneum_diag_sev_clin==1 & 
pneum_trt_sev_freq==1) | (pneum_diag_nonsev_clin==1 & 
pneum_trt_nonsev_freq==1) 
173. gen pneum_trt_dur = (pneum_diag_very_sev_clin==1 & 
pneum_trt_very_sev_dur==1) | (pneum_diag_sev_clin==1 & 
pneum_trt_sev_dur==1) | (pneum_diag_nonsev_clin==1 & 
pneum_trt_nonsev_dur==1) 
174. gen pneum_trt_use = (pneum_trt_very_sev_route==1 & 
pneum_trt_very_sev_dose==1 & pneum_trt_very_sev_freq==1 & 
pneum_trt_very_sev_dur==1) | (pneum_trt_sev_route==1 & 
pneum_trt_sev_dose==1 & pneum_trt_sev_freq==1 & pneum_trt_sev_dur==1) | 
(pneum_trt_nonsev_route==1 & pneum_trt_nonsev_dose==1 & 
pneum_trt_nonsev_freq==1 & pneum_trt_nonsev_dur==1) 
175. treatment score type 1 (sum of appropriate drug(s), dose, route, 
frequency and duration for severity classification) 
176. gen pneum_trt_sum1 = 0 
177. replace pneum_trt_sum1 = pneum_trt_very_sev_drug + 
pneum_trt_very_sev_route + pneum_trt_very_sev_dose + 
pneum_trt_very_sev_freq + pneum_trt_very_sev_dur if 
pneum_diag_very_sev_clin == 1 
178. replace pneum_trt_sum1 = pneum_trt_sev_drug + pneum_trt_sev_route + 
pneum_trt_sev_dose + pneum_trt_sev_freq + pneum_trt_sev_dur if 
pneum_diag_sev_clin == 1  
179. replace pneum_trt_sum1 = pneum_trt_nonsev_drug + pneum_trt_nonsev_route 
+ pneum_trt_nonsev_dose + pneum_trt_nonsev_freq + pneum_trt_nonsev_dur 
if pneum_diag_nonsev_clin == 1 
180. treatment score type 2 (appropriate drug + correct use) 
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181. gen pneum_trt_sum2 = pneum_trt_drug + pneum_trt_use 
182. *Diarrhoea/dehydration 
183. gen dnd_trt_shock_drug = fluid_pres1 == "nsal" | fluid_pres1 == "hs 
darr" 
184. gen dnd_trt_shock_dose = (total_vol1/(fluid_time1*4)) <= 20*i_weight*1.2 
& (total_vol1/(fluid_time1*4)) >= 20*i_weight*0.8 
185. gen dnd_trt_shock_freq = fluid_time1/4 >= 1 
186. gen dnd_trt_sev_drug = fluid_pres1 == "ring" | fluid_pres2 == "ORS" 
187. gen dnd_trt_sev_dose = (((total_vol1/fluid_time1) <= (((30*i_weight*1.2) 
+ (70*i_weight*1.2))/3) & (total_vol1/fluid_time1) >= 
(((30*i_weight*0.8) + (70*i_weight*0.8))/3)) & age_years !=.) | 
(((total_vol1/fluid_time1) <= (((30*i_weight*1.2) + 
(70*i_weight*1.2))/6) & (total_vol1/fluid_time1) >= (((30*i_weight*0.8) 
+ (70*i_weight*0.8))/6)) & age_years ==.) | (total_vol2/fluid_time2 <= 
(100*i_weight*1.2/6) & total_vol2/fluid_time2 >= (100*i_weight*0.8/6)) 
188. gen dnd_trt_sev_freq = step1_2 == "Y" 
189. replace fluid_pres2 = "hs darr" if fluid_pres2 == "HS Darr" | 
fluid_pres2 == "HSD" 
190. replace fluid_pres2 = "resomal" if fluid_pres2 == "RESOMAL" 
191. replace fluid_pres2 = "nsal" if fluid_pres2 == "Nsal" 
192. gen dnd_trt_some_drug = fluid_pres2 == "ORS" 
193. gen dnd_trt_some_dose = (total_vol2/fluid_time2 <= (75*i_weight*1.2/4) & 
total_vol2/fluid_time2 >= (75*i_weight*0.8/4)) 
194. gen dnd_trt_some_freq = fluid_time2/24 >= 1 
195. gen dnd_trt_none_drug = fluid_pres2 == "ORS" 
196. gen dnd_trt_none_dose = vol_stool <= 10*i_weight*1.2 & vol_stool >= 
10*i_weight*0.8 
197. gen dnd_trt_none_freq = vol_stool !=. 
198. replace dnd_trt_shock_dose = 1 if (dnd_trt_sev_drug & dnd_trt_sev_dose) 
| (dnd_trt_some_drug & dnd_trt_some_dose) | (dnd_trt_none_drug & 
dnd_trt_none_dose) 
199. replace dnd_trt_sev_dose = 1 if (dnd_trt_shock_drug & 
dnd_trt_shock_dose) | (dnd_trt_some_drug & dnd_trt_some_dose) | 
(dnd_trt_none_drug & dnd_trt_none_dose) 
200. replace dnd_trt_some_dose = 1 if (dnd_trt_shock_drug & 
dnd_trt_shock_dose) | (dnd_trt_sev_drug & dnd_trt_sev_dose) | 
(dnd_trt_none_drug & dnd_trt_none_dose) 
201. replace dnd_trt_none_dose = 1 if (dnd_trt_shock_drug & 
dnd_trt_shock_dose)| (dnd_trt_sev_drug & dnd_trt_sev_dose) | 
(dnd_trt_some_drug & dnd_trt_some_dose) 
202. replace dnd_trt_shock_freq = 1 if (dnd_trt_sev_drug & dnd_trt_sev_freq) 
| (dnd_trt_some_drug & dnd_trt_some_freq) | (dnd_trt_none_drug & 
dnd_trt_none_freq) 
203. replace dnd_trt_sev_freq = 1 if (dnd_trt_shock_drug & 
dnd_trt_shock_freq) | (dnd_trt_some_drug & dnd_trt_some_freq) | 
(dnd_trt_none_drug & dnd_trt_none_freq) 
204. replace dnd_trt_some_freq = 1 if (dnd_trt_shock_drug & 
dnd_trt_shock_freq) | (dnd_trt_sev_drug & dnd_trt_sev_freq) | 
(dnd_trt_none_drug & dnd_trt_none_freq) 
205. replace dnd_trt_none_freq = 1 if (dnd_trt_shock_drug & 
dnd_trt_shock_freq)| (dnd_trt_sev_drug & dnd_trt_sev_freq) | 
(dnd_trt_some_drug & dnd_trt_some_freq) 
206. gen dnd_trt_drug = (dnd_diag_shock_clin==1 & dnd_trt_shock_drug==1) | 
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(dnd_diag_sev_clin==1 & dnd_trt_sev_drug==1) | (dnd_diag_some_clin==1 & 
dnd_trt_some_drug==1) | (dnd_diag_none_clin==1 & dnd_trt_none_drug==1) 
207. gen dnd_trt_dose = (dnd_diag_shock_clin==1 & dnd_trt_shock_dose==1) | 
(dnd_diag_sev_clin==1 & dnd_trt_sev_dose==1) | (dnd_diag_some_clin==1 & 
dnd_trt_some_dose==1) | (dnd_diag_none_clin==1 & dnd_trt_none_dose==1) 
208. gen dnd_trt_freq = (dnd_diag_shock_clin==1 & dnd_trt_shock_freq==1) | 
(dnd_diag_sev_clin==1 & dnd_trt_sev_freq==1) | (dnd_diag_some_clin==1 & 
dnd_trt_some_freq==1) | (dnd_diag_none_clin==1 & dnd_trt_none_freq==1) 
209. gen dnd_trt_use = (dnd_trt_shock_dose==1 & dnd_trt_shock_freq==1) | 
(dnd_trt_sev_dose==1 & dnd_trt_sev_freq==1) | (dnd_trt_some_dose==1 & 
dnd_trt_some_freq==1) | (dnd_trt_none_dose==1 & dnd_trt_none_freq==1) 
210. *replace dnd_trt_none_dur = 1 if  
211. treatment score type 1 (sum of appropriate drug(s), dose, route, 
frequency and duration for severity classification) 
212. gen dnd_trt_sum1 = 0 
213. replace dnd_trt_sum1 = dnd_trt_shock_drug + dnd_trt_shock_dose + 
dnd_trt_shock_freq if dnd_diag_shock_clin == 1 
214. replace dnd_trt_sum1 = dnd_trt_sev_drug + dnd_trt_sev_dose + 
dnd_trt_sev_freq if dnd_diag_sev_clin == 1  
215. replace dnd_trt_sum1 = dnd_trt_some_drug + dnd_trt_some_dose + 
dnd_trt_some_freq if dnd_diag_some_clin == 1 
216. replace dnd_trt_sum1 = dnd_trt_none_drug + dnd_trt_none_dose + 
dnd_trt_none_freq if dnd_diag_none_clin == 1 
217. treatment score type 2 (appropriate drug + correct use) 
218. gen dnd_trt_sum2 = dnd_trt_drug + dnd_trt_use 
219. foreach score_part in assess_1_primary assess_1_secondary 
assess_1_complete diag_any_class diag_class_corr trt_drug trt_use { 
220. gen mpd1_`score_part' = 0 
221. replace mpd1_`score_part' = mal_`score_part' if mal_diag_id_clin == 1 & 
pneum_diag_id_clin == 0 & dnd_diag_id_clin == 0 
222. replace mpd1_`score_part' = pneum_`score_part' if mal_diag_id_clin == 0 
& pneum_diag_id_clin == 1 & dnd_diag_id_clin == 0 
223. replace mpd1_`score_part' = dnd_`score_part' if mal_diag_id_clin == 0 & 
pneum_diag_id_clin == 0 & dnd_diag_id_clin == 1 
224. replace mpd1_`score_part' = (mal_`score_part' + pneum_`score_part')/2 if 
mal_diag_id_clin == 1 & pneum_diag_id_clin == 1 & dnd_diag_id_clin == 0 
225. replace mpd1_`score_part' = (pneum_`score_part' + dnd_`score_part')/2 if 
mal_diag_id_clin == 0 & pneum_diag_id_clin == 1 & dnd_diag_id_clin == 1 
226. replace mpd1_`score_part' = (mal_`score_part' + dnd_`score_part')/2 if 
mal_diag_id_clin == 1 & pneum_diag_id_clin == 0 & dnd_diag_id_clin == 1 
227. replace mpd1_`score_part' = (mal_`score_part' + pneum_`score_part' + 
dnd_`score_part')/3 if mal_diag_id_clin == 1 & pneum_diag_id_clin == 1 & 
dnd_diag_id_clin == 1 
228. } 
229. *mpd - combined scores types 1 and 2 
230. foreach score_part in assess_1_primary assess_1_secondary 
assess_1_complete diag_any_class diag_class_corr trt_drug trt_use { 
231. gen mpd2_`score_part' = (mal_`score_part' == 1 & mal_diag_id_clin == 1 & 
pneum_diag_id_clin == 0 & dnd_diag_id_clin == 0) | (pneum_`score_part' 
== 1 & mal_diag_id_clin == 0 & pneum_diag_id_clin == 1 & 
dnd_diag_id_clin == 0) | (dnd_`score_part' == 1 & mal_diag_id_clin == 0 
& pneum_diag_id_clin == 0 & dnd_diag_id_clin == 1) | (mal_`score_part' 
== 1 & pneum_`score_part' == 1 & mal_diag_id_clin == 1 & 
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pneum_diag_id_clin == 1 & dnd_diag_id_clin == 0) | (pneum_`score_part' 
== 1 & dnd_`score_part' == 1 & pneum_diag_id_clin == 1 & 
dnd_diag_id_clin == 1 & mal_diag_id_clin == 0) | (mal_`score_part' == 1 
& dnd_`score_part' == 1 & mal_diag_id_clin == 1 & dnd_diag_id_clin == 1 
& pneum_diag_id_clin == 0) | (mal_`score_part' == 1 & pneum_`score_part' 
== 1 & dnd_`score_part' == 1 & mal_diag_id_clin == 1 & 
pneum_diag_id_clin == 1 & dnd_diag_id_clin == 1) 
232. } 
233. gen disease_count = mal_diag_id_clin + pneum_diag_id_clin + 
dnd_diag_id_clin 
234. foreach mpd_score in 1 2 { 
235. gen mpd`mpd_score'_diag_id_clin = disease_count > 0 
236. gen mpd`mpd_score'_trt_sum2 = mpd`mpd_score'_trt_drug + 
mpd`mpd_score'_trt_use 
237. } 
238. foreach disease in mal pneum dnd mpd1 mpd2 { 
239. gen `disease'_assess_sum2 = `disease'_assess_1_primary + 
`disease'_assess_1_secondary + `disease'_assess_1_complete 
240. gen `disease'_assess_sum3 = `disease'_assess_1_primary + 
`disease'_assess_1_secondary 
241. if "`disease'" != "mpd1" & "`disease'" != "mpd2" { 
242. gen `disease'_sum1 = `disease'_assess_sum1 + `disease'_diag_any_class + 
`disease'_trt_sum1 
243. } 
244. gen `disease'_sum2 = `disease'_assess_sum2 + `disease'_diag_any_class + 
`disease'_trt_sum2 
245. gen `disease'_sum3 = `disease'_assess_sum3 + `disease'_diag_any_class + 
`disease'_trt_sum2 
246. gen `disease'_sum4 = `disease'_assess_sum3 + `disease'_diag_any_class + 
`disease'_diag_class_corr + `disease'_trt_sum2 
247. } 
 
Estimating clinician- and hospital level agreement between the basic and modified scores 
1. foreach disease in mal pneum dnd { 
2. use datasets/scores_dhs, clear 
3. cap drop hospital 
4. encode clinician1, gen(clinician) 
5. encode hosp_id, gen(hospital) 
6. bootstrap "do bootstrap_rho.do `disease'" ((hosp_var_null[1,1] - 
hosp_var_alt[1,1]) / hosp_var_null[1,1]), reps(100) 
saving(bootstrap_rho_hosp_`disease') replace 
7. bootstrap "do bootstrap_rho.do `disease'" ((clin_var_null[1,1] - 
clin_var_alt[1,1]) / clin_var_null[1,1]), reps(100) 
saving(bootstrap_rho_clin_`disease') replace 
8. } 
9. foreach disease in mal pneum dnd { 
10. use datasets/scores_dhs, clear 
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11. cap drop hospital 
12. keep if `disease'_diag_id_clin == 1 & survey_no < 5 
13. encode hosp_id, gen(hospital) 
14. encode clinician1, gen(clinician) 
15. bootstrap "do bootstrap_pred_prob.do `disease'" (r(mean)), 
reps(100) saving(bootstrap_pred_prob_`disease') replace 
16. } 
17. foreach disease in mal pneum dnd { 
18. use datasets/scores_dhs, clear 
19. keep if `disease'_diag_id_clin == 1 & survey_no < 5 
20. bootstrap "do bootstrap_pred_prob_gologit.do `disease'" (1 - 
(ss_error[1,1]/ss_total[1,1])), reps(100) 
saving(bootstrap_pred_prob_gologit_`disease') replace 
21. } 
22. foreach disease in mal pneum dnd { 
23. use datasets/scores_dhs, clear 
24. cap drop hospital 
25. encode clinician1, gen(clinician) 
26. encode hosp_id, gen(hospital) 
27. bootstrap "do bootstrap_rho_gllamm.do `disease'" 
((var_null_g[2,2]^2 - var_alt_g[2,2]^2) / var_null_g[2,2]^2), 
reps(10) saving(bootstrap_rho_gllamm_hosp_`disease') replace 
28. bootstrap "do bootstrap_rho_gllamm.do `disease'" 
((var_null_g[1,1]^2 - var_alt_g[1,1]^2) / var_null_g[1,1]^2), 
reps(10) saving(bootstrap_rho_gllamm_clin_`disease') replace 
29. } 
30. (bootstrap_pred_prob_gologit.do) 
31. foreach var in s_pred agree2 sq_err sq_tot { 
32. cap drop `var' 
33. gen `var' = . 
34. } 
35. foreach var in s0 s1 s2 s3 s4 s5 s6 s_max { 
36. cap drop `var' 
37. } 
38. qui gologit2 `1'_sum2 `1'_sum1 
39. predict s0 s1 s2 s3 s4 s5 s6 
40. egen s_max = rowmax(s0-s6) 
41. local loop = 0 
42. while `loop' < 7 { 
43. foreach s_prob of varlist s0 - s6 { 
44. replace s_pred = `loop' if `s_prob' == s_max 
45. local loop = `loop' + 1 
46. } 
47. } 
48. replace agree2 = (`1'_sum2 == s_pred) 
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49. replace sq_err = (s_pred - `1'_sum2)^2 
50. qui mean `1'_sum2 
51. matrix means = e(b) 
52. replace sq_tot = (`1'_sum2 - (means[1,1]))^2 
53. qui tabstat sq_tot, stats(sum) save 
54. qui matrix ss_total = r(StatTotal) 
55. qui tabstat sq_err, stats(sum) save 
56. qui matrix ss_error = r(StatTotal) 
 
bootstrap_pred_prob.do for stimating clinician- and hospital level agreement between the 
basic and modified scores 
1. foreach var in `1'_sum2_pred `1'_sum2_pred_round agree1 { 
2. cap drop `var' 
3. gen `var' = . 
4. } 
5. cap drop u 
6. gen u = runiform() 
7. qui xtmixed `1'_sum2 `1'_sum1 if u > 0.5 || hospital: || clinician:  
8. matrix coefficients = e(b) 
9. replace `1'_sum2_pred = ((coefficients[1,1]) * `1'_sum1) + 
(coefficients[1,2]) if u < = 0.5 
10. replace `1'_sum2_pred_round = round(`1'_sum2_pred, 1) 
11. replace agree1 = (`1'_sum2 == `1'_sum2_pred_round) 
12. replace agree1 = . if u > 0.5 
13. summ agree1 
 
bootstrap_rho.do for stimating clinician- and hospital level agreement between the basic and 
modified scores 
1. qui xtmixed `1'_sum1 || hospital: || clinician: if `1'_diag_id_clin == 
1 & survey_no < 5, var 
2. estat recovariance, level(hospital) 
3. matrix hosp_var_null = r(cov) 
4. estat recovariance, level(clinician) 
5. matrix clin_var_null = r(cov) 
6. qui xtmixed `1'_sum1 `1'_sum2 || hospital: || clinician: if 
`1'_diag_id_clin == 1 & survey_no < 5, var 
7. estat recovariance, level(hospital) 
8. matrix hosp_var_alt = r(cov) 
9. estat recovariance, level(clinician) 
10. matrix clin_var_alt = r(cov) 
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bootstrap_rho_gllamm.do for stimating clinician- and hospital level agreement between the 
basic and modified scores 
1. gllamm `1'_sum1 if `1'_diag_id_clin == 1 & survey_no < 5, i(clinician 
hospital) family(binomial) link(ologit) adapt 
2. matrix var_null_g = e(chol) 
3. gllamm `1'_sum1 `1'_sum2 if `1'_diag_id_clin == 1 & survey_no < 5, 
i(clinician hospital) family(binomial) link(ologit) adapt 
4. matrix var_alt_g = e(chol) 
 
Structural equation modelling with Mplus™ (input and output piped through Stata™) 
1. foreach disease in mal pneum dnd mpd2 { 
2. tempname cfa_mod2_`disease'_inp 
3. file open `cfa_mod2_`disease'_inp' using 
"cfa_mod2_`disease'.inp", write replace 
4. #delimit ; 
5. foreach line in 
5. "TITLE:" 
6. "Factor Analysis with Categorical Outcome 
Variables;" 
7. "DATA:" 
8. "FILE IS cfa_mod_`disease'.raw;" 
9. "VARIABLE:" 
10. "NAMES ARE id hosp a_1 a_2 d_1 t_1 t_2 group 
survey;" 
11. "USEVARIABLES ARE a_1 d_1 t_1 t_2 group survey;" 
12. "IDVARIABLE IS id;" 
13. "AUXILIARY = hosp;" 
14. "CATEGORICAL ARE a_1 d_1 t_1 t_2;" 
15. "ANALYSIS:" 
16. "MODEL:" 
17. "assess BY a_1 d_1;" 
18. "treat BY t_1 t_2;" 
19. "assess ON group survey;" 
20. "treat ON group survey;" 
21. "assess WITH treat;" 
22. "OUTPUT:" "standardized modindices tech1;" 
23. "SAVEDATA:" 
24. "file is cfa_mod2_`disease'_scores.dat;" 
25. "save = fscores;" 
26. { 
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27. ; 
28. #delimit cr 
29. file write `cfa_mod2_`disease'_inp' "`line'" _n 
30. } 
31. file close `cfa_mod2_`disease'_inp' 
32. shell wine mplus.exe cfa_mod2_`disease'.inp 
33. type cfa_mod2_`disease'.out 
34. } 
 
Generating funnel plots for comparing hospitals  
1. foreach distribution in 1 2 { 
2. preserve 
3. keep if `disease'_diag_id_clin == 1 & disease_count > 0 & 
hospital > 0 
4. if `distribution' == 1 { // normal distribution 
5. collapse (mean) mean_score=`disease'_sum2 (semean) 
semean_score=`disease'_sum2 (count) n_score=`disease'_sum2, 
by (hospital survey_no group) 
6. gen sd_score = semean_score * sqrt(n_score) 
7. } 
8. if `distribution' == 2 { // Poisson-binomial distribution 
9. collapse (mean) p1=`disease'_assess_1_primary 
p2=`disease'_assess_1_secondary 
p3=`disease'_assess_1_complete p4=`disease'_diag_any_class 
p5=`disease'_trt_drug p6=`disease'_trt_use (count) 
n_score=`disease'_sum2, by (hospital survey_no group) 
10. gen mean_score = p1 + p2 + p3 + p4 + p5 + p6 
11. gen sd_score = sqrt((p1*(1-p1))+(p2*(1-p2))+(p3*(1-
p3))+(p4*(1-p4))+(p5*(1-p5))+(p6*(1-p6))) 
12. } 
13. cap funnelcompar mean_score n_score hospital sd_score, contours(5 
0.2) continuous markall vertical legend(off) ytitle("Precision 
(n)") xtitle("Mean score") 
14. restore   
15. } 
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